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SUMMARY
Aim: To independently evaluate the NHS Modernisation Agency’s “Modernising Endoscopy 
Services” (MES) project using routinely collected, service-related endoscopy data.
Methods: A random selection of 10 sites who had participated in the MES project (called MES 
sites) were compared to a random selection of 10 sites who were unsuccessful applicants for the 
MES project but had indicated their intention to redesign independently (called Non-MES sites). 
Data on Referral numbers, Number of patients waiting, Number of lost appointment slots and 
Activity were collected from all 20 sites for eight specific time periods ranging from January 2003 to 
April 2006 to evaluate the endoscopy services of MES and Non-MES sites and to compare both site 
types at specific points in time using various statistical tests. Activity data were validated where 
appropriate using an equivalent HES dataset. Details of innovations introduced were collected to 
explore possible trends.
Results: Data were not routinely collected by endoscopy units. NHS Trust datasets were 
subsequently included to ensure a full dataset for analysis. The accuracy of the Activity data was 
successfully validated. There were relatively few statistically significant results to report. 
Consequently, this study found that the MES project did not significantly improve the endoscopy 
services of the MES sites over time. It also found that there was no significant difference between 
the MES sites and the Non-MES sites in the improvement of their endoscopy services over time 
and that the Non-MES sites appeared to implement changes that led to improvements to their 
services, although they were not statistically significant.
Conclusions: Data was not routinely collected by most NHS endoscopy units participating in this 
study. Based on the data analysed, the MES project did not appear to have significantly improved 
NHS endoscopy services over and above what could have been achieved independently with only 
the intention to redesign.
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PREFACE
The work submitted within this thesis was undertaken within the remit of the “EvaluatiNg 
Innovations in Gastroenterology by the NHS Modernisation Agency” (ENIGMA) study (SDO 
46/2003) based at the Centre for Health Information, Research and Evaluation (CHIRAL) in the 
School of Medicine at Swansea University. The author and the work contained in this thesis were 
entirely funded by the ENIGMA study.
The work in this thesis was done in isolation from the main ENIGMA study. The author was solely 
responsible for the design, implementation, analysis and writing up of this research and there was 
no external input from any member of the ENIGMA study. The author was asked to contribute two 
chapters to the final report of the ENIGMA study based on the work in this thesis.
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1. INTRODUCTION
The National Health Service (NHS) is currently Britain’s biggest single employer with over 1.3 
million staff (The Information Centre, 2006), each with immensely varied skills and responsibilities 
encompassing a wide variety of medical, administrative and managerial disciplines in primary, 
secondary and tertiary healthcare. The highly complex networks that exist within the NHS are all 
interconnected and co-dependent. Few organisations in the world today provide so many different 
services on demand, free at the point of entry (NHS Modernisation Agency, 2003a).
Unfortunately, over time the NHS became a victim of the ever-increasing demands for free 
healthcare from a population that is not only growing exponentially, but that has an increasing 
proportion of elderly people within it -  the Office of National Statistics (ONS) has predicted that 
men aged 65 years will live a further 16.9 years and women aged 65 years, a further 19.7 years 
(Office of National Statistics, 2008) and Help The Aged recently reported that the proportion of 
people in the UK population aged 85 years and over in February 2008 was almost one and a 
quarter million, and this was projected to double within 20 years (Help the Aged, 2008). This, 
coupled with the increasing number of people of all ages with chronic illnesses, has placed an 
escalating financial burden on NHS resources that has been further exacerbated by the expansion 
of technological possibilities and scientific knowledge offering better, but more expensive 
diagnoses and treatments for patients. This forced the NHS to push its financial boundaries to 
breaking point just to maintain the most basic services on a nationwide level and has led to many 
patients effectively paying twice for access to good health services, once via their taxes and a 
second time for private healthcare as they elect to hasten their treatment at an additional cost.
Patients have become far more knowledgeable about their health, their rights and the treatments 
available and now expect free care from the NHS to encompass access to expensive procedures 
whilst also receiving an efficient service to treat their conditions quickly. These factors, along with 
the rising costs of healthcare, an increasingly elderly population and an increase in the prevalence 
of chronic diseases, have meant that the NHS long ago reached the point where it could no longer 
function efficiently using its limited resources and traditional working practices, some of which date 
back to its inaugural years.
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The original, founding principles of the NHS may have been appropriate at one time but today they 
reduce its adaptive capacity (Plamping, 1998). The system was originally designed to deal with 
acute illness and cannot adequately cope with the demands from today’s society. The increased 
burden on NHS services is already evident in the field of diagnostics. Between 1996/7 and 2003/4, 
the number of diagnostic scans increased by almost four million (14%), with an increase of 47% in 
the proportion of CT (Computerised Tomography) scans (Lewis and Appleby, 2006).
Many policies have been introduced over the years by governments to improve public confidence 
in the NHS but the same problems still persist 60 years on regarding how best to organise and 
manage it, how to fund it adequately, how to balance the conflicting demands and expectations of 
patients, staff and taxpayers, and how to ensure finite resources were targeted where they were 
most needed. Previous attempts at NHS reform have most commonly been politically-led and 
designed to ensure greater value for money (Feriie, 1997). Improvement has always been difficult 
because the NHS provides a vast range of services at no cost, it creates its own demand via 
referrals from its own primary and secondary care staff and it was enormously difficult to measure 
its output and productivity. Another preventative factor was the national variability of the provision 
of healthcare services. There were no clear instructions on best practice and guidelines (where 
available) were open to interpretation to suit local needs, so hospitals were left to develop their own 
ways of working in order to meet variable local demand and key government targets with minimal 
budgets (Klein, 2001).
Prior to 1997, the NHS lacked sufficient investment, national standards and incentives to improve 
its performance. It had old-fashioned demarcations between staff, barriers between services, was 
over-centralised and disempowered its patients. Reform fatigue had become a feature of 
healthcare systems and many changes had either, at best, not realised their full potential or at 
worst, simply failed, termed “dynamics without change” (Hunter, 2004). Many smaller reforms 
became absorbed into a system that was enormously resistant to change.
Following their election victory in 1997, the New Labour government responded to the demands of 
the population for improved access to NHS services to overcome its inertia and win back public 
confidence. Improvement initiatives gained momentum but unfortunately, a successful 
improvement culture could not be created overnight. It would require lots of hard work and 
commitment from dedicated staff going through the laborious process of analysing systems and
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implementing better ways of working. There was also the additional pressure of searching for a 
financial “breakeven” during the redesign process (Black, 2002) to lower the amount of investment 
required and to aid sustainability.
The NHS Plan initiated unprecedented levels of investment accompanied by a stipulation that new 
resources were not to be used to provide more of the same, or else they would not succeed in truly 
transforming the NHS (Department of Health, 2000c). The challenge was to use the investment 
provided and the resources already available to achieve real benefits for patients by modernising 
NHS services using radical redesign strategies. This would prove difficult due to the complex 
nature of the NHS organisation. Past reforms had assumed that change would occur in a linear or 
planned manner but NHS staff would need to abandon linear models, accept its unpredictable 
nature and become flexible, creative and autonomous in their responses to overcoming problems 
(Plsek and Greenhalgh, 2001), meaning that change(s) could be as much unplanned as planned 
(Feriie, 1997).
The NHS Cancer Plan pledged to reduce death rates from cancer by improving the referral route 
from their General Practitioner (GP) to NHS diagnostic services, by shortening the time taken from 
diagnosis to treatment and through population screening to increase the cancer diagnosis rate, 
especially for those at an earlier stage of cancer who would be more responsive to treatment 
(Department of Health, 2000b). These improvements were funded with an additional £570 million 
per annum and invoked the implementation of a major redesign programme for NHS diagnostic 
services for the diagnosis and treatment of patients with cancer.
The,NHS Modernisation Agency (NHSMA) was established in 2001 in accordance with the NHS 
Plan (Department of Health, 2000c) to introduce a unique approach to the implementation of 
redesign initiatives in NHS diagnostic services. It promoted closer relationships between NHS staff 
and the NHSMA specialist redesign teams to promote innovative thinking, to understand redesign 
theory and to drive modernisation forward with a view to making changes successful, diffusible and 
sustainable. They incorporated the need for a fundamental understanding of how the current 
service worked before attempting to improve it and introduced tools and guides for NHS staff to 
follow as they embarked on redesign projects. They also realised the benefits of providing funding 
with the specific remit of facilitating pre-agreed redesign plans due to the competition experienced 
by NHS departments in securing unmarked funding from the corresponding NHS Trust and various 
other sources. The Service Improvement Team was just one of the seven teams that sat within the
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umbrella of the NHSMA. Its primary function was to support the delivery of improved access to 
hospital services and to provide patients with certainty and choice. They were involved in a 
number of successful redesign projects. The one relevant to this thesis was the “Modernising 
Endoscopy Services” (MES) project.
Prompt and ready access to NHS endoscopy services was vital to improve the diagnosis and 
treatment of patients with a suspected gastrointestinal cancers in line with NHS Cancer Plan 
targets (Department of Health, 2000b). The MES project assisted 26 NHS endoscopy units across 
England with the modernisation of their service using data collection software, unmarked financial 
aid and continuous advice and support from the NHSMA during their 12 month redesign phase that 
ran from January to December 2003. The MES project advocated the collection of high quality 
data pertaining to demand, activity and capacity using their data collection software so that sites 
could identify problematic areas in their services and plan effective redesign initiatives aimed at 
solving the problems at source. Data were also analysed by the endoscopy unit staff to measure 
the impact of their modernisation plans over time and were uploaded to the MES Project Team 
(MESPT) on a monthly basis for independent analysis.
The NHSMA did their own internal evaluation of the MES project using the data collected and 
written feedback reports to assess each site’s ability to meet key service-related targets set by the 
project. The key findings of that evaluation were published in a report (NHS Modernisation 
Agency, 2004e). However, the report was subjective and only focussed on case studies of good 
practice, rather than presenting an unbiased report on the success and more importantly, the 
failures (if any) of each site in relation to each individual target set by the MESPT. An independent, 
objective evaluation was required to determine the true impact of the MES project on NHS 
endoscopy services.
That challenge was taken up by the EvaluatiNg Innovations in Gastroenterology by the NHS 
Modernisation Agency (ENIGMA) study as part of an independent, mixed-methods evaluation of 
the MES project. The study was set up in September 2003 and ran for just over four and a half 
years. The ENIGMA study based its evaluation on comparing a random selection of 10 sites 
participating in the MES project (designated MES sites) with a random selection of sites that were 
unsuccessful in their bid for the MES project but that went on to redesign their endoscopy services 
independently (designated Non-MES sites). Their evaluation was primarily focussed on patient
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quality of life (QoL) scores, with secondary outcome measures that included interviews with NHS 
staff and patients, GP questionnaires and health economics data analysis.
However, one important aspect of the MES project was missing from the ENIGMA study - an 
evaluation using service-related endoscopy data, namely demand, activity and capacity data. The 
author of this thesis was the quantitative researcher of the ENIGMA study and was keen to explore 
this further. She argued that it should have been the focal point of the main evaluation of the 
ENIGMA study, given that the MES project advocated the collection and analysis of high quality 
endoscopy data. With this in mind, she elected to perform an independent evaluation using data 
variables based on those collected by the data collection software used by the MES project in the 
same study sites as were recruited for the ENIGMA study.
The aims of this study were (1) to ascertain whether the MES project had improved endoscopy 
services significantly over time in the MES sites and whether any changes were sustained over 
time, (2) to ascertain whether the Non-MES sites who had modernised their services independently 
of the MES project has successfully improved their endoscopy services and (3) whether there was 
a significant difference in the endoscopy services of the MES sites and the Non-MES sites at any 
time.
This evaluation was based on a comparison of the MES sites and the Non-MES sites using the 
statistical analysis of service-related endoscopy data to determine firstly, whether there was any 
significant difference in the data within each Site type (MES or Non-MES) over time and secondly, 
to determine whether there were significant differences between MES sites and Non-MES sites at 
any point in time. The service-related data used encompassed the number of referrals received, 
the number of patients waiting for a specific period of time, the number of lost appointment slots 
and the number of procedures performed. All of these outcome measures were collected for eight 
specific time intervals over a period of 40 months between January 2003 and April 2006.
This evaluation also described the availability of these datasets, along with a descriptive summary 
of the innovations introduced by each site over time as secondary outcome measures. Data 
collected for this study were tested for their accuracy by comparing them to an equivalent dataset 
from Hospital Episode Statistics (HES). In doing so, any findings reported by this study could be 
done so with a degree of confidence.
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Based on the findings of this evaluation, conclusions were drawn regarding the impact of the MES 
project on both MES and Non-MES sites and any other issues that came to light during the course 
of the study.
This thesis is structured to provide a generic background of all the information relevant to this study 
before focussing in more specifically on specific aspects of the study background. Chapter 2 gives 
a broad descriptive account of past reforms in the NHS with an overview of any early changes 
followed by a more in-depth look at NHS reforms in the last decade under the leadership of the 
New Labour government. Since the list of reforms issued since 1997 by both government and 
local healthcare organisations are vast, this thesis focuses more specifically on describing, but not 
critically analysing, the reforms that may have affected this study in some way. Chapter 3 
introduces some of the redesign concepts used by the NHSMA in the MES project, providing both 
their theoretical bases and, where possible, examples of their application into the NHS setting in 
the past. The chapter ends by describing many of the problems encountered by NHS staff when 
trying to redesign their services followed by the principles of how the NHSMA taught NHS staff to 
overcome them.
Chapters 4 and 5 describe conditions of the gastrointestinal tract and how they are investigated 
using endoscopies. In doing so, they illustrate the level of demand on NHS endoscopy services 
due to the range of conditions that can be diagnosed and often treated using endoscopies, and 
how important the procedure is for identifying cancers of the gastrointestinal tract. Chapter 6 
contains a systematic literature review to comprehensively describe the history of NHS endoscopy 
services modernisation since 1997. It encompasses many aspects of service delivery (demand, 
activity, waiting lists, etc) to set the MES project into context.
Chapters 7 and 8 describe the MES project and the ENIGMA study in more detail prior to a 
comprehensive description of this study which is set out in Chapter 9 which details the research 
question, hypotheses being tested and why this study was so important.
Chapter 10 describes and discusses the data collection process undertaken for this study, whilst 
Chapter 11 describes and discusses how the data was validated by statistical comparison using an 
equivalent HES dataset. Chapter 12 describes the exploratory data analyses performed on data 
received from each study site prior to their aggregation into MES and Non-MES groups. All 
statistical analyses performed to address the research hypotheses listed in Chapter 9 are
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comprehensively described and discussed. Chapter 13 describes and discusses the past 
innovation histories of each site individually and according to MES and Non-MES grouping to 
ascertain whether there was any pattern in which types of innovations were introduced and when.
Chapter 14 provides an overall discussion of the work in this thesis, summarising and linking all 
results with the research hypotheses, discussing the strengths and weaknesses of the study 
design, discussing the results as a whole and comparing the results with other similar studies. The 
chapter closes with a discussion of the implications of the findings followed by the overall 
conclusions and recommendations arising.
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2. PAST NHS REDESIGN INITIATIVES
NHS reforms have been ongoing for many years, as unanticipated demands have resulted in 
spiralling financial and organisational pressures that were not comprehensively addressed by any 
political party in power at the time. Many initiatives have unsuccessfully attempted to modernise 
the NHS to a point where the organisation was able to operate efficiently without detriment to 
patients’ health.
This chapter will introduce some of the key NHS reforms implemented since the establishment of 
the NHS in 1948, with particular focus on reforms introduced in the last decade since the New 
Labour government came to power.
2.1 Background
The NHS was launched on the 5th July 1948 by Aneurin Bevan, the then Minister of Health for the 
Labour government, following the passing of the National Insurance Act 1946 to create the welfare 
state recommended by the Beveridge Report (Beveridge, 1942). It was set up as a single 
organisation based around 14 Regional Hospital Boards and brought hospital, GP and community- 
based services out of isolation to work together for the first time in a three-tiered structure. The 
aim of this ambitious undertaking was to provide safe, effective, dependable healthcare for people, 
removing the financial barriers to accessing healthcare. However, within three years of its 
investiture, the NHS was forced to introduce some modest fees as a result of unpredicted, 
spiralling running costs caused by an unanticipated increase in demand. Prescription charges and 
fees for dental treatment and glasses were introduced by Hugh Gaitskell, the Chancellor of the 
Exchequer at that time, prompting Bevan to resign in protest (Socialist Health Association, 1951).
A variety of independent reports criticised the structure and performance of the NHS during the 
1960s; The Porritt Report (1962) criticised the structure of the NHS into three tiers and 
recommended unification; the Cogwheel Report (1967) proposed specialist groupings that would 
arrange clinical and administrative medical work more logically and the Salmon Report (1966) 
made recommendations for developing the senior nursing staff structure and the status of the
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profession in hospital management. The NHS responded with many new proposals such as the 
Hospital Plan (National Health Service, 1962), the standardisation of medical records (Ministry of 
Health et al., 1965) and changes in staffing structures (Ministry of Health et al., 1961). Better 
management became a priority and professional divisions were created with the aim of grouping 
medical staff by speciality to arrange clinical and administrative work more logically. A new GP 
contract was introduced by the British Medical Association, initiating a new system of payment to 
GPs based on the number of patients registered, a basic practice allowance and fees for services. 
The advent of Information Technology (IT) saw the first steps in computerisation of administrative 
processes and clinical budgeting in the 1970s.
Margaret Thatcher’s Conservative government came to power between 1979 and 1997. At this 
time, advancements in technology had resulted in more complex procedures becoming available 
on the NHS. The original 14 Regional Hospital Boards in England were replaced in 1982 by 192 
District Health Authorities (DHAs) in an attempt to cut back bureaucracy and improve efficiency 
(Oliver, 2005). In 1984, the NHS introduced a system of hierarchical general management based 
on recommendations by the Griffiths report (1984), which highlighted the lack of a clearly defined 
general management structure as a weakness in the NHS and recommended that all levels should 
have a single general manager or chief executive (Oliver, 2005).
The 1990’s saw the Thatcher-Major administration enforce radical changes to the foundations of 
the way the NHS worked with the introduction of the Patients’ Charter (Department of Health, 
1991) and the Internal Market. The Patients’ Charter set out ten non-legally binding patients’ rights 
to care and seven aspirations for national standards of care. Standards for the Charter were set 
using measures of the processes of healthcare, rather than clinical quality. Hospital league tables 
were developed to show how individual NHS Trusts met Charter standards. The standards 
imposed became built into the NHS reforms, providing a benchmark of performance by which 
hospitals were judged.
The concept of an Internal Market was introduced in Working for Patients (Department of Health, 
1989), which passed into law as the NHS and Community Care Act 1990 (1990). On the 1st April 
1991, in the face of huge resistance from healthcare professionals, the NHS began the most 
significant cultural shift since its inception as the tripartite structure of hospital, community and GP 
services was breached. The aim was to introduce some market incentives into a centrally planned, 
hierarchical system while maintaining universal and free access to health services. At the heart of
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this reform was the devolution of financial control to DHAs and fundholding GPs, who were 
allocated funds for purchasing a defined set of elective services from “providers” including NHS 
Trusts, private sector organisations and other providers. The purchaser-provider split was meant 
to encourage competition between providers for contracts to boost their block grant allocated by 
the Department of Health (DH), thereby improving performance and service delivery and reducing 
costs as money followed patients. NHS Trusts were encouraged to merge to achieve economic 
gains by pooling resources, creating specialist teams, enlarging the organisation in response to 
challenges from purchasers and facilitating the sharing of good practice (Fulop et al., 2002).
Overall, the effects of the Internal Market were quite limited because the essential conditions for a 
market to operate were never completely fulfilled, so the reform did not improve NHS services as 
much as was theoretically possible (West, 1998, Mays and Pope, 2000). However, variations in 
prices existed between providers for seemingly similar services, regardless of the rules that 
effectively fixed prices at average cost (Propper and Soderlund, 1998). The Internal Market did not 
increase the choice for patients regarding procedures or provider (Le Grand, 1999), nor did it 
reduce the wait for “non-purchasable” treatments (Propper et al., 2000). Not all GPs joined the 
fundholding scheme and inequality in service provision arose, as patients of fundholding GPs were 
often able to obtain “purchasable” treatment more quickly than patients of non-fundholding GPs 
(Propper et al., 2000). There was little overall change for good or bad as a result of the reforms 
(Glennerster, 1998, Le Grand, 1999). Only modest improvements in healthcare were reported and 
these improvements were insufficient to justify their higher cost (Audit Commission, 1996).
The failure of the Internal Market to reform NHS services resulted in a crisis of confidence in the 
quality of care received by patients (Enthoven, 2000a). A 1996 survey of 1354 people reported 
that 56% thought that fundamental changes in the NHS were needed, whilst 41% expressed 
dissatisfaction with the services (Mossialos, 1997).
More comprehensive descriptions of the early reforms implemented during the history of the NHS 
are available from other authors (Rivett, 1998, Ham, 2004), whilst Ferlie has published a review on 
large-scale organisational and managerial change in healthcare that covers the 1980s and early 
1990s which can be referred to for further detail (Ferlie, 1997).
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2.2 NHS reform in the last decade (1997 to 2007)
The election of the New Labour government in May 1997 brought with it a radical approach to 
modernising NHS services. Pledging the abolition of the Internal Market and GP fundholding, they 
encouraged an environment of cooperation rather than competition. The White Paper A First Class 
Service: Quality in the new NHS laid out a 10-year programme of modernisation that focused on 
eliminating the national variability in standards of service delivery and placed more importance on 
the quality of healthcare, rather than playing a numbers game (Department of Health, 1998). It 
was the first time that patients’ needs had played a significant role in NHS reforms but it was a 
principle that would be the focus of NHS modernisation throughout New Labours’ time in power.
The White Paper The New NHS. Modern. Dependable, promised a new model for a new century, 
based on six key principles covering access to care, maximising efficiency and improving the 
quality of patient care (Department of Health, 1997). To facilitate NHS modernisation, two NHS 
regulators were established - the National Institute of Clinical Excellence (NICE) (Rodgers, 2002) 
(now the National Institute for Health and Clinical Excellence) and the Commission for Health 
Improvement (CHI) (now the Healthcare Commission) -  to pursue better quality, efficiency and 
consistency throughout the NHS (Walshe, 2002, Oliver, 2005).
During New Labour’s first term in office, the NHS was introduced to the concept of the electronic 
patient record (NHS Executive, 1998a), the National Booked Admissions Programme (NHS 
Executive, 2000, NHS Modernisation Agency, 2003c, The National Booking Team, 2004) and 
clinical governance (Department of Health, 1998). In 1999 the government replaced GP 
fundholding with the compulsory membership of GPs, community nurses and Family Health 
Services Authorities in England into 481 Primary Care Groups (PCGs). These groups were set up 
by 99 newly established Health Authorities (HAs) to delegate the responsibility for commissioning 
the majority of local hospital and community health services to the local PCG using a unified 
budget, in accordance with Section 31 of the Health Act 1999 (1999). Once a PCG had shown a 
systematic approach to monitoring and developing clinical standards within primary care, they were 
allowed to evolve into Primary Care Trusts (PCTs) with greater clinical and financial 
responsibilities, slowly replacing the executive regional offices of the NHS and HAs. PCTs held 
their own budget and deployed resources according to the needs of their community. In effect, 
fundholding became universalised, putting GPs in the driving seat in shaping local health services 
in the future (Department of Health, 1997) in the hope that it would result in the most radical
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change in NHS history: a service driven from the bottom-up, reflecting local rather than national 
priorities.
As the NHS entered the new millennium, the government published The NHS Plan: A plan for 
investment. A plan for reform (Department of Health, 2000c). Its vision was to offer people fast and 
convenient care delivered to a consistently high standard and available when people required it, 
tailored to their individual needs. The government offered extra investments to coincide with the 
NHS Plan, taking NHS funding from 6% to 7.6% of the gross domestic product (GDP), equating to 
an increase from just under £50 billion to almost £70 billion over a four year period (Ferriman, 
2000). This cash boost was earmarked to finance the modification of existing services, designing 
new services, building new “superhospitals”, buying new equipment, establishing links with the 
private healthcare sector and improving conditions for both staff and patients. However, this 
additional funding came at a price - tougher standards for NHS organisations to achieve, including 
reducing unnecessary hospital admissions, providing the correct number of beds, reaching high 
standards of working, eliminating demarcations, introducing more flexibility into staff roles, adopting 
best practice and applying a more systematic approach to treating patients with chronic diseases.
“We would spend money if, but only if, we also changed the chronic system failures of 
the NHS. Money had to be accompanied by modernisation; investment, by reform”
Tony Blair, Foreword of the NHS Plan (Department of Health, 2000c)
Following their commitment to cut death rates from cancer in people under 75 years of age by at 
least a fifth by 2010, as set out in their White Paper Saving Lives: Our Healthier Nation 
(Department of Health, 1999), the government initiated the biggest ever programme to replace and 
update screening, diagnosis and treatments for cancer. They released the White Paper The NHS 
Cancer Plan: A plan for investment. A plan for reform in July 2000, pledging that no one should 
wait longer than one month from an urgent referral for suspected cancer to the beginning of 
treatment except for good clinical reasons or through patient choice (Department of Health, 2000b). 
The plan promised additional expenditure in cancer services but reiterated the importance of this 
investment being accompanied by massive organisation-wide reforms to produce successful and 
sustainable services.
Following their second successful election in 2001, New Labour built on past policies with Shifting 
the Balance of Power (Department of Health, 2001b), which described more radical changes
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planned for both the organisational structure and the services provided by many NHS 
organisations. This was followed in June 2004 by the NHS Improvement Plan which, as well as 
describing the successes of past reforms in line with previous targets listed in past white papers, 
also highlighted many more policies to be implemented between 2005 and 2008 (Department of 
Health, 2004c). It stated that the next stage for the NHS was delivering more care, more quickly 
through investment and reform; offering people more personalised care and a greater degree of 
choice and finally, greater concentration on prevention rather than cure. The targets for NHS 
reforms since 1997, when New Labour came into power, that are relevant to this thesis are 
described in more detail below.
2.2 .1 Changing the way the NHS was structured
April 2002 saw the evolution of the 99 HAs in England into 28 Strategic Health Authorities (SHAs), 
each covering an average population of 1.5 million people. All local NHS organisations became 
part of a single structure and were accountable to their respective SHA. Their main functions 
included supporting PCTs and NHS Trusts in delivering government targets locally, building 
capacity and supporting performance improvement across all their local health agencies. Each 
SHA produced a local delivery plan for their health community detailing the actions local health 
services would undertake to meet the needs of their patients and ensuring that each local PCT 
participated in a wide-ranging programme of improvement. In 2006, the number of SHAs was 
reorganised as part of a cost-cutting exercise, reducing the number to 10.
Foundation Trusts (FTs) were first introduced in Delivering the NHS Plan: next steps on 
investment, next steps on reform with the aim of devolving NHS services away from central 
government to allow local ownership and accountability and an ability to tailor services to best meet 
the needs of the local community (Department of Health, 2002d). Eligibility to become an FT arose 
from achieving three-star status in inspections (see later). FTs were controlled and run locally 
rather than nationally, with the maximum devolution of power to local GPs and health professionals 
to innovate locally with minimal intervention from Whitehall. They benefited from substantial 
financial, operational and managerial autonomy, and were free to develop their board and 
governance structures to ensure more effective involvement of patients, staff, the local community 
and other key stakeholders, whilst still treating NHS patients according to NHS principles. 
Devolution of control would inevitably lead to national variability, but supporters believed that a
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varying quality of NHS services nationwide was inescapable within such an immense healthcare 
system and highly variable regional demands.
The concept of FTs was met with hostility by many politicians who feared they would run up huge 
debts as a result of their financial autonomy. There was also concern at the potential for creating a 
two-tier system whereby the best hospitals received more money, resulting in inequalities in patient 
care nationwide, although there is no evidence that this has happened to date (Lewis, 2005). A 
review of FTs by the Healthcare Commission commented that many of the concerns initially 
expressed about FTs did not manifest and that they had shown significant achievements during 
their first year of existence (Healthcare Commission, 2005b). The independent regulator “Monitor” 
gave 31 of 32 FTs a clean bill of health in their 2005 report, commenting that they had generated a 
£20 million surplus over nine months (O'Dowd, 2006). However, these viewpoints were 
contradicted by Lewis who reported little evidence of any major improvements in quality of care 
and no particular advantage to patients (Lewis, 2005). There is a deadline of December 2008 for 
all NHS Trusts to achieve FT status but Mooney recently reported that at the end of 2007, there 
were still approximately 140 Trusts who had not yet met the criteria and for those who would never 
be financially viable, the only options included merger or closer (Mooney, 2007).
NHS walk-in centres have been introduced across England to improve the accessibility of 
healthcare to patients both in terms of location (there are no location-based restrictions) and 
availability (to reduce the time taken off work to seek medical advice). They reduce the demand on 
primary care and also maximise the role of nurses to allow doctors to apply their skills more 
appropriately (Salisbury, 2003). However, there is also evidence to the contrary suggesting that 
NHS walk-in centres do not have a significant impact on GP workload (Hsu et al., 2003).
The NHSMA was the third regulatory body to be established by the government. Its aim was to 
help local clinicians and managers redesign local services around the needs and convenience of 
patients. It was established in April 2001 and was made up of key stakeholders, health 
professionals, patients, frontline managers and public representatives drawn from high-performing 
NHS organisations on secondment, with regional teams based in regional offices and working 
closely with regional NHS staff. The NHSMA operated across all sectors of the NHS - primary 
care, secondary care, mental health and ambulance trusts - abiding by the major principles of 
quality, patient safety, leadership and workforce development. The NHSMA disbanded at the end 
of March 2005, although most of its literature was available at an online legacy repository
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(www.wise.nhs.uk) until recently. A statement on the ex-NHSMA website (www.modern.nhs.uk) in 
March 2005 reported that the NHSMA would “continue to act as a catalyst for change within the 
NHS, helping administrators and staff to improve working conditions and care outcomes”.
On 1st July 2005, the NHS Institute for Innovation and Improvement superseded the NHSMA, 
heralding a new era of improvement and change for the NHS in England. Established as a SHA 
and based on the campus of the University of Warwick, its mission was to support the NHS and its 
workforce in accelerating the delivery of world-class health and healthcare for patients and the 
public by encouraging innovation and developing capability at the frontline.
2.2.2 Increasing NHS funding
The three main goals of healthcare reform were improved access and quality and reduced costs, 
with the issue of cost (or more accurately, the rate of increase in costs) as the driving force (Eddy,
1993). Three quarters of all health expenditure was spent on NHS staff wages (Black, 2002). 
Upwards pressures on costs from new technologies and rising public expectations collided with 
downwards pressures from economic recession and political unwillingness to increase taxes 
(McKee et al., 1998). Health professionals struggled daily to maintain processes with limited 
resources. Most funding allocated to the NHS was marked for specific use and while this ensured 
that the investment was correctly targeted, it meant difficulties in securing unmarked funding for 
lower profile, non-target-related improvements due to competition.
There was a commonly held view that high quality care was expensive, but this failed to recognise 
that poor quality care also generated unnecessary costs through the underuse, overuse and 
misuse of services (Department of Health, 1998, McLoughlin and Leatherman, 2003) as the NHS 
continued to fail to provide treatments that worked, persisted in giving failing treatments, enforced 
delays and tolerated high levels of error (Smith, 2001).
The government invested nearly 7% of its GDP on the NHS during its first term in 1997. In 2000, 
they announced plans to increase this to 7.6% by 2004, putting the UK in line with the European 
average (Ferriman, 2000). The Wanless Review was commissioned to assess the resources 
required for the NHS to continue to meet its core objectives and it recommended large increases in 
NHS investment (Wanless, 2002). When NHS services did not improve as fast as the investment, 
the government pledged that healthcare spending would reach 9.4% of the GDP by 2008
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(Department of Health, 2002b). However, there has been concern that the Wanless review was 
used by the government to justify, rather than inform its spending plans (Oliver, 2005).
The aim of Payment by Results (PbR) was to provide a transparent, rules-based system for paying 
NHS Trusts (Department of Health, 2002f). Each case (admission) was grouped into a healthcare 
resource group according to the treatment carried out and the clinical condition of the patient. 
Then a fixed tariff was assigned to each healthcare group based on the national average cost of 
treatment in NHS Trusts in England (Dixon, 2004). It rewarded efficiency, supported patient choice 
and diversity and encouraged activity for sustainable waiting time reductions as Trusts were being 
paid per case rather than the existing block contract basis (Dixon, 2004). Importantly, this system 
ensured a fair and consistent basis for hospital funding rather than being reliant principally on 
historic budgets and the negotiating skills of individual managers. Under these reforms all 
providers were paid for the activity they undertook, so PCTs commissioned the volume of activity 
required to deliver service priorities from a plurality of providers on the basis of a standard national 
price tariff, adjusted for regional variation in wages and other costs of service delivery. It was 
hoped that this incentive structure would encourage extra activity and for expensive providers to 
reduce their costs to the average, allowing more care to be purchased within existing budgets 
(Lewis and Appleby, 2006). PbR was gradually implemented by PCTs from 2002/3 with the 
national tariff in place within five years.
2.2 .3 Increasing NH S capacity
Most buildings used by the majority of NHS sectors were ill-equipped to meet modern requirements 
and house new technologies whilst facilitating an improvement in service delivery. Most small, 
local hospitals were unable to support medical training, accreditation and governance issues, whilst 
the larger hospitals were unable to cope with the increasing demand for beds and services.
The NHS Plan instigated the building of more than 100 new, state of the art hospitals for large NHS 
Trusts by 2010, 500 new one-stop primary care centres and more than 3,000 modernised GP 
centres (Department of Health, 2000c). The old ward system was phased out in favour of intimate 
bays or rooms for those requiring overnight stays. New hospitals had an increased capacity with 
an extra 7,000 beds, reducing “bed-blocking” and waiting on trolleys in Accident and Emergency 
(A&E) departments. However, the timescale needed to realise these improvements meant that the 
benefits were not seen nationwide for a considerable time. Also, whilst new buildings were 
necessary, they did not themselves contribute much to “health gain” (Black, 2002).
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Prior to the NHS Plan, only a few medical areas had partnerships with the private healthcare 
sector, and these were only short-term. Until recently, over 95% of interactions between a patient 
and doctor took place in the public sector (Smith, 2005). The policies of Frank Dobson, the 
Secretary of State for Health between 1997 and 1999, discouraged cooperation between the NHS 
and the private sector, a decision that was later reversed by Alan Milbum in 2000 when he signed 
a concordat with the private sector encouraging the NHS to buy spare capacity and make 
thousands of extra beds available to the NHS whilst keeping the patients within the NHS system 
(Department of Health, 2000a). The government believed that the use of private providers did not 
undermine the principles of the NHS if care was still free to patients (Timmins, 2005a). Private 
hospitals came to be seen by the New Labour government not as their nemesis, but as their 
saviour (Smith, 2005) as they increasingly provided ‘pay as you go’ schemes for NHS patients with 
fixed tariffs for common surgical procedures. This provided an element of competitiveness with 
public healthcare services to encourage innovation (Smith, 2005).
Long before 2000, the NHS was buying in between 60,000 to 80,000 procedures from private 
providers at a cost of around £100 million, approximately 40% or more above the average NHS 
cost for each operation it bought (Timmins, 2005b). Rather than continue this financial drain, the 
government created a network of Diagnostic and Treatment Centres (DTCs) in 2002 to provide 
safe, fast, pre-booked surgery and diagnostic tests for patients to meet targets for reducing NHS 
waiting lists, to increase capacity, to optimise service efficiency and to maximise patient 
satisfaction (Department of Health, 2002c). DTCs have traditionally focused on medical 
specialities which have the highest hospital waiting lists, such as orthopaedics and ophthalmology. 
Some DTCs were NHS-run whilst others were run by independent sector providers (Department of 
Health, 2005b), manned by overseas staff to reduce the poaching of NHS staff (Timmins, 2005b). 
In 2005, the DH reported that approximately one billion pounds worth of additional diagnostic scans 
would be procured from independent sector DTCs to bolster NHS capacity (Lewis and Appleby, 
2006). The throughput of patients at these centres was eight times higher than in an NHS hospital 
(Andalo, 2005) because DTCs could focus on acute elective procedures in a purpose-built unit with 
emphasis on patient choice and convenience and were not affected by knock-on effects from other 
departments. By Dec 2004, more than 120,000 patients had been treated in DTCs (Andalo, 2005). 
To date, independently-run DTCs have had a much bigger effect on NHS waiting lists than can be 
accounted for by the number of procedures they perform (Timmins, 2005a).
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2.2 .4 Improving NHS information technology systems
NHS clinical information systems such as the Patient Administration System (PAS) and the 
computer hardware used in most hospitals were antiquated, inefficient and often not networked 
within the department, let alone the hospital or Trust. This caused an unnecessary amount of 
duplicated administrative work for both medical and clerical staff, repeatedly entering patient details 
on individual systems rather than being able to access and edit a patient’s records from any remote 
terminal. Many tasks were done using paper-based methods because it was often easier and 
quicker, a practice stemming from the traditional working culture of the old NHS that was often 
“kept alive” by technophobes, or the lack of funding to upgrade inadequate computer equipment 
and software.
The successful reform of the NHS required a radical revamp of the current information technology 
(IT) situation in all sectors so that initiatives such as electronic booking and electronic patient 
records (NHS Executive, 1998a) could be implemented. The National Programme for Information 
Technology (NPfIT) was established in October 2002 to facilitate the NHS-wide reforms planned by 
the NHS Plan in line with the DH strategic documents Information for Health (NHS Executive, 
1998a) and Delivering 21st century IT support for the NHS (Department of Health, 2002a). New IT 
systems for the NHS delivered services faster and more conveniently for patients. The 
government invested a total of £450 million to support GPs being connected to NHSnet by 2002, 
access to electronic personal medical records by 2004, electronic prescribing of medicines by 2004 
and the electronic booking of patient appointments by 2005. Many IT systems were networked 
with automated diagnostic equipment in the laboratory, linking directly to the electronic patient 
record so results were immediately available. In April 2005, NHS Connecting for Health was 
formed as an agency of the DH to continue the delivery of the NPfIT. More details regarding this 
agency can be found at www.connectinqforhealth.nhs.uk.
2.2 .5 Increasing staff numbers
In the late 1990s, there was a shortage of people training to enter the NHS. Job prospects for 
other healthcare workers were not attractive, with low pay, long hours and inflexible working 
patterns. The NHS Plan intended to increase staff numbers by an additional 7,500 consultants,
2,000 GPs, 20,000 nurses and 6,500 therapists (Department of Health, 2000c). More places at 
medical schools were made available and healthcare workers were offered more attractive salaries
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and flexible schedules. To cover the deficit in the short term, suitably qualified nursing staff from 
foreign developed countries were recruited.
The numbers of nurses increased from 256,000 in 1997 to 291,000 in 2002 but the numbers of 
GPs and consultants did not increased anywhere near as fast (Smith, 2003). The NHS Information 
Centre reported increases by 2006 in hospital-based medical staff of over 29,000, in nurses of over 
73,000, in scientific and technical staff of over 40,000, in GPs of over 6,200 and in managerial staff 
of over 15,000 -  an overall increase of 27% in the total number of NHS staff from 1996 to 2006 
(The Information Centre, 2006).
Newly qualified health professionals were a significantly different workforce to that of decades ago, 
with women making up more than 50% of doctors qualifying and many of those in post under the 
age of 40 (Allen, 2000). This modern workforce required flexibility and the opportunity to train 
within and outside their profession if they were to remain dedicated. Consequently, plans to 
introduce more flexible working conditions, research schemes for medical staff and childcare 
support for all NHS employees were implemented.
2.2 .6 Improving staff morale
The most valuable resources in the NHS were its dedicated staff, yet the majority were underpaid 
and felt undervalued for their level of skills and responsibilities, resulting in poor staff morale. Many 
disheartened staff had already left NHS employment, leaving departments understaffed and the 
remaining staff bearing additional loads. The recruitment of ex-NHS staff proved difficult, with 
many not wanting to re-enter the service due to bad past experiences and poor pay and conditions 
(BBC news, 1999). There lack-lustre implementation of the NPfIT programme also resulted in poor 
morale in NHS staff (Hendy et al., 2005). There were also problems with many highly skilled 
healthcare professionals consistently working below their level of expertise. Consequently, scarce 
resources were wasted, care was more expensive and boredom and frustration occurred.
Reforms meant that employees were rewarded for their dedication with improved pay and 
conditions. They also found their roles expanding as they were subsequently trained for and 
entrusted with increasing responsibilities. This allowed the highly skilled health professionals to 
delegate some of their more routine tasks to other suitably trained but lower-ranking staff, freeing 
up their time and expertise to be applied more effectively on difficult cases. Consequently, the
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traditional demarcation that had existed between groups of professionals decreased as they 
voluntarily combined their efforts and cooperated to implement changes worthy of benefits in the 
form of financial rewards or an improved quality of working life.
The Agenda for Change (AfC) was introduced in December 2004 by the DH to improve the way 
NHS staff were paid, their career structures and the terms and conditions of their employment 
(Agenda for Change Project Team, 2004). It covered more than one million people, harmonising 
their pay scales and career progression arrangements across traditionally separate pay groups to 
ensure fair pay and a clearer system for career progression. For the first time staff were being paid 
on the basis of the jobs they were doing and the skills and knowledge they applied to these jobs. 
This reform was underpinned by a job evaluation scheme specifically designed for the NHS. More 
detail regarding AfC can be found at the NHS Employers website at www.nhsemplovers.org/pav- 
conditions/aqenda-for-chanqe.cfm.
2.2.7 Improving the patient experience
With public opinion of the NHS running low, NHS services needed to be reshaped around the 
needs and preferences of its patients, their families and their carers to provide convenient care 
delivered to a consistently high standard, available when required, and tailored to individual needs. 
In principle, NHS organisations aimed to serve patients but in practice, they did not always put the 
patients’ needs before the convenience of the organisation. Employers, payers and providers, 
rather than patients, primarily influenced the way the healthcare system functioned (Berry et al.,
2003). The relationship between service providers and patients was previously too hierarchical 
and paternalistic. The NHS was designed to meet the needs of patients as defined by the 
professionals delivering the services rather than responding to the demands articulated by patients 
(Klein, 2001). The public’s freedom was reduced by being forced to pay excessive taxation for the 
NHS (Bradshaw, 2003). However, the public could not tell whether they were getting value for 
money.
At the heart of the new reform plans was the stipulation that patients should be at the centre of any 
improvement culture. Patient choice and empowerment were major features of the redesigned 
NHS and by 2005, non-negotiable appointment dates were replaced by multiple choices. Patients 
were provided with better quality information about their procedures, leading to a reduction in the 
number of patients failing to attend their appointments (Hardy et al., 2001). Patients also indicated
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their wish to see changes to normal working practices such as the introduction of “out of hours” or 
weekend clinics (Feeney et al., 2005, Douglas et al., 2005).
Patients were empowered with more information about looking after their own health, their local 
health services and being given the right to choose their GP based on published information about 
GP practices. NICE published “patient-friendly” versions of its clinical guidelines and NHS Direct 
was established in 1997 as a telephone helpline that later evolved into an additional web-based 
information source at www.nhsdirect.nhs.uk. Patients were also given the right to see their medical 
records in accordance with the Freedom of Information Act 2000 (2000).
The National Booked Admissions Programme (NBAP) let patients choose and pre-book the date of 
their appointment or admission. The programme helped NHS Trusts redesign their booking 
systems, and also worked with health communities to develop electronic booking. An in-house 
questionnaire-based evaluation of the fourth wave of the programme by the NHSMA found that day 
case targets had been achieved, there had been an increase in the number of call centres and a 
significant decrease in non-attendance and cancellation rates (The National Booking Team, 2004). 
Patients had more choice, flexibility, information, awareness and control, whilst staff morale also 
improved as an indirect consequence.
The “Choice at six months” programme was introduced on a phased basis from April 2004 and 
became fully operational in September 2004. It offered the choice of alternative providers to those 
patients waiting over six months for elective surgery in cases where it was faster to offer an 
alternative provider than it was to continue waiting for the original hospital. It aimed to offer 
patients certainty and also encouraged service improvement as public and private providers 
competed to provide these services (Smith, 2005) in accordance with PbR regulations. Lewis and 
Appleby commented on two pilots for patient choice of provider and reported that 62% and 57% of 
patients took the opportunity to select an alternative provider (Lewis and Appleby, 2006), although 
these figures appear to be hugely inflated when compared to official DH figures -  the national 
average was 20.7% for the period April 2004 to March 2005, with some individual regions reporting 
figures ranging from 3.1% to 48.4% (Department of Health, 2005a) -  and a report by Taylor et al 
commented that most patients still opted for their local hospital (Taylor et al., 2004).
The “Choice at point of referral” initiative officially superseded “Choice at six months” in December 
2005 and meant that patients needing elective treatment were offered a choice of four or five
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hospitals once their GP has decided that a referral was required (Department of Health, 2006a). 
The choice included NHS Trusts, FTs, DTCs or GPs with a special interest operating within primary 
care. This initiative was independently monitored by the National Audit Office (NAO) in 2005, who 
highlighted the need for an electronic booking system known as Choose and Book to be in place 
by the end of 2005 (National Audit Office, 2005). They also commented that the estimated cost of 
the scheme (£122 million) would lead to increased efficiencies worth an estimated £71 million to 
offset these costs.
The recent 2007 National Patient Choice Survey by the DH reported that 43% of approximately
62,000 patients surveyed recalled being offered a choice of hospital for their first outpatient 
appointment, 38% were aware before visiting their GP that they had a choice (Department of 
Health, 2007). A major contributing factor when choosing a hospital was location or transport 
considerations for 72% of patients, followed by the reputation of the hospital (22%), waiting times 
(22%), cleanliness (22%) and quality of care (17%). A higher proportion of patients selected an 
independent provider for their first outpatient appointment compared with the corresponding 2006 
patient survey (62% Vs 43%) (Department of Health, 2006c). Unfortunately, the report did not 
extend to cover the proportion of patients selecting local hospitals when given a choice, although 
the proportion who stipulated location as a selection criterion suggests that many patients would 
have selected their local provider.
2.2.8 Improving the quality of NHS services
The inherent lack of communication between and within NHS departments and sectors often 
resulted in patient information not being shared, often resulting in the duplication of tests or more 
worryingly, a lack of tests. Patients often saw a number of health professionals during the course 
of their “journey”, many of who may not have liaised with each another, so they end up asking the 
patient the same questions, causing unnecessary stress and extending the patients’ journey time.
Another problem regarding the quality of care received by patients was that it had never been 
clearly defined who runs a hospital: managers or consultants (Probert et al., 1999). Neither has 
been willing to take responsibility for improving patient care in a proactive manner, with both 
professional groups preferring a reactive rather than a proactive role by simply responding to 
problems as they occurred instead of designing quality into the patient pathway.
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NHS organisations have now been given higher national standards of quality as targets for 
achievement by the government as a way of improving the quality of service delivery by the NHS. 
It was hoped that there would also be an increase in productivity and a decrease in waiting lists 
and waiting times prior to treatment. Clinical governance was introduced into all parts of the NHS 
to facilitate this (Walshe et al., 2000). It was defined as “a framework through which NHS 
organisations are accountable for continually improving the quality of their services and 
safeguarding high standards o f care by creating an environment in which excellence in clinical care 
will flourish” (Scally and Donaldson, 1998). Clinical governance was to be the main vehicle for 
continuously improving the quality of patient care and developing the capacity of the NHS in 
England to maintain high standards (including dealing with poor professional performance). It 
required the NHS to improve the quality of clinical care according to professional performance, 
resource use, risk assessment and patient satisfaction (Scally and Donaldson, 1998)
Strategies for the improvement of delivery of healthcare at a national level included evidence- 
based practice, clinical effectiveness, evidence-based clinical guidelines and audits (Rycroft- 
Malone et al., 2002). At the heart of a scientifically grounded theory for improving healthcare was 
the premise that quality is a system property and that what primarily determined the level of 
performance was the design of a healthcare system, not simply the will, native skill or attitude of 
the people who worked in that system (Berwick, 2003). Berwick wrote, “Every system is perfectly 
designed to achieve exactly the results it gets” which he has called the First Law of Improvement. 
To get a better result required changing the system (Berwick, 2003).
The NHS was never particularly stringent in enforcing the collection, analysis and dissemination of 
information. Instruments for identifying persistent failure regarding standards of care were old- 
fashioned and inadequate. Following the Internal Market reforms, the value of comparative data as 
a basis for purchasing decisions was realised and there was a drive to improve the collection of 
valuable data in the NHS (Goddard et al., 2000). New redesign strategies established by the 
NHSMA used healthcare-based guides and data collection software to allow the effective analysis 
of their current working practices to identify persistent problems so that they could target redesign 
resources towards solving the real cause of the problem. Process mapping also became a key 
feature of redesigning NHS services, encouraging health professionals to look from the patients' 
perspective at a specific process from start to finish to identify where problems or delays occurred 
in patient flow so that they could effectively focus their redesign efforts on that area (Locock, 2001).
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The evaluation of NHS services using these methods became even more important with the 
introduction of assessments and inspections in NHS Trusts by government agencies to evaluate 
their overall performance against key targets and to help them to identify areas in need of 
improvement. The first report on performance ratings (also known as star ratings) was published in
2001 on Acute Trusts (Department of Health, 2001a) followed by a report on all NHS Trusts in
2002 (Department of Health, 2002e). CHI took over the inspections for 2002/03 and the 
Healthcare Commission in 2004.
Thresholds were set and NHS Trusts could achieve, under-achieve, or significantly under-achieve 
these targets. Taken together with the key target measures, the measures of clinical, staff and 
patient focus constituted a "balanced scorecard" approach, allowing a broad range of areas to be 
measured within a single methodology and all NHS Trusts performances were scored using a star 
rating system. Trusts with the highest levels of performance were awarded three stars and were 
eligible to become FTs whilst Trusts with the poorest levels of performance were awarded zero 
stars and were actively guided through improvement by NHSMA specialist redesign teams.
The performance rating system later came under fire for flawed inspection criteria using absolute 
rather than relative figures for some measures, consequently biasing results against the larger 
Trusts (Barker et al., 2004), for having a scoring system that did not take into account the quality of 
care, only measuring in absolutes of either achieving or not achieving targets (Gulland, 2002) and 
for not reflecting the quality of clinical care provided by hospitals (Rowan et al., 2004). It was also 
blamed by senior NHS staff for a number of detrimental effects on NHS services including reducing 
staff morale and distorting clinical priorities (Mannion et al., 2005). Consequently, the Healthcare 
Commission announced in November 2004 that the performance rating system was to be 
abandoned and that from April 2005, a “health check” for the NHS would be introduced that 
included spot inspections and unannounced visits and measured against core standards in seven 
areas set by the DH, developmental standards and new national and local targets (Healthcare 
Commission, 2005a).
2.2.9 Reducing waiting fists
The length and number of waiting lists have been a constant problem for a range of NHS services. 
Martin et al reported that there were substantial numbers of patients waiting more than six months 
for selected elective treatments, although these figures were limited to a small number of hospitals 
(Martin et al., 2003). They also reported that measures of capacity did not appear to be associated
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with prolonged waiting. However, it appears that since 1999, there has been a sustained decline in 
the total number of patients waiting for a procedure in the NHS (Lewis and Appleby, 2006). The 
NHS Improvement Plan outlined new government targets for the NHS, including a maximum wait 
of eight weeks from referral to treatment for cancer patients by the end of 2005 and aimed to 
improve on that achievement to accomplish a maximum wait of 18 weeks from GP referral to the 
initiation of treatment in hospital for any patient by December 2008 (Department of Health, 2004c). 
To support this target, a website was established to facilitate the reduction of waiting lists in a 
variety of specialist fields (www.18weeks.nhs.uk/public/default.aspx). Despite considerable 
scepticism from many within and outside the NHS that previous waiting time targets would not and 
could not be met, they have been mostly achieved (Lewis and Appleby, 2006). This, along with a 
new understanding of waiting lists and their origins, makes the likelihood of achieving the 18 week 
target by the end of 2008 a real possibility for most NHS services.
2.2 .10 Implementing new ways of working
Working in teams was promoted not only within departments but across departments in the 
creation of multi-disciplinary teams (MDTs) (Firth-Cozens, 1998). They were made up of a variety 
of health professionals with different roles from a range of interacting specialties and were 
responsible for patient care. The evolution of MDTs allowed the improvement of care of patients 
compared to individuals working in isolation (Carter et al., 2003). Referral to MDTs was essential 
to provide adequate support and clear information from the time of diagnosis throughout the care 
pathway (Broughton et al., 2004).
Collaborative programmes created specific improvements in healthcare for patients based on 
evidence-based principles for spreading best practice. They brought together groups of 
professionals from different healthcare organisations to work in a structured way to improve just 
one aspect of the quality of their services within a specified time period (Ovretveit et al., 2002). 
The collaborative methodology employed within the NHS originated from the work of the Institute of 
Healthcare Improvement (IHI) in the United States, who launched the “Breakthrough Series” of 
collaborative programmes (Institute for Healthcare Improvement, 2003) to support local teams to 
make ‘breakthrough’ improvements in quality for patients while reducing costs. The driving vision 
behind it was that sound science existed on the basis of which the costs and outcomes of current 
healthcare practices can be greatly improved, but that much of this science was unused in daily 
work. Collaboratives have become more widespread throughout the NHS, examples of which
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include the primary healthcare collaborative (Smith, 2001), coronary heart disease collaborative 
(Coronary Heart Disease Collaborative, 2005) and cancer services collaborative (CSC) (Robert et 
al., 2003).
This chapter has summarised some of the many reforms that the NHS has undergone in the last 
decade to achieve significant improvement in line with government targets. To do this, it had to 
adopt a “modernisation mindset” which was made possible, in part, by the establishment of the 
NHSMA who educated healthcare professionals in various redesign theories and facilitated their 
application into various aspects of the NHS organisation. The origins of the main theories 
introduced to NHS services by the NHSMA are discussed in the next chapter.
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3. ORGANISATIONAL REDESIGN
Organisational redesign can be initiated either by force in response to a pressure, political or 
otherwise, or by the free will of staff based on evidence of successes in similar fields. In the NHS, 
many valuable cultural traits already existed and were not to be changed, such as the principles of 
the NHS, a commitment to care, etc., but it was also important to identify any potential for 
improvement or if resistance was commonplace.
Redesign aimed to change a “process” -  a collection of activities that takes one or more inputs to 
create an output that added value to the customer (Hammer and Champy, 1993). In the case of 
the NHS, this referred to any processes where a patient was directly the input and was directly on 
the receiving end (the output) (Probert et al., 1999). When applied to healthcare, the term 
“redesign” did not necessarily mean the change or reorganisation of a system. It required thinking 
from scratch to design the best process by which to achieve speedy and effective care from a 
patients’ perspective, identifying where delays, unnecessary steps or the potential for error were 
built into the current process and then removing them to dramatically improve the quality of 
healthcare (Locock, 2003).
NHS redesign had to challenge the “organisational treadmill”, questioning whether some working 
practices needed to be done at all and causing staff to reconsider their whole approach to 
improving the quality of their services. A key element of this thinking was to place the patients’ 
perspective at the heart of understanding the purpose and value of NHS service delivery. What 
redesign theories offered were helpful ways to identify, analyse and reconceptualise many 
problems so that an effective course of action could be planned. It did not in itself provide a set of 
transferable solutions, and changes in both funding and the use of existing resources were 
necessary to support the redesigning of processes. Continuous evaluation and reflection with 
participants helped refine peoples’ understanding of how to approach change in different 
circumstances and what might or might not be useful strategies to test out, helping to generate a 
“family of answers” rather than a single formula for success.
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The problem with directly applying industry-based redesign methodologies was that they used 
jargon not commonly encountered within the healthcare setting and it was difficult for NHS staff to 
apply these redesign techniques to an organisation as complex as the NHS. The NHSMA played 
an important role in “interpreting” these methodologies for application within the NHS, and then 
actively guided both managerial and clinical staff on their use.
The NHSMA synthesised many industry-based redesign theories into one simple format for 
dissemination to NHS staff. These theories included Business Process Re-engineering (BPR) 
(Hammer and Champy, 1993), Total Quality Management (TQM) (also known as Continuous 
Quality Improvement or CQI) (Deming, 2000), Lean Thinking (Womack et al., 1990, Womack and 
Jones, 1996) and the Theory of Constraints (Goldratt, 1994, Goldratt, 1984). Each is described in 
more detail in Table 1. All advocated a “customer-centred” approach to redesign, examined whole 
processes rather than single tasks or departments and aimed for dramatic improvements in quality 
(Locock, 2001).
3.1 NHS reforms using industry-based redesign methodologies
The four redesign theories discussed in this thesis have been implemented within a number of 
NHS Trusts, although peer-reviewed publications citing examples of their application were limited. 
Each is discussed in more detail below.
3.1.1 Business Process Reengineering
There are many reports from authors who claim to have re-engineered but closer scrutiny of their 
methodology shows that they have used the terminology loosely and have not applied true BPR as 
described in Table 1.
Of those true BPR redesign studies published, the most infamous was implemented in Leicester 
Royal Infirmary in the 1990s. Its transformation was not to the extent and pace intended at the 
start of the initiative, but service efficiency had improved marginally faster than a peer group of the 
same status during this time (McNulty and Ferlie, 2002). Two external evaluations of this BPR 
project came to the same conclusion (Bowns and McNulty, 2000, Brennan et al., 2005), and also 
reported cash savings and that improvements had been sustained (Bowns and McNulty, 2000).
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Business Process Reengineering (BPR) Total Quality Management (TQM)
Methodology - Process mapping to identify the current 
process from the customers’ perspective.
- Start from scratch in deciding the best way to 
completely redesign the process from a 
customer-centred perspective.
- Conduct a comprehensive pilot of the new 
design using meticulous measurements.
- Monitor activity and the results of any action 
continuously.
- The “Plan; Do; Study; Act (PDSA)” cycle.
■=>Plan - Identify and evaluate all causes of 
a problem.
^  Do -  Change a process to eliminate the 
problem.
■=> Study - Measure the effects of the 
change.
=> Act - Make the change permanent.
- Monitor activity and the results of any action 
continuously.
Criteria required 
for successful 
introduction
- Decisions are made at the level where the 
work is carried out.
- Preserving the trust of employees.
- Extensive use of benchmarking.
- An aggressive BPR performance target.
- Strong emphasis on IT.
- Reward positive behaviour.
- BPR at the top of the corporate agenda.
- Organisation-wide philosophy of quality as 
everyone’s business.
- Eliminating numerical quotas.
- Giving workers respect and feedback about 
how they are doing their jobs.
- Reporting errors / defects without fear of 
blame.
- Creating a culture of open questioning and 
constant learning.
- Concentrating on prevention, not correction.
Advantages - Has a dramatic potential for radical, high 
quality improvements within an organisation in 
a short space of time (-1 year).
- Does not require total upheaval.
- Has achieved successful improvement in 
many defined project areas.
- Professional and departmental barriers are 
broken down.
Disadvantages - Causes dramatic reductions in staff.
- Has a high (50-70%) failure rate.
- Is violent and aggressive in sweeping aside 
existing practices.
- Failure destroys morale and momentum.
- Is often at odds with organisational values.
- Cannot be achieved by simply fine-tuning or 
fixing a process.
- It is not advisable to expend energy across 
too many BPR projects.
- Is best applied to organisations that “have 
nothing to lose".
- Produces only slow, incremental 
improvements over many years.
- Changes are usually on a relatively small 
scale.
- Lack of immediate results can raise doubts 
as to whether the investment of time and 
money is justified.
- Little evidence of any organisation-wide 
impact.
- Does not advocate creating novel, innovative 
solutions.
- Promotes single-loop learning rather than 
multi-loop learning.
- Focuses on cost efficiency that could limit 
the capacity and opportunity for innovation.
(Cont’d...)
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(...Cont’d)
Lean thinking Theory of Constraints
Methodology - Understanding what value is and what 
activities and resources are necessary to 
create that value - everything else is waste.
- Process mapping to identify all steps in the 
value stream for each product, eliminating 
where possible those steps that do not create 
value.
- Making value-creating steps occur in tight 
sequence so product flow is smoother.
- Letting customers pull value from the next 
upstream activity.
- Aims for perfect value with no waste.
- Identify the system’s constraint.
- Decide how to exploit the system’s constraint, 
since it determines system throughput.
- Subordinate everything else to the decision 
made in step 2.
- Elevate the system’s constraint.
- If a constraint has been broken, go back to the 
start. Anything that increases throughput at a 
bottleneck, almost without regards to cost, adds 
value to the system.
Criteria required 
for successful 
introduction
- Short cycle times of design, production, and 
delivery.
- Dedicated leaders at every level of the 
supply chain.
- Constant evaluation of the process to identify 
new bottlenecks.
Advantages - A lean environment will have sufficient 
capacity to handle variations without 
introducing queues.
- A control system with a short feedback loop 
is far more effective than a long feedback loop 
at maintaining control of a process.
- Very low failure rates.
- 99% of organisational constraints in a company 
are policies or lack of and management can 
resolve them.
- There will always be a bottleneck but it allows 
the decision as to where it is best managed.
- It recognises that the whole is much more than 
the sum of its parts.
Disadvantages - Must be sustained long-term for performance 
improvement.
- It may be possible to identify a better 
pathway but it may not be clear how to 
resource it.
- As products move from one department to 
another, gaps can develop, especially if each 
department has its own set of performance 
measures.
- Removing one bottleneck will inevitably result 
in another forming at another point.
- The location of bottlenecks is not obvious so 
rigorous analysis is necessary.
Table 1: A description of the main four industry-based redesign strategies, BPR, TQM, Lean Thinking and 
the Theory of Constraints, applied to NHS redesign programmes by the NHSMA.
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BPR has also been successfully applied to the fields of patient admissions and the dermatology 
diagnostic patient process (Probert et al., 1999), trauma wards (Leverment et al., 1998, Nicholson, 
1995), surgery (Casaletto and Rajaratnam, 2004), pharmaceutical care (al-Shaqha and Zairi, 
2000), A&E and orthopaedics (Nicholson, 1995). The reported impact of BPR included saving 
money (Probert et al., 1999), better patient care (Probert et al., 1999, al-Shaqha and Zairi, 2000), 
the restructuring of wards and improved admissions procedures (Leverment et al., 1998), the 
improved hospital documentation, the reduction of duplications and rich data sources (Nicholson, 
1995) and a reduction in procedure time (Casaletto and Rajaratnam, 2004). However, one study 
reported that it was not well received by the relevant health professionals (Leverment et al., 1998).
3.1.2 Total Quality Management
The implementation of TQM in the NHS is more widespread, but less well reported than BPR due 
to its less invasive characteristics. The more commonly published TQM-related texts are 
concerned with the evaluation of TQM application by independent bodies. These reports all 
comment on the success of TQM at a generic level throughout NHS Trusts (Joss et al., 1994) or 
when applied to specific targets such as outpatient clinics (Hart, 1996), orthopaedics (Bate et al., 
2002) and risk management (Scholefield, 2007). TQM successes include improvements in the 
proportion of patients seen within 30 minutes, a goal set out in the Patients’ Charter (Hart, 1996), a 
decrease in mean length of stay for patients (Bate et al., 2002) and reduced risks in accordance 
with National Patient Safety Agency guidelines (Scholefield, 2007).
One DH-funded study evaluating the introduction of TQM at a sample of NHS Trusts (Joss et al.,
1994) also led to the publication of a paper listing the clear factors that predict the successful 
implementation of TQM (Joss, 1994).
3.1.3 Lean thinking
The NHSMA published The big referral wizard - a guide to systems management in healthcare in 
September 2002 to introduce Lean Thinking to NHS staff (NHS Modernisation Agency Demand 
Management Group, 2002). Since then, Lean Thinking has been widely promoted by the NHS 
Institute for Innovation and Improvement as a method of improving turnaround times and reducing 
waste. Case studies on the application of Lean Thinking are available on their website (NHS 
Institute for Innovation and Improvement, 2008). The DH has also published literature to educate 
NHS staff on the benefits of Lean Thinking (Department of Health, 2006b).
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Very little peer-reviewed literature has been published describing the impact of Lean Thinking on 
NHS services to date. The only relevant reference retrieved referred to its successful application of 
in a medical photography department within Cardiff and Vale NHS Trust (Crompton, 2005).
3.1.4 The Theory of Constraints
The Theory of Constraints was introduced to three departments -  Neurosurgery, Eyes and the Ear, 
Nose and Throat (ENT) -  at Radcliffe Infirmary in Oxford in 1997 to reduce waiting lists and 
improve patient throughput (Lubitsh et al., 2005). Successes were reported for Eyes and ENT but 
none for Neurosurgery, possibly due to the self-contained nature of Eyes and ENT departments 
and the fact that they were not subject to emergency referrals, whilst Neurosurgery was far more 
complex and relied on other diagnostic services.
Another study at the Oxford Radcliffe Hospitals NHS Trust focussed on the inability of their A&E 
services to meet the four hour turnaround targets because they were unable to move patients from 
one kind of care to the next (Goldratt, 2002). The implementation of the Theory of Constraints 
significantly improved their services as it led to the development of dynamic buffer management 
and treating the discharge practice as a complex, multi-project environment.
3.2 Problems with redesigning NHS services
The traditional working culture of an organisation may reflect what worked well in the past but 
equally, it may equally reflect a reluctance to change, either because of a lack of impetus or due to 
the fear of making things worse. The rules and regulations vital for safe and effective healthcare 
sometimes constrained redesign attempts. Some traditional working practices were based on rules 
that either no longer existed or were someone’s personal interpretation of a guideline that 
remained unquestioned by management.
Healthcare workers operated in a fishbowl characterised by high expectations, deep personal 
commitment, and a low tolerance for error (Berwick, 2003). The weight of both political and public 
expectation made redesigning NHS services a difficult challenge. Most redesign strategies can 
work if managed effectively and given the necessary time, but they rarely live up to the dramatic 
claims made for them in the early stages of their promotion. Staff often became disheartened 
when evidence and benefits of successful change did not emerge in a short period of time, and 
keeping them motivated became more difficult.
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Health professionals have no prior training in the design or management of radical changes 
needed to improve healthcare (Leach, 2001). Prior to the NHSMA, no clear advice or guidance 
had been published for inexperienced NHS management on how to effectively modernise NHS 
services to meet government targets efficiently and effectively on a nationwide level. Most 
redesign guides were targeted at redesign within the industrial sector and used complex jargon that 
health professionals were not familiar with. With no guidance on the best ways to redesign 
services, past attempts at reform were usually based on a safe, minor reorganisation of services as 
opposed to the radical, “starting from scratch” approach promoted by the NHSMA. Also, many 
changes were directed at solving one particular problem and did not address the process as a 
whole. Health professionals had been left to their own devices when it came to making the most of 
their resources to meet targets, resulting in a wide variety of working practices across the country 
and a two-fold difference in the cost of care between the best and the least efficient hospitals 
(Enthoven, 2000b).
Organisations do not change unless the people within them do (Killigrew, 2002). If NHS Plan 
targets were to be achieved, the number of staff actively involved in redesign needed to increase, 
but most were not keen to take on redesign challenges due to a history of unsuccessful reform 
causing low morale. Less than 15% of all NHS staff were actively involved in improvement 
activities prior to the publication of the NHS Plan (NHS Modernisation Agency, 2002a). There had 
been no personal or departmental incentives during past reform attempts, which led to a lack of 
ownership, failure of the redesign project and lack of motivation to support any future changes. 
Past improvements to strengthen management to increase efficiency created resentment amongst 
healthcare professionals who perceived it as a threat to their status and autonomy (Klein, 2001), 
believing that decision-making had become managerialised and hence, deprofessionalised (Ferlie, 
1997). The improvement of healthcare required an increased emphasis on team working (Firth- 
Cozens, 1998), but the issue of professional trust also came to the foreground (Berwick, 2003). 
Professional demarcations between staff types needed to be tackled if team working was to result 
in effective modernisation.
Scepticism of redesign plans among key individuals (clinical and managerial alike) negatively 
affected the implementation of new practices and often manifested at the practical level as 
resistance. The causes of scepticism were complex and interconnected and included emotional, 
intellectual and organisational objections to change. The following reasons for scepticism towards
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redesign have been identified (Leach, 2001, NHS Modernisation Agency, 2002a, Gollop et al.,
2004):
•  Bad presentation of information about the nature, purpose and significance of the 
redesign, leaving staff confused and unconvinced of the benefits.
•  Perceiving that the redesign attempt has been politically inspired, or is a “top-down” 
management initiative.
•  Believing that other competing priorities should take precedence.
•  Believing that the change will not be beneficial to staff, patients or the organisation.
•  Fearing that the change will be threatening to the individual’s status and power.
•  Dislike of the jargonistic language and theory associated with industry-based redesign 
initiatives.
On a positive note, scepticism can also highlight potential pitfalls, add an influx of energy to the 
change process, encourage searching for an alternative (and possibly superior) method and help 
to balance the pressure for change against the need for stability (NHS Modernisation Agency, 
2002a).
A successful change can only truly be classified as such if it is capable of being naturally spread 
through the organisation and more importantly, sustained in the long term. However, the NHS has 
not been good at learning from itself in the past, with examples of good practice often not 
replicated in the same hospital, let alone the next town (Coombes, 2003). Successful reforms 
often exhibited an “Island of Improvement” effect, remaining confined to their department of origin 
and were often not applicable elsewhere, and/or an ’’Improvement Evaporation” effect if the reform 
was not continuously managed.
3.3 Overcoming the problems of redesigning the NHS
The principle underlying the new NHS reforms was “what counts is what works” (Goddard et al., 
2000) i.e. retaining what works and discarding what doesn’t. Healthcare systems cannot be 
reformed with single initiatives - multifaceted strategies are needed and even then, it needs to be 
acknowledged that some parts of the initiative may still fail (Smith, 2003).
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The NHSMA introduced a unique approach to the implementation of redesign initiatives in the 
NHS. They promoted close relationships between NHS staff and their own specialist redesign 
teams to drive changes forward with a view to making them successful, sustainable and diffusible. 
They also incorporated the need for a fundamental understanding of how the current service 
worked before attempting to improve it and they introduced tools and guides for NHS staff to follow 
as they embarked on modernising their services. They also realised the benefits of providing some 
unmarked funding with the specific remit of facilitating pre-agreed redesign plans due to the 
difficulties faced by most units in securing this type of funding from NHS Trusts.
The NHSMA were guided by the Principles of Modernisation: Renewal -  more modern buildings 
and facilities, new equipment and more staff; Redesign -  services delivered in a radically different 
(but better) way; and Respect -  a culture of mutual respect between politicians and the NHS, 
between different groups of staff in the service and between the NHS and the public (NHS 
Modernisation Agency, 2003a). In order to redesign healthcare services effectively, the NHSMA 
strongly advised seeing the whole of the patients’ journey from the patients’ perspective and giving 
frontline staff the time and the tools to tackle any problems. The complexities of applying any 
redesign strategy to the NHS were further confounded by the fact that there were often no suitably 
qualified individuals in post in the NHS to oversee their implementation. To address this, the 
NHSMA published guides geared towards both clinical and management professionals, as well as 
providing support and advice on demand.
Using the same successful evidence-based approaches applied to the industrial sector, the 
NHSMA blended the strengths of various redesign strategies whilst adapting them for use in NHS 
organisations. They combined the radical redesign concept and the value of “quick wins” from 
BPR with the incremental testing on a small scale using measurable data advocated by TQM, the 
process mapping techniques of Lean Thinking and the identification of constraints described by the 
Theory of Constraints.
Decisions on the leadership of a redesign project were made internally by NHS staff and not by the 
NHSMA, based on staff and resources available. Sometimes it was clinical professionals who 
assumed overall responsibility, while in other cases it was a management-based person with an 
interest in facilitating change, designated a “change agent”. Both types of leader had 
advantageous qualities: clinical leads were well respected and better at connecting with and 
motivating their departmental staff, usually due to their common goal of improving the department,
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whereas change agents tended to have more of the skills required to properly manage a redesign 
project, using more evidence-based ideas and being more conscious of the financial situation, 
impacts on other departments and other redesign projects within the hospital. No one position was 
better at leading redesign projects than the other -  the best leader was usually the one with a 
strong belief that they could change anything they wanted (Smith, 2001).
Once a leader for the project was assigned, a redesign team was assembled consisting of both 
clinical and management staff from the frontline and all departmental staff were required to 
participate on some level. The redesign team had the day-to-day responsibility of setting up the 
project, implementing the changes and monitoring the results, whilst the leader posed as a 
“figurehead” for the project, acting as a catalyst for the redesign process and using their authority 
to overcome any barriers to change, political or financial.
Examination of the existing system was essential to identify problematic areas and then focus 
redesign efforts where they were most needed. It usually encompassed taking baseline (pre­
redesign) measurements of demand, capacity and activity for a specific period of data collection at 
the ‘raw’ data level, to be analysed and evaluated by the redesign team. This would highlight any 
problems in the system. Many redesign tools and guides were available for performing this type of 
analysis but most were aimed at industrial organisations and many could not be applied to the 
NHS.
The NHSMA designed their own improvement guides (NHS Modernisation Agency, 2002d, NHS 
Modernisation Agency, 2002b, NHS Modernisation Agency, 2002c, NHS Modernisation Agency, 
2002e, NHS Modernisation Agency, 2004b, NHS Modernisation Agency, 2004c, NHS 
Modernisation Agency, 2004a) and used data collection software called “Toolkits” designed 
specifically for use by inexperienced NHS staff for the examination of specific processes within 
areas of healthcare including endoscopy (NHS Modernisation Agency, 2003b) and radiology (NHS 
Modernisation Agency, 2003d).
Process mapping was implemented for analysing the patient journey during their time in the 
department. A specific process was selected and defined from starting point to finishing point and 
all members of staff within the department described the patient process from their perspective to 
allow a map of a patients’ real journey to be drawn, ideally from the patient’s perspective, and 
identifying all staff involved at each step and their roles. Timings of each step were necessary to
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identify delays. Process mapping was a powerful tool for convincing staff to embrace change 
because it could successfully highlight unnecessary but engrained practices, the number of 
different staff a patient may see during their journey, any duplication in tasks, inadequate staffing 
levels and the inappropriate tasks being done by highly skilled professionals.
Once the baseline data collection and analysis was complete, and the problems were identified, 
the next step was to develop new ways of working that would solve those problems. The goal for 
redesign was based on what would be a “perfect” experience for patients. When all staff in the unit 
were involved in the redesign effort and asked for their opinions and ideas, it was thought that they 
would feel a sense of ownership of the changes and would be more motivated to help facilitate 
change.
It was vital that any successful modernisation initiatives were also sustainable, or else redesign 
efforts would have been wasted and staff morale would suffer. Changes also needed to be 
manageable but there had to be lateral thinking to look beyond existing processes to address the 
whole process. It was also important that the impact of the redesigns were measurable using 
consistent and accurate data in order to detect any positive or negative effects. The redesign team 
needed to consider all possible consequences of their redesign plans, both positive and negative, 
within and outside the department being redesigned. However, in complex and dynamic 
organisations such as the NHS, redesign plans could never anticipate everything.
Small scale testing of any redesign ideas was important to determine whether they had achieved 
the desired outcome, whether there were any unforeseen problems and whether they were 
financially and willingly sustainable for the foreseeable future. This was usually done using PDSA 
cycles taken from the Model for Improvement®, advocated by the IHI. Control charts monitored 
improvements by plotting data collected against theoretically achievable and sustainable targets. 
Small variations were acceptable, but if the data went beyond the upper or lower process control 
limits, action was necessary. Data collection could be used as evidence of successful 
improvements, helping to gain the interest and acceptance of staff as they saw demonstrable 
benefits, although it was unrealistic to assume a radical transformation overnight.
One specific aspect of NHS modernisation covered by the NHSMA was the modernisation of NHS 
endoscopy services in England. This focussed on the need to diagnose and treat patients with 
gastrointestinal (Gl) complaints, especially those presenting with suspected Gl cancers, in
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accordance with the targets set by the NHS Cancer Plan (Department of Health, 2000b) and later 
on, the NHS Improvement Plan (Department of Health, 2004c). The next chapter explains the 
types of Gl conditions that patients referred to an NHS endoscopy unit may be investigated for, as 
well as describing the way the service commonly operated.
4. CONDITIONS OF THE GASTROINTESTINAL TRACT
The human Gl tract begins at the mouth and ends at the anus and is responsible for the intake and 
digestion of food, and the excretion of any remaining waste products. In a normal adult male, the 
Gl tract is approximately 6.5 meters long and is split into the upper Gl tract (mouth, pharynx, 
oesophagus, stomach and duodenum) and the lower Gl tract (the small and large intestines, 
rectum and anus). The Gl tract is prone to many acute and chronic health problems, both 
cancerous and non-cancerous. This chapter discusses the more commonly diagnosed disorders 
of the human Gl tract in more detail.
4.1 Cancers of the Gl tract
Gl cancers usually begin as a benign growth known as an adenomatus polyp (or adenoma), that 
are formed as the result of uncontrolled cell division in the Gl mucosal cells following damage to 
the cell nuclei. Some of these may later develop into adenocarcinomas -  cancers of the Gl 
mucosal tissues. The reason(s) for the development of a polyp into a malignant tumour are not 
known but may include diet, a genetic predisposition, age or DNA damage leading to abnormal 
apoptosis (programmed cell death). The organs of the Gl tract possess a high capability of 
continuous tissue regeneration in response to acute or chronic disorders, largely maintained by a 
stable pool of peripheral stem cells that are tightly regulated in their proliferative capacity and give 
rise to a pool of highly proliferative progenitor cells (Neureiter et al., 2006). It is abnormalities with 
these cells that can lead to some Gl cancers. The three most commonly occurring Gl cancers in 
the UK are oesophageal cancer, stomach (or gastric) cancer and colorectal cancer (CRC). Each of 
these will be described in more detail below.
In oesophageal cancer, the lining of the oesophagus changes into either squamous cell 
carcinomas or adenocarcinomas, depending on their location. Approximately 74% of patients with 
oesophageal cancer present with dysphagia as the growing cancer obstructs the passage of food 
(Enzinger and Mayer, 2003), often leading to a significant amount of weight loss prior to diagnosis. 
Chest pain or retrosternal discomfort can occur in patients who have oesophageal spasm, again 
from irritation by the tumour. A larger tumour can erode the wall to the point where it causes
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bleeding, noticed either when the patient vomits or with blackening of the stool. Oesophageal 
cancer is thought to be a multifactoral disease but may develop from oxidative damage caused by 
factors including smoking, alcohol and inflammation caused by conditions such as oesophagitis. 
All of these factors can increase cell turnover, possibly instigating the carcinogenic process 
(Enzinger and Mayer, 2003). McCabe and Dlamini have published a review of the molecular 
genetics and candidate genes thought to be associated with the development of oesophageal 
cancer (McCabe and Dlamini, 2005).
Stomach cancer, also known as gastric cancer, generally occurs when cells of the mucosa or 
submucosa (the lining of the stomach) grow uncontrollably and form adenocarcinomas. Studies 
suggest that genetic predisposition, alcohol, diet and smoking are part of a complex interaction that 
forms the cancer (Hohenberger and Gretschel, 2003, Catalano et al., 2005). Some gastric cancers 
have also been linked to Helicobacter pylori (H. pylori) infection during childhood (Hohenberger 
and Gretschel, 2003). Patients do not tend to be symptomatic at the early stage of the disease and 
at later stages the symptoms are often still non-specific and hard to diagnose (Catalano et al., 
2005). The vast majority of patients present with vague complaints such as upper abdominal 
discomfort or indigestion, loss of appetite, occasional vomiting, flatulence, belching, or fullness 
(Catalano et al., 2005). Other symptoms such as vomiting blood or dysphagia are less common.
The majority of CRC tumours begin when normal tissue in the colon wall forms an adenomatous 
polyp, or pre-cancerous growth projecting from the colon wall. As the polyp grows into a tumour, it 
may bleed or obstruct the colon, causing symptoms including bleeding from the rectum visible in 
the stool or toilet after a bowel movement, a change in bowel habit, cramping pain in the abdomen, 
and iron deficiency anaemia (Majumdar et al., 1999, Hay, 2002). The incidence of CRC differs 
according to the region of the bowel (see Figure 1). CRC symptoms can vary according to whether 
the carcinoma is on the left or the right of the colon (Baig and Marks, 2000), but tend to include 
symptoms such as rectal bleeding, a change in bowel habit or a rectal mass. The cause of CRC is 
not known but there is evidence to suggest that diet, smoking and a genetic predisposition to the 
disease can greatly increase the relative risk for a person (Midgley and Kerr, 1999), as well as the 
age of the individual, with 95% of CRCs presenting in patients aged over 50 (Baig and Marks, 
2000).
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Anus 2%
Figure 1: Percentage distribution of CRC cases by site within the large bowel, England 1997 to 2000. 
Illustration taken from Cancer Research UK website at in fo .cancerresearchuk.org.
4.1.1 Gl cancer incidence
There is an increase of between 1.4% and 2% per year in the number of people who will be 
diagnosed with a cancer because of better screening and diagnoses, and our ageing population 
(Department of Health, 2004b, Bosanquet and Sikora, 2004).
According to the ONS, the incidence of oesophageal cancer has increased since 1995 (see Figure 
2). Cancer Research UK incidence reports ranked oesophageal cancer as the ninth most common 
cancer in 2004, accounting for 3% of all cancers diagnosed in 2003 (excluding non-melanoma skin 
cancer) (Cancer Research UK, 2008a). Table 2 gives the number of newly diagnosed cases of 
oesophageal cancer in the UK in 2002/04, along with an age-standardised incidence rate, split 
according to gender and country. Males had the highest incidence rate overall. When examined 
according to country, the incidence rate was highest in Scotland (17.9 for males and 7.4 for 
females) and lowest was in Northern Ireland (11.2 for males and 4.5 for females). A recent study 
by Moller et al estimated the number of oesophageal cancer cases to increase from 2001 to 2020 
by 58% for males and 21% for females (Moller et al., 2007).
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Figure 2: Incidence of newly registered cases of the three most common Gl cancer types in England 
between 1995 and 2003. SOURCE: ONS (accessed Jan 2006).
Site
description Sex
UK England Wales Scotland N Ireland
N°. Rate N°. Rate N°. Rate N°. Rate N°. Rate
Oesophagus M 4,817 14.0 3,953 13.7 257 13.9 515 17.9 92 11.2
(C15) F 2,760 5.6 2,225 5.4 166 6.3 315 7.4 54 4.5
Stomach M 5,422 15.3 4,408 14.8 345 18.2 521 18.0 148 17.5
(C16) F 3,103 6.2 2,472 5.9 212 7.9 332 7.8 87 7.2
Colorectal M 18,773 53.7 15,336 52.2 1,087 57.9 1,851 63.7 499 59.6
(C18-C20) F 15,622 33.7 12,754 32.8 870 35.2 1,562 38.9 435 39.1
Table 2 Newly diagnosed cases of cancer and directly age-standardised1 incidence rates per 100,000 
population from Gl cancers (according to ICD-10 codes). Selected sites by gender and country, UK, 2002- 
20042 (1 Using the European standard population,2 All numbers and rates in this table are calculated as 
three-year averages) SOURCE: ONS (accessed Sept 2007).
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The incidence of stomach cancer has decreased over the last few years (see Figure 2). Cancer 
Research UK also reported that the incidence of stomach cancer fell from the sixth most common 
cancer to be diagnosed in 2000 to eighth in 2004 (excluding non-melanoma skin cancer) (Cancer 
Research UK, 2008a). Table 2 gives the number of newly diagnosed cases of stomach cancer in 
the UK in 2002-04, along with an age-standardised incidence rate, split according to gender and 
country. Males had the highest incidence rate overall. When examined according to country, the 
incidence rate was highest in Wales (18.2 for males and 7.9 for females) and lowest was in 
England (14.8 for males and 5.9 for females). Moller et al estimated that the number of stomach 
cancer cases will increase from 2001 to 2020 by 6% in males but that there will be a 7% decrease 
for females (Moller et al., 2007).
The incidence of CRC has risen and fallen over the last few years and is currently on the increase 
again (see Figure 2). Cancer Research UK also reported that in 2004, CRC incidence was ranked 
in third place, accounting for 13% of all cancers diagnosed that year (excluding non-melanoma skin 
cancer) (Cancer Research UK, 2008a). Table 2 gives the number of newly diagnosed cases of 
CRC in the UK in 2002-04, along with an age-standardised incidence rate, split according to 
gender and country. Males had the highest incidence rate overall. When examined according to 
country, the incidence rate was highest in Scotland (63.7) for males and in Northern Ireland (39.1) 
for females. The lowest was in England (52.2 for males and 32.8 for females). Moller et al 
estimated an increase from 2001 to 2020 in colon cancer cases by 32% for males and 12% for 
females and in rectal cancer cases by 52% for males and 35% for females (Moller et al., 2007).
4.1.2 Gl cancer mortality rates
Cancer Research UK recently reported that oesophageal cancer was the fifth most common cause 
of cancer-related death in the UK in 2002 and 2003, accounting for 5% of all cancer-related deaths 
(Cancer Research UK, 2008b). Table 3 gives the number of deaths from oesophageal cancer in 
the UK in 2002-04, along with an age-standardised mortality rate, split according to gender and 
country. Males had the highest mortality rate overall. When examined according to country, the 
mortality rate was highest in Scotland (16.9 for males and 6.5 for females) and lowest was in 
Northern Ireland (12 for males and 4 for females).
Cancer Research UK also reported that stomach cancer was the seventh most common cause of 
cancer-related deaths in 2002 and 2003 (Cancer Research UK, 2008b). Table 3 gives the number 
of deaths from stomach cancer in the UK in 2002-04, along with an age-standardised mortality
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rate, split according to gender and country. Males had the highest mortality rate overall and when 
examined according to country, the mortality rate was highest in Scotland (12.7) for males and in 
both Wales and Northern Ireland (5.5) for females. The lowest was in England (10 for males and 
4.2 for females).
Cancer Research UK reported that CRC was the second most common cause of death by cancer 
in the UK in 2002 and 2003 (Cancer Research UK, 2008b). Table 3 gives the number of deaths 
from CRC in the UK in 2002-04, along with an age-standardised mortality rate, split according to 
gender and country. Males had the highest mortality rate overall. When examined according to 
country, the mortality rate was highest in Scotland (28.5 for males and 16.5 for females) and lowest 
was in England (23.1 for males and 14.1 for females).
Site
description Sex
UK England Wales Scotland N Ireland
N°. Rate N°. Rate N°. Rate N°. Rate N°. Rate
Oesophagus M 4,660 13.4 3,813 13.1 255 13.7 491 16.9 100 12.0
(C15) F 2,617 5.1 2,124 4.9 153 5.6 289 6.5 51 4.0
Stomach M 3,766 10.4 3,061 10.0 235 12.1 371 12.7 99 11.5
(C16) F 2,322 4.4 1,863 4.2 154 5.5 234 5.2 71 5.5
Colorectal M 8,496 23.9 6,932 23.1 498 26.1 839 28.5 228 27.2
(C18-C20) F 7,412 14.4 6,087 14.1 407 14.5 724 16.5 194 16.2
Table 3: Deaths from cancer and directly age-standardised1 mortality rates per 100,000 population from Gl 
cancers (according to ICD-10 codes). Selected sites by gender and country, United Kingdom, 2002-20042 (1 
Using the European standard population,2 All numbers and rates in this table are calculated as three-year
averages) SOURCE: ONS (accessed Sept 2007).
4.1.3 Gl cancer survival
The results of the Eurocare-3 study show that all three cancer types have a low one-year and five- 
year survival rate in the UK compared to the European average (see Figure 3) but recent data from 
ONS indicated that survival rates are gradually increasing, more so for cancers of the colon and 
rectum that for upper Gl cancers (see Table 4) (Eurocare-3,2006).
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Figure 3: Age-standardised one-year and five-year survival rates (%) for oesophageal, stomach and 
colorectal cancer in England and Europe, of patients diagnosed between 1990-4, split by gender.
SOURCE: EUROCARE-3 study, 2005.
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Cancer
location
Gender
1991-95 f 1996-991 Total difference 
(1991 to 1999)N°. patients Survival (%) N°. patients Survival (%)
Oesophagus M 14,644 5.6 12,814 6.9 +1.3
F 9,928 8.3 8,219 8.2 -0.1
Stomach M 25,793 10.0 19,555 12.6 +2.6
F 14,608 12.4 10,618 14.7 +2.3
Colon M 36,978 42.1 31,977 46.9 +4.8
F 39,668 42.8 32,243 47.9 +5.1
Rectum M 27,636 40.3 24,702 46.8 +6.5
F 20,053 44.8 17,264 51.1 +6.3
Table 4: Five-year age-standardised relative survival (%) for adult patients from England and Wales 
diagnosed during 1991-95 and 1996-99, split by gender and cancer type. SOURCE: ONS 2005.
CRC patients who are diagnosed at an early stage have a much better prognosis than those who 
present with more extensive disease, as shown by the five year survival rates for CRC patients 
according to the stage of the tumour, as designated by modified version of the Duke’s classification 
whereby A is an early stage tumour and D is a late stage tumour (Dukes, 1932). Campbell et al 
who reported that the proportion of patients surviving past five years is highest with earlier stage 
tumours (Stage A = 83%, B = 64%, C = 38% and D = 3%) (Campbell et al., 2001).
4.2 Non-cancerous conditions of the Gl tract
Whilst cancerous conditions of the Gl tract are more renowned, there are many other non- 
cancerous disorders of the Gl tract that occur both acutely and/or chronically, in the general 
population far more frequently. The most common of these conditions are described in more detail 
below.
Dyspepsia is a heterogeneous disorder of as yet unknown aetiology (Chua, 2006). It consists of a 
variety of combinations of symptoms including abdominal pain or discomfort, bloating, nausea, 
heartburn and acid regurgitation. For those patients with the latter two symptoms, they are
65
commonly diagnosed with gastroesophageal reflux disease (see below) but for the many patients 
who do not have a definite cause for their symptoms, they are usually characterised as suffering 
from dyspepsia (Chua, 2006), although dyspepsia is not a diagnosis in itself (Arents et al., 2002). 
The condition occurs in between 19% and 41% of the Western population (Arents et al., 2002) and 
tends to be chronic but periods of remission are common. There is some evidence to suggest a 
role for the bacterium H. pylori as a causal agent for the disorder, but as yet, nothing conclusive.
H. pylori does play a significant role in the cause of peptic ulcer disease (PUD) (Arents et al., 2002, 
Chan and Leung, 2002). PUD occurs in the stomach and proximal duodenum and symptoms can 
include epigastric discomfort (specifically, pain relieved by food intake or antacids and pain that 
causes awakening at night or that occurs between meals), loss of appetite and weight loss 
(Ramakrishnan and Salinas, 2007). When H. pylori infection is diagnosed, the infection should be 
eradicated to alleviate symptoms.
Gastroesophageal reflux disease (GERD) is a chronic, relapsing condition suffered by 
approximately 40% of people in the Western world (Pettit, 2005). It is caused by a transient 
decrease in tension in the lower oesophageal sphincter that allows the gastric contents to leak into 
the oesophagus (Malfertheiner and Hallerback, 2005). In cases where this reflux is prolonged, the 
condition is considered abnormal and may cause oesophagitis (inflammation of the oesophagus) 
(Malfertheiner and Hallerback, 2005, Pettit, 2005). Patients classically present with symptoms 
such as heartburn, dysphagia, regurgitation, belching and chest pain (Hay, 2002, Prakash and 
Genreali, 2003). Risk factors for GERD include diet, alcohol, stress, pregnancy and some 
medications (Pettit, 2005).
In some patients GERD can develop into Barrett’s oesophagus as the oesophageal mucosa 
develops into metaplastic columnar-specialised intestinal epithelium whereby the cells are 
abnormal but not yet cancerous (Malfertheiner and Hallerback, 2005, Flejou, 2005, Fitzgerald, 
2005). A recent systematic review reported the cancer incidence from Barrett’s oesophagus in the 
UK as 10 in 1000, although this reduced to 6 in 1000 for short segment Barrett’s oesophagus 
(Thomas et al., 2007). Symptoms are similar to those of GERD but are longer in duration, earlier in 
onset and the complications seen in GERD are more common (Hay, 2002). Barrett's oesophagus 
is diagnosed in between 4% and 12.4% of patients with endoscopic examination for the symptoms 
of GERD or heartburn (British Society of Gastroenterology Working Party, 2005a, Fitzgerald, 2005) 
and is far more common in men than women (Spechler, 2003, Jeffery, 2005). The British Society
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of Gastroenterology (BSG) have recommended biannual endoscopic surveillance for the early 
detection of any changes in the cells that may lead to cancer, since Barrett's oesophagus 
increases cancer risk anywhere between 10 - 150 fold (Jeffery, 2005, British Society of 
Gastroenterology Working Party, 2005a).
Inflammation is commonly caused by infection and can occur anywhere in the Gl tract, manifesting 
as conditions including oesophagitis, gastritis and duodenitis and inflammatory bowel diseases 
(IBDs). The gut associated lymphoid tissue usually mediates all immune inflammatory processes, 
but occasionally the reaction is inappropriate. When it is not down-regulated, it can result in a 
contribution to the mucosal damage, as seen in IBDs including Ulcerative Colitis (UC) and Crohn’s 
disease (CD) (Pathmakanthan and Hawkey, 2000, Griffiths, 2005, Beattie et al., 2006). UC 
presents in patients as chronic, bloody diarrhoea and depending upon the severity of the condition, 
can also cause pain and weight loss (Hay, 2002). The inflammation seen in UC is usually confined 
to the colonic mucosa. The annual incidence of UC in the UK is between five and eight cases per 
100,000 population (Ghosh et al., 2000). Patients with CD commonly complain of pain, weight loss 
and diarrhoea (Hay, 2002). The condition can occur anywhere in the Gl tract but is most common 
at the terminal ileum and/or colon (Head and Jurenka, 2004). The aetiology of CD remains 
unknown but it may be caused by genetic factors, diet, infective agents, smoking or stress 
(Metcalfe, 2002). A recent study has shown a continuing increase in the incidence of CD over time 
from 2.7 cases per million per year in 1931-1935 to 70 cases per million per year in 2001-2005, 
with a higher incidence in females than males (Gunesh et al., 2008).
Irritable bowel syndrome (IBS) is a complex, multifaceted condition broadly characterised by 
abdominal discomfort or pain in the setting of altered bowel function (Foxx-Orenstein, 2006) and 
can be caused by altered motility, visceral hypersensitivity, psychological factors and infection and 
usually occurs in young adulthood as a chronic condition (Hay, 2002). Patients experience 
abdominal pain or discomfort over a prolonged period of time associated with diarrhoea, 
constipation or both, and other problems with stool passage (Hay, 2002). The exact cause of IBS 
is unknown but it is believed to be multifactorial in origin. The symptoms are highly variable 
between patients and disease episode (Gilkin, 2005) but may be associated with increased stress 
which, in turn, affects the levels of stress-related hormones which may be responsible for an 
underlying predisposition to IBS (Foxx-Orenstein, 2006). Other potential factors include genetics, 
bacterial infections and food intolerance (Foxx-Orenstein, 2006). IBS is prevalent in approximately 
10% -15% of the UK population (Foxx-Orenstein, 2006) and is more prominent in females than
67
males (Spiller, 2004, Foxx-Orenstein, 2006). It is the most common of the functional Gl disorders 
and constitutes approximately 3% of all primary care consultations in the UK (Spiller, 2004).
Haemorrhoids are a pathologic engorgement of the submucosal vascular plexus and can be 
located internally or externally (Tang et al., 2005). They are commonly classified into four types 
ranging from 1st degree (bleeding only) to 4th degree (permanent prolapse) (Hancock, 1992). 
Although they are often asymptomatic, haemorrhoids may cause bleeding and pain. They usually 
arise as a result of constipation and straining to pass hard stools and are a common side effect of 
pregnancy. They affect between 4% and 36.4% of the UK population (Nisar and Scholefield, 2003, 
Hardy et al., 2005). Endoscopy can help visualise the source of the internal haemorrhoids and a 
therapeutic procedure called “banding” may also take place during the examination to strangulate 
the haemorrhoids, causing them to become necrotic and slough away whilst the underlying tissue 
undergoes fixation by fibrotic wound healing (Nisar and Scholefield, 2003).
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5. GASTROINTESTINAL ENDOSCOPY
Disorders of the Gl tract are becoming more common in today’s society. Factors such as diet, 
environment, and genetics can contribute towards many of the Gl conditions described in Chapter 
4. Patients presenting with these symptoms are often referred by their GP for a Gl endoscopy, an 
examination that allows the direct visualisation of the extreme upper and lower ends of the Gl tract 
through a natural body opening such as the throat or rectum using an instrument called an 
endoscope.
The word endoscopy is derived from the Greek words endo, meaning “within” and skopeo, “to look” 
(D'Silva, 1998). The endoscope was developed in 1806 by Philip Bozzini, but it wasn’t until the 
1930s that the first gastroscope was successfully used on a human subject (Shah, 2002, Sircus, 
2003). Technological advancements led to the development of the flexible fibreoptic endoscope by 
Basil Hirschowitz in the 1950s (Shah, 2002). The introduction of wireless capsule endoscopy in 
more recent years has provided a new way of investigating the Gl tract in its entirety. It involves 
the patient swallowing a capsule that contains fibreoptic bundles, video signals and power to allow 
a gastroenterologist to visualise regions of the small intestine not seen by traditional endoscopic 
techniques (Swain, 2003). It is not yet routinely available in all NHS endoscopy units.
The instrument shaft of a modern endoscope is composed of 20,000 to 40,000 specialised glass 
fibres, each approximately 10}im in diameter that allow the transmission of a light source with 
minimal distortion. The multiple fibre-optic images are integrated at the 2 - 3mm proximal eyepiece 
unit by a complex system of lenses. Within the instrument shaft are several “operating” channels 
designed for passage of optional devices such as biopsy forceps, polyp snare, cytology brush, 
cautery or laser devices, or a suction device. The channel also allows the transmission of air or 
water. At the head of the endoscope are two control devices that manoeuvre the instrument tip as 
it advances (Cotton and Williams, 1996). A camera or video recorder is often used during an 
endoscopic procedure to provide permanent records of internal organs, which may be used for 
later reference. Endoscope designs vary depending upon their purpose, with rigid endoscopes 
used for investigating short distances and flexible endoscopes with increased manoeuvrability used 
for more invasive procedures. Scope length varies, depending upon its intended target range.
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An upper Gl endoscopy (UGE) examines the first four feet of the Gl tract to enable an accurate 
diagnosis of many conditions where the symptoms are visible on the lining of the oesophagus, 
stomach or duodenum. The colon and rectum make up the last few feet of the Gl tract and are 
examinable using lower Gl endoscopy (LGE), which can comfortably visualise the whole of the 
large intestine as far as the caecum (see Figure 4). The majority of Gl complaints tend to occur 
within the limited range of an endoscope, with the 20 feet of unscopable small intestine only 
causing problems such as obscure Gl bleeding in approximately 5% of patients (Lahoti and 
Fukami, 1999, Ali et al., 2004).
Figure 4: The human Gl tract. This illustration was found using Google™ images (ww w .qoogle.co.uk).
Endoscopy is credited with being able to identify the source of Gl haemorrhaging in more than 90% 
of lesions, reducing the incidence of emergent surgeries and the overall mortality from acute upper 
Gl bleeding (Vitale et al., 2005). It can also be used therapeutically to perform treatments or to 
take biopsies for diagnosis. Treatments can include controlled tissue destruction by photodymanic 
therapy, coagulation techniques and mucosal resection (Kuipers and Haringsma, 2005). 
Approximately 90% of acute Gl bleeding occurring with peptic ulcers can also be treated at initial 
diagnosis (Vitale et al., 2005) and colonoscopic polypectomy (polyp removal) can reduce the 
incidence of CRC (Winawer et al., 1993).
Lower endoscopy Upper endoscopy
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It is likely that endoscopy will replace many surgical approaches in the management of many 
diseases over the next decade (Vitale et al., 2005), since it is a far less invasive procedure than 
open surgery, resulting in less scarring and a quicker recovery time. However, the appropriateness 
of its application needs to be balanced with the assessment and management of any potential 
complications in the patient (Kavic and Basson, 2001). Risks can include sedation (D'Silva, 1998, 
Kavic and Basson, 2001), cardiopulmonary problems (Shimamoto et al., 1999, Yazawa et al., 
2000), perforation and haemorrhaging (Kavic and Basson, 2001) and patient distress (D'Silva, 
1998). There is also a potential risk from incomplete decontamination of the endoscope (Gamble 
et al., 2007).
The increased versatility of modern endoscopy has also led to it replacing some radiological 
investigations. Recent studies have compared the effectiveness of endoscopic techniques with 
radiological ones in the identification of CRC and all concluded that colonoscopy had a superior 
sensitivity for polyps than barium enemas (Winawer et al., 2000, de Zwart et al., 2001, Smith and 
O'Dwyer, 2001, Menardo, 2004, Rockey et al., 2005). However, improvements in ultrasound 
technology has begun to redress this balance in the areas where Gl endoscopy was largely blind 
(Hirschowitz, 2000).
5.1 Types of Gl endoscopy
There are four main types of Gl endoscopy performed routinely in NHS endoscopy units: 
Gastroscopies and oesophago-gastro-duodenoscopies (OGDs), which are both UGEs, and 
colonoscopies and sigmoidoscopies, which are both LGEs. All are discussed in more detail below.
5 .1.1 Upper Gl endoscopies
An OGD is a UGE procedure whereby a 120cm gastroscope is inserted via the mouth for a visual 
examination of the oesophagus, stomach, and duodenum, including the mucous membrane of the 
stomach from the top to the bottom. A gastroscopy uses the same equipment but involves the 
examination of the stomach only. The procedures can take between 10-15  minutes and localised 
sedation using a throat spray is optional. Gastroscopies account for approximately 70% of all 
investigations of the Gl tract (D'Silva, 1998).
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5.1.2 Lower Gl endoscopies
Colonoscopies are one type of LGE procedure. At 160cm, the colonoscope is inserted via the 
anus to visualise the entire colon as far as the junction with the small intestine. The procedure can 
take between 1 5 - 6 0  minutes, depending upon the quality of the visualisation of the bowel, the 
location of the abnormality and the skill of the endoscopist. Discomfort during and after the 
procedure due to the insufflation of the bowel is common and sedation is highly recommended. 
Approximately 90% of polyps can be seen and removed during a colonoscopy (National Institute 
for Clinical Excellence, 2004b). It is an expensive procedure but is considered to be the “gold 
standard” for detecting small and pre-malignant lesions in the bowel.
Sigmoidoscopies are the other type of LGE and can be either rigid or flexible. Rigid sigmoidoscopy 
uses a short endoscope that examines only the rectum and usually takes approximately 10 
minutes. Flexible sigmoidoscopy (FS) uses a 60cm long endoscope to examine the distal colon, 
which can take between 15-40 minutes. Approximately 70% of polyps can be seen and removed 
with FS (National Institute for Clinical Excellence, 2004b). However, FS is limited in its ability to 
examine the whole colon due to the length of the scope. Only the descending colon can be 
completely visualised, although two thirds of adenomas and cancers are located within the reach of 
a FS (Atkin et al., 1993). The presence of any abnormalities in the left side of the colon makes 
additional investigation necessary (Papagrigoriadis et al., 2004).
5.2 Complications of endoscopy
Complications can occur following an endoscopy whereby the patient has to be admitted to 
hospital within typically 30 days of their procedure for symptoms related to the condition that was 
investigated, or for other problems including angina or myocardial infarction, for observation or for 
pneumonia (Bowles et al., 2004). Complication rates for UGEs have been reported as high as 
0.025% (Reed et al., 2004) whilst those for LGEs are far higher: colonoscopy at between 1.2% and 
3% (Thomas-Gibson et al., 2002, Bowles et al., 2004) and for FS at 1.2% (Farraye et al., 2004).
Perforation rates for each procedure type have been reported as high as 4.5% for colonoscopy 
(Rembacken et al., 2000, Kavic and Basson, 2001, Gatto et al., 2003, Bowles et al., 2004, 
Rembacken, 2005). The perforation rate for FS is reportedly between 0.0001% and 0.00088% 
(Segnan et al., 2002, Gatto et al., 2003) and for UGEs it is approximately 0.02% to 0.2% (Kavic 
and Basson, 2001).
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The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report into patient 
outcomes and death following endoscopy reported a mortality rate in 2002/03 for therapeutic UGEs 
as 5% (2,200 of 47,931 patients) and for LGEs (colonoscopy and FS combined) of <1% (102 of 
40,378 patients) (National Confidential Enquiry into Patient Outcome and Death, 2004).
5.3 NHS Gl endoscopy services
All UK NHS Trusts have at least one endoscopy unit to allow the investigation of Gl symptoms. 
Referrals for Gl endoscopy primarily originate from GPs within the primary care setting, or from 
medical staff via an outpatient clinic. Occasionally, secondary care referrals will also come from 
within the Trust for inpatients or for emergency cases via the A&E department.
Referral documentation originating from primary care varies according to the NHS Trust’s protocols 
but in general, GPs complete referral proforma and/or letters of referral stating symptoms, patient 
history, the test required and the degree of urgency of the test (urgent, soon or routine). Some 
NHS Trusts operate a referral and appointment system from designated Trust-based appointment 
centres that allocate all diagnostic appointments, not just endoscopies, whilst others have the 
option for GPs to send referrals straight to the endoscopy unit. In some Trusts, referrals are 
validated by a consultant prior to entering the patient into the appointment system to ensure the 
referral is appropriate, based on the patient information on the referral. In 1999 a fast-track route 
was established specifically for patients presenting to their GP with symptoms indicative of a 
cancer, designated “Two-Week Rule” referrals. These referrals were faxed from GP practices 
direct to the endoscopy unit on a dedicated number and the patient was allocated an appointment 
to be seen at the hospital within two weeks of the referral (see Section 6.1.1 for more detail).
It is common practice that once a referral has been entered onto the system, the patient is sent a 
confirmation letter by the hospital and further correspondence by phone or letter that informs them 
of their appointment date if this was not available for inclusion in the confirmation letter. 
Information sheets and consent forms are posted prior to their appointment, along with bowel 
preparation when LGE is required. Complete evacuation of the Gl tract is important for the 
visualisation of any abnormalities and patients are told to not eat for 12 hours prior to a UGE and 
24 hours prior to an LGE. Some Trusts operate a system whereby the clerical staff phone patients 
who have reached the top of the waiting list to ensure that they still want their procedure as a way
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of validating their waiting lists and in doing so, they are able to allocate a suitable appointment date 
over the phone.
Gl endoscopies usually take place in the endoscopy unit but UGEs are more frequently occurring 
in specialist outpatient clinics in some Trusts. Most endoscopies are carried out by a skilled 
medical or nurse endoscopist as a day case procedure and unless there are complications, the 
patients are sent home the same day. On their arrival to the endoscopy unit, patients are greeted 
by staff who explain the procedure, take consent and give sedation where necessary. Once the 
endoscopist is ready and all equipment and supporting staff are present, the patient is taken into 
the procedure room. The time taken for procedures varies upon the type of examination, the ease 
of passing the scope and the added time taken for any therapeutic measures. Once the procedure 
has been successfully completed, the patient is taken to a recovery area while the sedation wears 
off. Once well, they are offered refreshments and assessed by nursing staff prior to discharge. 
The majority of procedures can yield a diagnosis immediately and this may be discussed with the 
patient during recovery. Where biopsies have been taken, results can take a few weeks.
5.4 Government targets for NHS Gl endoscopy services
The NHS Plan, NHS Cancer Plan and later, the NHS Improvement Plan all advocated timely 
patient access to NHS services as being central to supporting the delivery of access targets. 
These targets included:
•  Full booking by the end of 2005 (Department of Health, 2000c).
•  Reducing the maximum wait for first routine outpatient appointment with a consultant from 
six months to three months by the end of 2005 (Department of Health, 2000c).
•  A maximum two month wait from urgent GP referral to treatment for all cancers by the end 
of 2005 (Department of Health, 2000b).
•  A maximum one month wait from diagnosis to treatment for all cancers by the end of 2005 
(Department of Health, 2000b)
•  A maximum 18 week wait from GP referral to treatment by the end of 2008 (Department of 
Health, 2004c).
•  A choice of any providers for patients by the end of 2008 (Department of Health, 2004c).
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To achieve these targets, major changes were needed to the most fundamental aspects of service 
delivery within NHS Gl endoscopy units. These included changes in the way they managed their 
demand, waiting lists, capacity and activity. Since 1997, major changes have occurred within NHS 
endoscopy units, most of which have been politically driven and target-based, although some have 
been motivated by the desire to improve services by NHS staff. Some of these will be described in 
the following chapter.
6. MODERNISING NHS ENDOSCOPY SERVICES: A 
REVIEW OF THE LITERATURE
A comprehensive, systematic literature search was performed to retrieve all peer-reviewed 
publications that referred to any changes in service delivery implemented within NHS endoscopy 
services since 1997. This time point was chosen because it signified the introduction of the 10- 
year modernisation programme set out by the New Labour government when they came to power. 
The search criteria encompassed articles describing changes in the NHS endoscopy services in 
terms of demand, waiting lists, lost slots and activity, as a result of implementing any redesign 
initiatives. It also included the evaluation of any redesign initiatives by either the endoscopy unit 
itself or by an independent organisation.
Table 5 defines all inclusion and exclusion criteria applied to the literature search. The inclusion 
criteria were designed to include only those publications that were of immediate relevance to the 
research question being addressed by this thesis, namely the evaluation of modernisation within 
NHS endoscopy services in England, either as a consequence of being associated with the MES 
project or as a result of modernising independently, for political, target-driven or internal reasons.
Inclusion criteria Exclusion criteria
1. NHS-based endoscopy 1. Endoscopy performed outside the NHS
2. Colonoscopy, FS, gastroscopy and OGD 2. All other types of endoscopy
3. Gl disorders 3. Non-GI disorders & disorders of the liver / pancreas
4. Non-inherited Gl conditions 4. Inherited Gl conditions
5. Endoscopy in adults 5. Paediatric endoscopy
6. Peer-reviewed articles 6. Non-peer-reviewed articles / abstracts
7. Studies conducted from 1997 onwards 7. Studies conducted before 1997
8. Studies encompassing demand, waiting lists, 8. Studies encompassing technological advances,
cancellations and activity cost effectiveness or patient satisfaction
Table 5: The inclusion and exclusion criteria of the literature search.
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Only literature pertaining to studies initiated from 1997 onwards were included but where no study 
period was reported, a decision was made on its eligibility based on the date of acceptance for 
publication, the time span of the study, and any other relevant information. Since patient 
satisfaction and cost-effectiveness issues were major themes covered by the ENIGMA study (see 
Chapter 8) and did not fall within the remit of this study, they were not included in this literature 
review.
The primary literature search was performed using Entrez Pubmed 
(www.ncbi.nlm.nih.qov/sites/entrez?db=pubmed) based on a keyword search using the terms listed 
in Table 6 applied to the title and abstract of all entries. These same keywords were also used to 
locate any additional relevant literature from the Cochrane Library (www.cochrane.org/index.htm). 
Emerald Fulltext (www.emeraldinsiqht.com/lnsiqht/menuNaviqation.do?hdAction=lnsiqhtHome) 
and Centre for Reviews and Dissemination (www.vork.ac.uk/inst/crd/index.htm).
An additional Medical Subject Headings (MeSH) terms search strategy was also used on Entrez 
Pubmed during the initial search phase but it did not reveal any additional items not already 
identified using the keyword search. It also failed to identify many important articles retrieved by 
the keyword search, possibly due to the ambiguous nature of the classification of the terminology 
used under the umbrella of NHS service redesign and so, was not used any further.
Independently published reports relating to NHS endoscopy services were later included as an 
additional source of information to increase the quality of the literature review with this sometimes 
non-peer-reviewed, but highly informative material. The old NHSMA website (last accessed Jan
2007) (www.wise.nhs.uk/cmswise/default/) and the National Library for Health 
(www.librarv.nhs.uk/Default.aspx) were searched for relevant reports using the same keyword 
searches as described in Table 6.
Where appropriate numerical data were retrieved in sufficient quantities, a meta-analysis was 
performed by aggregating common datasets from different sources and calculating a weighted 
average to determine a more relevant, overall picture of NHS endoscopy services.
In total, 154 publications were included in this literature review, the details of which are 
summarised in Appendix 16.1 (peer reviewed literature) and Appendix 16.2 (non-peer reviewed 
literature).
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NHS AND Modernis* OR Demand OR Booking OR Staff
Gastroint* Innovati* Referr* Appointment Consultant
Gastroent* Redesign* Wait* Guideline Nurse
Endoscop* Chang* Activity Clinic Endoscopist
Cancer Improve* Capacity Complication GP
,*„ .
Service delivery Cancel* Audit Patient*
Evaluat* Attend* Data Train*
Manag* Screen* Information Consent
Quality TWR Outpatient Symptom*
Measur* Fast-track Inpatient Views
- „ -
Two-week Day case
One-stop Access
Table 6: Keyword combinations used in the literature search strategy. The asterisk indicates where the
truncated version of the word was used.
6.1 Changes affecting the demand on endoscopy services
Over the last 15 years the demand on NHS Gl endoscopy units has gradually increased. In 
1991/2, approximately 8.7% of patients attending a GP surgery had disorders of the Gl tract, an 
increase by one fifth from 7.2% in 1981/2 and if this trend had continued, the figures for 2001/2 
would have been 10.4% (Williams et al., 2007). In 1991/2 Gl disorders accounted for one 
consultation for every five people in the population (Williams et al., 2007). Approximately 17% of 
finished consultant episodes in England had Gl disease as the principal diagnosis and roughly 45% 
of these episodes were referred for endoscopic assessment (Williams et al., 2007).
As well as the demand from primary care for endoscopies to investigate Gl diseases, NHS 
endoscopy services generated a proportion of their own demand typically from outpatient 
consultations. Between 38% and 40.3% of secondary care referrals were for surveillance patients 
who required regular follow-up appointments (Bowles et al., 2004, Shoaib et al., 2006), either to 
assess the progress of an abnormality or to check that there has been no regrowth following a 
polypectomy (polyp removal). Repeat procedures were necessary when cancellations occurred or 
when an endoscopy failed for any reason, which also increased demand on the unit. There was
78
also an element of “emergency demand” within NHS Trusts with no out-of-hours endoscopy 
service. A survey by Douglass et al reported 35 Trusts with no such service and discussed the 
implications of the average figure of 90.2 emergency endoscopies per 100,000 population per 
annum that were performed for upper Gl bleeding, of which 26.7 were out-of-hours (Douglass et 
al., 2005).
There have been a number of initiatives, both govemment-led and Trust-led, that have affected the 
demand on NHS endoscopy services, some of which will be discussed at length in this chapter.
6.1.1 The Two-Week Rule
The Two-Week Rule (TWR) referral (NHS Executive, 1999) was introduced by the New Labour 
government to tackle the increasing problem of patients presenting to their GP with symptoms 
indicative of a cancer who, although urgently referred, did not get a hospital appointment in 
sufficient time as to significantly improve their health outcome. The aim of the TWR referral route 
was to reduce the number of cancer-related deaths by 20% in people under the age of 75 by 2010, 
thereby saving approximately 130,000 lives (Department of Health, 2000c). The scheme allowed 
GPs to “fast-track” these patients to shorten the length of time they waited for a diagnosis followed 
by potentially life saving treatment. TWR referrals were faxed to the endoscopy unit using a 
dedicated number and an appointment was made for the patient within two weeks. Only delays 
due to patient choice were acceptable reasons to over-run the two week target.
The NHS Improvement Plan claimed that nearly 99% of patients with a suspected cancer were 
being seen by a specialist within two weeks of an urgent GP referral compared to 63% in 1997 
(Department of Health, 2004c). Peer-reviewed literature suggests that the actual number of TWR- 
referred patients seen within the two-week target ranges from 50% in 1998 (Raje et al., 2006) to 
67% in 1999/2000 (Davies et al., 2007) to 96% in 2001 (Debnath et al., 2002, Barwick et al., 2004) 
and to 100% in 2004 (Stoker et al., 2005), although one 2006 study reported only 92% of patients 
being seen within two weeks (Rao, 2006).
Many studies have reported that the TWR has reduced the time from referral to diagnosis when 
compared to other referral routes (Walsh et al., 2002, Davies et al., 2002, Rao, 2006, Bevis et al.,
2008). However, there was some evidence that it had not shortened the overall time to diagnosis 
or treatment due to lags before presentation to the GP and between outpatient appointment and 
procedure (Flashman et al., 2004).
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GPs were given specific TWR referral guidelines to follow by the DH in 2000 (Department of 
Health, 2000d) that were later updated by NICE in 2005 (National Institute for Health and Clinical 
Excellence, 2005) for the appropriate, timely referral of patients with suspected cancers. This was 
done so that the TWR initiative was not overburdened to the detriment of other service users or 
NHS staff. It was hoped that by implementing TWR referral guidelines, more patients with a Gl 
cancer would be diagnosed at an earlier stage of their disease. However, the TWR has placed a 
significant burden on the resources of most gastroenterology services in the NHS with little gain in 
identifying malignancies (Martin et al., 2002). A systematic review and meta-analysis of peer- 
reviewed studies published by the author of this thesis in 2006 reported that CRC was diagnosed 
in only 10.3% of those patients with lower Gl tract symptoms referred using the TWR (Thorne et 
al., 2006). To justify a meta-analysis, only studies that were sufficiently comparable in the way that 
data were collected and reported were used. More evidence has since been published and the 
updated meta-analysis in this chapter now shows that the actual proportion of patients referred 
using the TWR who were eventually diagnosed with a Gl cancer was 3.8% for UGEs and 9.1% for 
LGEs (see Table 7). This means that the pick-up rate for CRC detection via the TWR has actually 
decreased in recent years.
The table also showed that 30.1% of all CRC patients diagnosed in endoscopy units had been 
referred using the TWR route, implying that nearly 70% of CRC patients were referred by 
alternative routes including routine referrals and A&E. This figure is higher than the 24% figure 
originally published in 2006 (Thorne et al., 2006) using the literature available at that time. This 
indicates that more recent studies have found a larger proportion of CRC patients diagnosed using 
the TWR, suggesting that the TWR route may be becoming more effective over time.
The TWR guidelines were based on the assumption that patients with more advanced stages of 
the disease would exhibit specific alarm symptoms and that patients with “low risk” symptoms may 
be unnecessarily over-investigated, thereby increasing the demand on the service. The evidence 
presented here suggests that the guidelines are not sensitive enough, with many Gl cancer 
patients not presenting with the required “high-risk” symptoms necessary to elicit the TWR referral 
route into secondary care. This is a major concern because it is patients exhibiting low risk 
symptoms who are at an earlier, more treatable stage of their disease, yet the guidelines are not 
sensitive enough to identify them.
80

The effect of the TWR on long term survival remains unknown (Walsh et al., 2002). Many studies 
have reported no significant difference in the stage of the disease in CRC patients referred via the 
TWR compared with other referral routes (Eccersley et al., 2003, Flash man et al., 2004, Chohan et 
al., 2005, Smith et al., 2007, Bevis et al., 2008). This finding was supported by a study by Kiran et 
al who reported that there was no relation between the duration of CRC symptoms and the stage at 
presentation (Kiran and Glass, 2002). This means that those patients with advanced stages of 
CRC do not necessarily become symptomatic at a particular time, so the TWR does not 
necessarily improve the survival of CRC patients but does reportedly reduce the number of patients 
presenting as emergency cases (Raje et al., 2006). Contrary to this, one study has shown that the 
TWR route has more CRC patients with Duke’s classification stage D (late stage) tumours than any 
other route (TWR = 14, outpatient clinics = 8, A&E = 5) (Chohan et al., 2005). The embarrassing 
nature of CRC means that many symptomatic patients do not present to their GPs until the latter 
stages (Jiwa and Burr, 2002), which tend to be too advanced to confidently predict a good outcome 
for the patient. Another reason for late presentation was limited access to GP appointments (Jiwa 
and Burr, 2002).
Based on local data, Ward et al recently estimated the demand on endoscopy services from TWRs 
alone was approximately 65,000 per annum (Ward et al., 2006). To meet TWR targets, capacity 
needs to exceed mean demand by two patient slots per week for 99% success, or by one slot per 
week for 90% success (Thomas et al., 2001). The effect of the TWR on referral patterns is still 
debated, with some authors reporting increasing numbers of TWR referrals (Walsh et al., 2002, 
Stoker et al., 2005) whilst others report no significant rise (Debnath et al., 2002, Mahon et al., 
2002).
In most hospitals, the TWR has a dedicated list to ensure NHS Trusts met the strict two-week 
target. This should, in theory, have a negative impact on all other aspects of the service, although 
no evidence of this has been found to date. Three studies reported a decline in the routine 
endoscopy waiting lists following the introduction of the TWR (Walsh et al., 2002, Spahos et al., 
2005, Rao, 2006), possibly due to an increased awareness of the guidelines for patient referrals, 
the more efficient organisation of services or the introduction of nurse endoscopists to cope with 
increased demand (see later).
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The response by GPs to the TWR has been generally positive, with 81% of GP reporting a 
perceived reduction in appointment waiting times and 86% reporting good communication with the 
hospital as a result of the initiative (Dodds et al., 2004).
6.1.2 Referral guidelines for GPs
Whilst it is widely acknowledged that referral for a diagnostic endoscopy has become the favoured 
method of diagnosing certain Gl disorders, there was limited guidance for GPs to select which 
patient groups were most suitable for this procedure type and which needed to be referred urgently 
to prevent GPs referring their patients this way en masse.
The failure of GPs to refer patients in good time assigning the appropriate degree of urgency may 
have implications for timely diagnosis, especially in the case of Gl cancers. Guidelines are more 
frequently being advocated to facilitate an appropriate plan of action resulting in the best care for 
the patient whilst trying to reduce the cost of that care where possible by avoiding the need for 
unnecessary investigations. However, they can also have a significant impact on the demand for 
various diagnostic services, as has been previously mentioned in the case of TWR referral 
guidelines.
Clinical decisions should be based on evidence-based medicine. This usually involves the 
identification and appraisal of high quality medical literature to make an informed decision about 
the treatment of a patient. In the case of patients with dyspepsia, GPs may take advice from a 
Cochrane review published in 2000 that recommended GPs recognise that endoscopy as an early 
investigation may not be cost-effective as a management strategy (Delaney et al., 2000). In the 
absence of high quality Randomised Controlled Trial (RCT) publications on specific clinical 
questions or established common practice, expert guidance is used.
Since 1997, there have been a number of government-backed guidelines published to facilitate 
appropriate, timely and cost-effective medical care to minimise error and provide uniformity of care 
and standardisation of treatment (Hodder et al., 2005a). Those relevant to NHS endoscopy 
services include the following:
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•  Investigation and management of suspected cancers of the upper Gl tract (Department of
Health, 2000d, Allum et al., 2002, National Institute for Health and Clinical Excellence,
2005).
•  Investigation and management of suspected cancers of the lower Gl tract (Department of 
Health, 2000d, Thompson, 2002, National Institute for Clinical Excellence, 2004b, National 
Institute for Health and Clinical Excellence, 2005).
•  Investigation and management of dyspepsia presenting with acute Gl bleeding (National 
Institute for Clinical Excellence, 2004a, Mason et al., 2005).
•  Barrett’s oesophagus (British Society of Gastroenterology Working Party, 2005a).
•  IBDs (Carter et al., 2004).
•  CRC screening in high risk groups (Caims and Scholefield, 2002).
It has been widely acknowledged that the creation of guidelines to identify patients with Gl cancers 
is essential to decrease the number of inappropriate referrals of patients with insignificant 
symptomatology via the TWR. Their accuracy is open to improvement, although it comes at a cost 
- increasing their sensitivity means losing the specificity, which will lead to an increase in the 
number of patients eligible to be referred, thereby increasing demand on endoscopy services and 
reducing timeliness, etc -  the very things they were meant to enhance. Another confounding factor 
is that many serious conditions share the same symptomatology as benign disorders, many of 
which have a high incidence rate in the general population (Harinath et al., 2002). NICE reports 
have estimated that between 80% and 85% of CRC patients present with two or more of the 
symptoms stipulated by the DH TWR guidelines (National Institute for Clinical Excellence, 2004b), 
although the literature quotes this figure as between 35% and 94% (Mahon et al., 2002, Debnath et 
al., 2002, Flashman et al., 2004, Jiwa and Hamilton, 2004, Spahos et al., 2005, Chohan et al., 
2005, Allgar et al., 2006, Bevis et al., 2008).
Many problems have been reported in the past with the inappropriate referral of patients for an 
endoscopy by their GP when their symptoms are not considered by published guidelines to be 
either appropriate or high-risk enough to warrant the procedure (Debnath et al., 2002, Dodds et al., 
2004, Chohan et al., 2005, Pickard et al., 2007, Shaw et al., 2008). Reasons for inappropriate 
referrals included the fear of missing an important diagnosis, clinical uncertainty, patient pressure
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and the long waiting times for routine referrals (Dodds et al., 2004). High levels of inappropriate 
referrals whereby patients are being over-investigated will have major implications with regards 
patient safety, service provision and cost to the NHS (Pickard et al., 2007).
Rigid application of guidelines can occasionally result in the routine referral of patients exhibiting 
low-risk symptoms listed in the guidelines who later develop a serious condition. In the case of the 
TWR guidelines for suspected CRC, between 10% and 15% of CRC patients will present with low- 
risk symptoms and will not qualify for the TWR referral (Thompson, 2002). The literature reported 
these figures as between 2% and 26.1% (Debnath et al., 2002, Eccersley et al., 2003, Flashman et 
al., 2004, Jiwa and Hamilton, 2004). A 2006 systematic literature review suggested that the actual 
figure is far higher, with an average of 52.4% of all CRC patients diagnosed at a given time 
originally being referred by a non-urgent, non-emergency route by their GP (Thome et al., 2006). 
However, it could be that these patients presented with no significant alarm symptoms and so, may 
have been appropriately referred as routine. This begs the question, are the TWR guidelines 
working properly? Many authors argue that they are not sensitive enough (Harinath et al., 2002, 
Eccersley et al., 2003, Hodder et al., 2005a). Only one publication supported their effectiveness for 
selecting patients with cancer (Mahon et al., 2002). The number and length of the CRC guidelines 
from the DH have been criticised by GPs, as well as their accuracy, with many calling for a 
standardised protocol (Jiwa and Burr, 2002).
The erratic implementation of the guidelines was also a problem for healthcare professionals in 
secondary care, with 43 clinicians exhibiting a wide degree of variation in their assessment of 40 
symptomatic colorectal referrals, with only 71.3% of CRC patients being correctly diagnosed and of 
those, only 47% were classified as urgent referrals (Hodder et al., 2005b). Four GPs were included 
in the test group and they, along with the 21 registrars scored highest in their ability to identify the 
CRC patients (82%). Surprisingly, the nine professor I consultant I associate specialist subjects 
only identified 51% of CRC patients (Hodder et al., 2005b).
A study providing clinical guidelines within a district general hospital showed that there was an 
extremely low adherence to the guidelines for upper Gl bleeding (3%) and that this did not increase 
in the light of online guidelines being made available (Williams et al., 2004). Qualitative interviews
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with the clinical staff indicated that the guidelines had been briefly consulted but not used in 
accordance with instructions.
6.1.3 GP referral practices
Jiwa et al identified problems in the referral documentation completed by GPs, with many missing 
relevant history and examination (Jiwa et al., 2002), as high as 97.5% in one study (Debnath et al.,
2002). This may be because GPs are not formally trained in completing this type of paperwork or 
because they have limited consultation times with patients, so the referral is written once the 
patient has left (Jiwa and Burr, 2002). A qualitative study by Jiwa and Burr reported that GPs 
believed that consultants did not read the referral letter, but did acknowledge the need to be 
responsible for communicating with their colleagues (Jiwa and Burr, 2002). There was much 
confusion about what constituted an adequate referral letter (Jiwa and Burr, 2002), and the need 
for the standardisation of referral forms has been recognised (Dodds et al., 2004). When feedback 
was given to a selection of GPs about the quality and quantity of information they included on their 
referral letters, there was a significant improvement following the period of feedback (Jiwa et al.,
2004).
There is often an absence of established clinical practices or RCT evidence due to health service 
delivery issues, funding and ethical issues. A poor evidence base for guidelines often presents 
itself as a reason for non-adherence by health professionals (Mandal et al., 2003). Other GPs 
commented that they found the guidelines for referring patients with a suspected cancer difficult to 
interpret and that they often felt pressure from patients for a quick referral (Dodds et al., 2004).
Referral proforma have been advocated for all NHS Trusts by NICE, along with a central referral 
system for the rapid and efficient referral of patients to the designated diagnostic service (National 
Institute for Clinical Excellence, 2004b). Faxable referral proforma for suspected CRC patients 
have been successfully introduced and in one Trust, the aim was to eventually replace it with Email 
referrals (UK NHS Cancer Services Collaborative, 2004).
One study has reported the successful introduction of referral assessment, with GPs obtaining 
feedback on dyspepsia referrals based on their adherence to the NICE dyspepsia guidelines.
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Mean adherence rates of GPs referring to all three study sites rose by 20% to 75% (95% 
Confidence Interval (Cl) 13.6% to 26.4%, p < 0.001). The adherence rate of the hospital doctors 
was 70% at baseline but did not follow the same trend as a result of the intervention. The referral 
assessment also resulted in a decrease in gastroscopy referrals from GP by 3.2 per week (p = 
0.065) and by 10 per week from hospital doctors (p < 0.001), and significantly decreased the 
referral-to-procedure interval for gastroscopy (52.1 days Vs. 39.4 days, p < 0.001) (Elwyn et al.,
2007).
6.1.4 Open access referrals
Open access (OA) referrals have been in operation since the 1970s (Marshall, 1998) but have 
become more commonly used in NHS endoscopy units in the last few years. In most NHS Trusts, 
GPs can now refer patients for an endoscopy using OA (also called direct access) referral services. 
This entails the GP making a referral for a specific endoscopic procedure directly to the endoscopy 
unit, with the GP maintaining overall management of the patients condition (Dougall et al., 2000) 
and avoids the involvement of the consultant. Barrison et al highlighted the quality criteria essential 
in any OA service (Barrison et al., 2001).
Whilst MacKenzie et al reported that OAs have not resulted in an increase in the number of 
investigations being booked (MacKenzie et al., 2003), Paterson et al reported a 32% increase in 
endoscopy workload following the introduction of an OA route (Paterson et al., 2006). OAs have 
successfully contributed to a significant reduction in the waiting time from referral to procedure and 
diagnosis (Verma and Giaffer, 2001, Maruthachalam et al., 2005). MacKenzie et al found that OAs 
were equally effective at diagnosing cases of CRC as consultant-led services (63.6% consultant 
Vs. 61.8% OA, p = 0.558) (MacKenzie et al., 2003), whilst Verma and Giaffer reported a 
significantly better diagnostic yield for OAs compared with hospital-initiated endoscopies (44% OAs 
Vs. 29% Hospital, p = 0.01). OAs have also been reported to be more effective at diagnosing 
earlier stage gastric cancer than conventional routes (Stephens et al., 2005), a finding contradicted 
by Paterson et al who found that there was no improvement of disease stage at diagnosis using the 
OA route (Paterson et al., 2006).
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OAs are highly acceptable to patients (Maruthachalam et al., 2005), although GPs have been 
reported to prefer one-stop dyspepsia clinics as opposed to an OA clinic (Rutter et al., 1998). OA 
can be successfully applied to follow-up referrals for the outpatient follow-up of IBD patients 
(Williams et al., 2000). A qualitative evaluation of this system showed GP preference towards the 
service as opposed to the routine follow-up service (Cheung et al., 2002).
6.1.5 Alternatives to endoscopy
The “test and treat” initiative advocated in the NICE guidelines (National Institute for Clinical 
Excellence, 2004a) uses H. pylori testing on young patients with dyspepsia as a replacement for 
endoscopy and has been proposed to reduce the demand for endoscopy by up to 74% (Shaw et 
al., 2006).
6.1.6 CRC screening
Most CRCs result from malignant changes in polyps that developed at least a decade earlier 
(National Institute for Clinical Excellence, 2004b). Following the success of a trial by the UK CRC 
Screening Pilot Group (UK CRC Screening Pilot Evaluation Team, 2003, UK Colorectal Cancer 
Screening Pilot Group, 2004), the NHS Bowel Cancer Screening Programme (NBCSP) was 
initiated in England in April 2006. This dramatically increased the demand on NHS endoscopy 
services, as people aged between 60 and 69 years of age were invited to participate in biannual 
CRC screening. They were posted a Faecal Occult Blood Test (FOBT) kit to their home to test for 
the presence of blood in their stool. Positive FOBTs resulted in an invitation to a follow-up to have 
a colonoscopy at an endoscopy unit. More details of the NBCSP can be found on their dedicated 
website at www.cancerscreenina.nhs.uk/bowel/.
The first round of the pilot study reported that the uptake for screening was 58.5% and that the 
number of positive tests from FOBTs increased the demand for colonoscopy by 1.5% (4116 of 
478250 subjects screened), of which 81.5% of FOBT-positive subjects attended (UK Colorectal 
Cancer Screening Pilot Group, 2004). Ward et al calculated that this increase, if applied to all age 
groups, would result in a total increase of 69% in annual endoscopy investigations in the UK (Ward 
et al., 2006). However, Price et al argued that the pilot report was an under-estimate of the real 
demand and showed that colonoscopy activity following the CRC screening study actually
increased by 31% in Scotland and 21% in England due to FOBT-positive patients (Price et al.,
2005).
The second round of screening by the pilot study was performed two years later. Uptake was 
significantly lower than in the first round (51.9% vs. 58.5%, p < 0.001), but there was a significantly 
higher number of positive FOBTs (1.77%) (Weller et al., 2007). The cancer detection rates were 
lower in the second round than the first round (0.94 per 1000 vs. 1.35 per 1000, p = 0.02).
The impact of the NBCSP has not been well documented, but Goodyear et al reported the effect of 
FOBT screening for CRC on emergency admissions in Coventry and North Warwickshire and 
concluded that since the pilot in 1999, there was a significant decline in emergency CRC workload 
with a marked improvement in 30 day mortality and decreased stoma formation (Goodyear et al.,
2008). West et al reported an improvement in the standards of NHS endoscopy services in terms 
of patient experience, safety and improved practice (West et al., 2007). However, Thompson et al 
described the impact of screening for those subjects not at high risk of CRC, highlighting that for 
the UK population, the lifetime risk of death from CRC was approximately 1:50 and that more than 
98% of the population would not benefit from CRC screening (Thompson et al., 2006). They also 
commented that the screening programme may be prone to bias whereby only healthy subjects 
tend to volunteer for screening and the problem associated with aggressive CRCs tending to have 
a shorter history which means that they are less likely to be identified during screening.
The DH allocated approximately £19 million per annum to fund the additional costs of diagnostic 
investigation as part of the NBCSP but the real costs of the FOBT alone have been estimated to be 
closer to £28 million (Ward et al., 2006), leaving the endoscopy units with inadequate funding to 
meet the anticipated increase in demand from patients with suspected bowel cancer.
6.1.7 Implementing new ways of predicting Gl disorders in patients 
Selvachandran et al developed a novel and successful system to predict whether patients with 
colorectal symptoms had CRC using a questionnaire completed by patients based on their history 
which was scored by a senior colorectal surgeon and proved to be more accurate than the GP 
referral letter at predicting patients with CRC (Selvachandran et al., 2002). This system was
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independently evaluated by Hodder et al and was proven to have a sensitivity of 96.8% compared 
to the 80.1% from the guidelines (Hodder et al., 2005a).
Studies have been performed in NHS endoscopy units with the intention of informing guidelines on 
how to increase their sensitivity without losing their specificity, as well as decreasing the cost of 
endoscopy by reducing the number of inappropriate referrals. In a study by Mathew et al, 
approximately one fifth of patients who had an FS to investigate a rectal bleed were aged under 45 
but the incidence of CRC in those patients was zero (Mathew et al., 2004). The authors went on to 
recommend that new guidelines should consider the age of patients. Kapoor et al used the DH 
upper Gl cancer guidelines to identify high-risk cancer patients referred using a rapid access 
service, and then calculated the predictive value of the alarm features (Kapoor et al., 2005). From 
this, they restricted the guidelines to identify 99% of cancer patients with a specificity of 30.5%, 
compared with the 3.8% originally identified. When the redefined guidelines were applied to a 
validation cohort, they identified 92.3% of cancer patients and proposed a theoretical reduction in 
urgent workload by one third with the formal application of their revised guidelines.
A short dyspepsia questionnaire administered by a nurse in both primary and secondary care 
settings was found to be a valid, reliable tool for measuring the presence and severity of dyspepsia 
in patients (Moayyedi et al., 1998). When the questionnaire was compared to the GP assessment 
of the patient, it was found to have a sensitivity of 80% and a specificity of 79%.
Robertson et al tried to determine which characteristics of rectal bleeding were predictive of CRC 
from a sample of 604 patients referred to an OA FS clinic who completed a questionnaire, 22 
(3.6%) of which were later diagnosed with CRC (Robertson et al., 2006). The most significant 
predictors were age (> 70 years) (odds ratios = 8.2, 95% Cl 2.1 to 31.8) and having blood mixed 
with the stool (age adjusted odds ratios = 3.8, 95% Cl 1.4 to 10.5 respectively). However, the 
authors concluded that as an isolated symptom it held insufficient diagnostic value to be useful in 
general practice.
Haemorrhoids are a common problem but many patients are further investigated by LGE to rule out 
the possibility of CRC, whereby rectal bleeding is a significant predictor. When Tang et al studied
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the impact of a new management strategy for patients with haemorrhoids they found that careful 
assessment at presentation meant that there was no requirement for LGE as no CRCs were 
missed (Tang et al., 2005).
6.2 Changes affecting the waiting lists of endoscopy services
Waiting times have always been and probably always will be a sticking point for most NHS 
services. Over time, the demand for an endoscopy has increased exponentially due to many of the 
reasons described above, amongst others, but the capacity of the units in terms of resources and 
space has remained static in most cases. Whilst there has been a marked reduction in waiting list 
numbers in some NHS Trusts as a result of the innovations that will be described in this chapter, 
they will never completely disappear because demand will almost always exceed activity, 
especially as the life expectancy of the population increases and as screening programmes are 
implemented.
Clinical decisions regarding whether to refer a patient, at what point to operate, etc., are crucial in 
determining success or failure in reducing waiting times (Lewis and Appleby, 2006). There is 
currently a far wider understanding of ways to tackle waiting times such as streamlining systems 
and the application of admission criteria to patients (Lewis and Appleby, 2006). Most endoscopy 
units try to operate at maximum efficiency with allocated resources most of the time. Even so, the 
demand placed on endoscopy units mean that some referrals are placed on a waiting list, usually 
the non-urgent ones. Waiting lists in the endoscopy unit can be split into active and planned: the 
active waiting list includes patients recently referred for the first time for an endoscopy whilst the 
planned waiting list contains mostly surveillance patients who are seen on an annual or biannual 
basis.
A retrospective survey of waiting times experienced by 13,454 cancer patients showed that waiting 
times for urgent appointments were significantly less than those for non-urgent appointments - 
median time in days to first outpatient appointment for CRC was 13 days for urgent and 27 days for 
non-urgent; for stomach cancer was 10 days for urgent and 27 days for non-urgent; and for 
oesophageal cancer was 11 days for urgent and 24 days for non-urgent (Spurgeon et al., 2000). It
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also highlighted the need for a clear referral code relating to the degree of urgency based on these 
differences in waiting times.
Tactics for managing waiting lists have included the delaying of non-urgent patients in the hope 
that they will get better or go elsewhere, as well as the overbooking of patients because there is a 
good chance that patients who have waited a long time will not attend, and finally, the ring-fencing 
of capacity in the belief that they can predict the demand from urgent patients (Silvester et al., 
2004). Instead, recent advice from the NHSMA has been to manage the bottlenecks and to reduce 
the variation in capacity (Silvester et al., 2004).
Long waiting lists are common for LGE procedures because they take longer to perform. UGEs 
can be completed within 15 minutes whilst LGEs can take up to 60 minutes, depending upon the 
location of the abnormality, the completeness of bowel evacuation and the need for therapeutic 
measures (e.g. biopsy). This means that far more UGEs can be done in a session than LGEs, 
resulting in a short UGE waiting list and a long LGE waiting list. There are also implications 
involved when allocating procedures to different staff types. Far more nurse endoscopists (see 
Section 6.4.2) are qualified to do UGEs than LGEs, whilst only a few skilled endoscopists are 
capable of performing certain therapeutic procedures. There is also a variation in working 
practices whereby some can complete a list in significantly less time than others. As a result, the 
efficient endoscopists tend to have lower numbers on their waiting lists whilst the slower ones will 
have an increasing backlog. Whilst communal waiting lists have been advocated by the NHSMA 
(NHS Modernisation Agency, 2004e) and the BSG (British Society of Gastroenterology, 2006a), 
this has resulted in a resistance to pooling waiting lists by the efficient endoscopists. The pooling 
of endoscopy waiting lists was advocated by the Belfry Plan and also included patients waiting for 
radiological procedures in the pooling (Richards, 2004) and has been successfully introduced in 
many endoscopy units as part of the MES project (NHS Modernisation Agency, 2004e).
The 2005 cancer waiting times targets stated that all patient with a suspected upper or lower Gl 
cancer would be treated in secondary care within 31 days of diagnosis and also issued a target for 
a maximum 62 days from urgent GP referral to treatment (Department of Health, 2004b). The 
Belfry Plan was written following a meeting by various health professionals to improve on existing
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cancer waiting times to meet the 2005 targets (Richards, 2004). The Plan advocated the need to 
review existing pathways, make sure referrals are appropriate, and to consider referrals of patients 
for investigation without the need for a consultation first. As of June 2004, the 31 day target was 
being met in 87% of CRC patients and 95% of upper Gl cancer patients, but the 62 day target was 
only being met in 53.5% of CRC patients and 70% of upper Gl patients (Richards, 2004).
Some Trusts have successfully implemented waiting list strategies that involve periodic waiting list 
validation, whereby those patients no longer requiring a procedure are taken off the list. 
Approximately one quarter of colonoscopy surveillance referrals are inappropriate (Cairns and 
Scholefield, 2002) and by applying recent CRC surveillance guidelines, one hospital was able to 
reduce their colonoscopy waiting lists by 76% by either rebooking patients for a later date (42%) or 
cancelling their appointment completely (34%) (Shoaib et al., 2006). This resulted in a reduction in 
urgent and routine waiting times as well as potentially saving the cancer network an estimated £1 
million per annum.
The NBAP facilitated faster access to services and reducing waiting times, resulting in a decrease 
in DNAs from 5.6% in 1999 to 3.2% in 2000, and in patient cancellations from 12.8% to 11.9% for 
the same period (Kipping et al., 2000). This was attributed to the fact that most patients were 
allocated appointment dates rather than being kept on a long waiting list with no impending date.
An independent evaluation of three colorectal projects within the Cancer Services Collaborative 
(see Section 6.5.1) by Robert et al reported a non-significant decrease in the median waiting time 
from 64.5 days to 57 days -  an 11.6% reduction (Robert et al., 2003).
The MES project used a variety of methods including waiting list validation, primary targeted lists 
and agreed follow up protocols to reduce active waiting lists in 22 endoscopy units by 27% over a 
10 month period (NHS Modernisation Agency, 2004e). Individual sites commented on reductions 
in waiting lists attributed to validation, partial booking, guidelines, partial pooling and nurse 
endoscopists (NHS Modernisation Agency, 2004e). Unfortunately, the planned waiting list was not 
so successfully reduced but the NHSMA attributed this mainly to the nature of this type of follow- 
up.
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A report by the Kings Fund for the DH highlighted five important factors for sustaining reductions in 
waiting times: Understanding the whole system, sustaining action over time, keeping up the work, 
coping with unexpected shocks and clinical ownership and involvement (Appleby et al., 2005). 
However, they were unable to attribute any magnitude of effect to each.
A “straight to test” strategy is currently being employed whereby the patient is referred directly for 
an endoscopic investigation and does not first see a specialist for an opinion. This cuts down the 
number of outpatient appointments and shortens the length of time patients wait for an endoscopy 
but relies on accurate referral information and a clear history (Richards, 2004).
6.3 Changes affecting lost slots in endoscopy services
The Patient’s Charter clearly states that patients have a responsibility to attend outpatient 
appointments or to notify the hospital if they are unable to do so (Department of Health, 1991). 
However, the failure of patients to attend appointments is on the increase (Spinks, 2003). Patients 
who do not attend (DNA) or cancel too late are a huge problem for endoscopy units which carefully 
allocate slots on lists to best suit the medical needs of the patient and the availability of the 
necessary resources, which end up wasted. Reasons for not attending include forgetting about 
their appointment, forgetting to cancel it, symptoms resolving by the time their appointment date 
arrives, clerical errors and fear (Murdock et al., 2002). Some NHS Trusts offer patients who DNA a 
second appointment, negatively affecting the waiting lists.
One hospital attempted to reduce their colonoscopy DNA rate by introducing a system whereby a 
nurse specialist provided a patient study group with additional verbal information regarding the 
procedure two weeks prior to their appointment (Spinks, 2003). However, they were unable to 
show a significant difference between the study group and the control group who received only 
written information, but the study only used 19 patients and commented that the control group DNA 
rate of 10% was below their usual 35%.
The implementation of a nationwide booking system and a telephone reminder system has 
decreased the number of patients who DNA’d (Hardy et al., 2001, Dockery et al., 2001, Lee, 2003,
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Tayal et al., 2006). However, in one study a reminder system resulted in no change to DNA rates, 
from 9.9% to 9.8% during a six month period (Bateson, 2004). The study also reported an overall 
increase from 1997 to 2002 in DNA rates from 7.8% to 10.3%.
In some cases it is the hospital that is forced to cancel a list when there are insufficient resources 
such as staff, facilities or equipment. Consultants are now required to cancel fixed lists to attend 
acute emergency duties and the lost sessions are difficult to backfill (British Society of 
Gastroenterology Working Party, 2005b). Endoscopy units need sufficient numbers of 
appropriately trained staff to safely tend for the patient, in accordance with JAG regulations (Joint 
Advisory Group on Gastrointestinal Endoscopy, 2004).
Many Trusts have introduced DNA policies to reduce the number of slots left empty by those 
patients either cancelling late or who DNA (NHS Modernisation Agency, 2004e). This involved 
strategies to fill empty slots following late cancellations with patients on the waiting list who had 
indicated that they were available at short notice. Many Trusts also referred patients who DNA’d 
back to their GP instead of rebooking them. By introducing annual leave policies, some Trusts 
have placed a minimum limit of six weeks notice for staff to book their annual leave so that those 
scheduling the endoscopy lists know who will be available at any given time. In this way, staff 
shortages could be anticipated and planned for to a degree.
The MES project reported a significant reduction in DNA rates in participating sites, with 71% of 
sites having DNAs of less than 5% and no sites with DNAs more than 10% by the project close 
(NHS Modernisation Agency, 2004e). Reasons for the reductions included reducing waits, 
introducing booking systems, implementing a DNA policy and rewriting patient literature in “plain 
English”.
6.4 Changes affecting activity in endoscopy services
HES data showed that for 2000/01, approximately 9.5% of surgical procedures in England were 
performed on the Gl tract, of which 73% were endoscopies (Williams et al., 2007), whilst a 2004
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survey by the NAO reported increases in the number of FS and colonoscopies between 1995/6 and 
2000/1 of 85% and 65% respectively (National Audit Office, 2004).
The NICE website (www.nice.orq.uk/paqe.aspx?o=352025) currently states that the benchmark 
UGE rate should be 0.75% per year, or 750 endoscopies per 100,000 population and includes all 
diagnostic and follow-up endoscopies. Areas with a relatively elderly population, or a population 
with other risk factors, might be expected to have a slightly higher rate.
The activity in an endoscopy unit is greatly dependent on the potential capacity of the unit in terms 
of the availability of resources. Even though there is a theoretical maximum output that can be 
achieved by the unit, it is almost never reached in practice due to limited resource availability, 
problems with patient attendance and the actual time taken to examine patients resulting in 
bottlenecks in patient flow through the unit. The NCEPOD report highlighted that of 263 hospitals 
included in the survey, approximately 7% had only one endoscopy room (National Confidential 
Enquiry into Patient Outcome and Death, 2004).
Many changes have been implemented in NHS endoscopy units to improve their activity that 
included changes to staff types and roles and also changes to working practices. Details of these 
are given below.
6.4.1 Developing endoscopy staff roles
Patient access is restricted by a shortage of trained personnel (UK NHS Cancer Services 
Collaborative, 2004). The NHS Cancer Plan and the new NHS reported a 72% workforce 
expansion in the field of gastroenterology between 1999 and 2004 (Department of Health, 2004b). 
The number of Gl consultants in England and Wales increased from 335 in 1993 to 725 in 2004, a 
216% increase overall (Williams et al., 2007).
The European Working Time Directive from the Council of Europe (93/104/EC) was introduced into 
the NHS in 2004 and enforced a maximum 48 hour working week (NHS Executive, 1998b). This 
reduction in the hours of training grade doctors and led to the gradual disappearance of on-call 
rotas in favour of a more structured arrangement (Bam'son et al., 2001). Specific out-of-hours
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services have been established in many NHS Trusts to manage emergency cases in need of 
endoscopy in accordance with the basic requirements of an emergency endoscopy service 
(Barrison et al., 2001). There is evidence of dissatisfaction in the medical profession with the 
arrangements (Morris-Stiff et al., 2005). The DH published guidelines to advise on how best to 
cope with the reduced staff availability of doctors in training (Department of Health, 2004a).
Gl endoscopy could fall under the umbrella of the medical directorate, the surgical directorate or 
both, depending on the Trust, resulting in inefficient administration systems (National Audit Office,
2004). The BSG recommended the need for medical gastroenterologists and Gl surgeons to 
integrate and cooperate to provide the best care for patients with Gl disorders (British Society of 
Gastroenterology, 2006a).
6.4.2 Nurse specialists in endoscopy
Demand for endoscopy often outstrips the capacity for medical endoscopists to provide the service 
within a reasonable time scale (Barrison et al., 2001). Following recommendations by the BSG 
(British Society of Gastroenterology Working Party, 2005b, British Society of Gastroenterology, 
2006a), many nurses employed within endoscopy units have now progressed to become nurse 
endoscopists (NEs). They currently undergo rigorous training to reach set standards before 
qualifying to practice on patients and are trained to a greater level than doctors to work to 
guidelines and protocols (British Society of Gastroenterology Working Party, 2005b). Most 
clinicians have recognised the importance of the NE in reducing waiting lists but some have voiced 
a preference for their roles to be purely diagnostic (Pathmakanthan et al., 2001).
A recent tally of NEs in the UK reported 312 in post, 268 of which were in England (Williams et al., 
2007). A 2004 survey of UK endoscopy units by Douglass et al reported that there were 149 NEs 
in post in 96 JAG-registered units, of which 32% did UGEs, 55% did LGEs and 20% did both 
(Douglass et al., 2004). Larger units tended to have more NEs and approximately 92% of them 
had their own dedicated lists. They contributed to a significant proportion of the unit’s workload, 
performing 30.7% ± 6.7% of UGEs and 74% ± 6.3% of all FS procedures (Douglass et al., 2004). 
However, only a small number of NEs performed colonoscopies. The NCEPOD report highlighted 
that of 263 hospitals included in the survey, approximately 76% used a NE for at least one session
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a week. However, of these, 17% did just one session, meaning that they did not maintain their 
competence (National Confidential Enquiry into Patient Outcome and Death, 2004).
NEs have now become an established feature in NHS endoscopy units, with 64% of units having at 
least one NE in post in 2004 (Douglass et al., 2004). The quality of endoscopy performed by NEs 
is high, with 99% of LGEs counted as successful (Duthie et al., 1998, Goodfellow et al., 2003). 
Evaluations of NEs show that they can perform with up to 99% sensitivity when compared to 
alternative methods of diagnosing CRC such as barium enema, and even detected anomalies not 
seen using radiological methods in 18% of patients (Goodfellow et al., 2003). No complications 
due to the performance of a NE have been reported to date (Goodfellow et al., 2003, Smale et al.,
2003) and they have been shown to perform UGEs as safely as medical endoscopists (Smale et 
al., 2003).
Two RCTs comparing the effectiveness of endoscopy performed by nurses with medical 
endoscopists concluded that there was no statistically significant difference in their clinical 
effectiveness in diagnostic endoscopy for upper Gl procedures only (Meaden et al., 2006) and for 
both upper and lower Gl procedures (Williams et al., 2006). Meaden et al also reported that the 
NEs took significantly longer to perform the procedure (8.1 mins Vs. 4.6 mins, p < 0.001), whilst 
Williams et al found that the NEs were significantly more thorough in exploring the upper Gl tract 
and that patients were significantly more satisfied with the endoscopy when done by an NE than a 
medical endoscopist (Williams et al., 2006).
There is much evidence indicating the benefits of nurse-led care in terms of diagnosing problems 
and improved patient satisfaction (Goodfellow et al., 2003, Jeffery, 2005, Mason, 2005, Pearson,
2005). Nurses have been proven to be more effective than endoscopists at assessing pain in 
patients whilst undergoing endoscopy (Ramakrishnan et al., 2004).
The advanced skills of nurses have led to the establishment of nurse-led clinics and dedicated 
nurse-run endoscopy lists (Loftus and Weston, 2001, Douglass et al., 2004) to facilitate medically 
qualified specialists undertaking more complicated, specialist investigations. They were also far
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more flexible in their ability to fill in at short notice when consultants were called away for acute 
emergency duties (British Society of Gastroenterology Working Party, 2005b).
The multifaceted role of the Clinical Nurse Specialist (CNS) in the area of Gl medicine has been 
described in detail (Hands, 2004). They have been allocated nurse-led clinics to investigate and/or 
manage patients with dyspepsia (Carter et al., 2004, Mason, 2005, Anagnostopoulos et al., 2006), 
IBD (Pearson, 2005), Barrett’s oesophagus (Jeffery, 2005, Hall, 2006), and those patients with co­
morbidities such as iron deficiency anaemia (Griffiths, 2002) as well as one-stop clinics 
(Goodfellow et al., 2003), TWR referral clinics (Maruthachalam et al., 2005, Smith et al., 2007) and 
endoscopy clinics set in primary care (Maruthachalam et al., 2006). A review of the work by the 
CSC reported one nurse-led “change of bowel habit" service saved 98 years worth of patients 
waiting in just one year (UK NHS Cancer Services Collaborative, 2004).
Gl specialist nurses have recently been charged with the responsibility of ensuring that patients 
referred for endoscopies are fit enough for not only the procedure but also, in the case of LGEs, the 
bowel preparation (Maruthachalam et al., 2005, Stoker et al., 2005). This is usually done via a 
telephone pre-assessment and not only reduces the chances of the patient cancelling the 
appointment through ill health, but is also a source of comfort to the patient as they get to ask 
questions about the procedure and allay their anxiety. This role is most commonly applied to the 
TWR referral system within the endoscopy unit to ensure the Trust can meet the two-week target 
(Stoker et al., 2005).
There is also evidence that nurse practitioners can be successful in the dissemination and 
implementation of guidelines and the running primary care-based clinics (Chan, 2004). In some 
cases, the nurse is able to triage the patient based on their comments to ensure that they have 
been referred to the most appropriate pathway and investigation, which is particularly beneficial to 
both patient and endoscopy unit when the triaging results in a less complicated procedure e.g. FS 
replacing a colonoscopy (Stoker et al., 2005).
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6.4.3 Improving the quality of endoscopies
The quality of an endoscopy is typically measured according to how successful the endoscopist 
has been at visualising the furthest required point. A “complete” colonoscopy means visualising 
the caecum or terminal ileum (Bowles et al., 2004). Following the publication of the NCEPOD 
report (National Confidential Enquiry into Patient Outcome and Death, 2004), many endoscopy 
units have evaluated the quality of their colonoscopies to determine whether their completion rates 
compared favourably with the national target of 90% set by the BSG. Reasons for excluding an 
uncompleted procedure to produce an adjusted completion rate included the abortion of the 
procedure due to patient discomfort, uncontrolled looping of the bowel, poor bowel preparation, 
diverticulosis and adequate delineation of subtotal colitis (Bowles et al., 2004). Adjusted 
completion rates range from 86% to 94% for hospitals as a whole (Ball et al., 2004, Fasih et al., 
2004, Gorard and McIntyre, 2004), with individual endoscopist rates ranging from 74% to 97% 
(Fasih et al., 2004, Gorard and McIntyre, 2004), although the study by Gorard and McIntyre 
included trainees in the evaluation. A multi-centre study using 68 endoscopy units reported 
adjusted completion rate of only 80.4% (Bowles et al., 2004). For those sites participating in the 
NBSCP pilot, the completion rate reached 89.9% (UK Colorectal Cancer Screening Pilot Group,
2004). Only 19.1% of endoscopy units achieved the recommended 90% completion rate. When 
comparing adjusted completion rates according to the age of the patient, Karajeh et al found that 
there was a similar completion rate in those patients aged under 65 to those aged 65 and over 
(88.1% Vs. 87.6%, p = 0.18) (Karajeh et al., 2006).
The training of endoscopy, both doctor and nurse-led, has varied nationwide over the past decade, 
with many independent, successful training programmes in operation (Duthie et al., 1998). 
However, some endoscopists have not until recently attended a formal training course (Bowles et 
al., 2004). The endoscopy training project, funded by the DH, was implemented in 2001 at the 
Royal College of Surgeons and by March 2004, 797 participants had undertaken training in UGEs 
and LGEs (Keen, 2004). All endoscopists (nurses and doctors) now have to be trained in 
accordance with recommendations by JAG before they are permitted to practice on patients. It 
was hoped that this would reduce the variation in working practices across the UK and would 
improve the quality of expertise to allow the endoscopist to be more productive and to improve the 
patients’ experience. As well as allowing endoscopy services to meet government targets, the
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training of more endoscopists would also relieve the demand when the NBCSP was implemented 
(Keen, 2004). The use of simulators in training NEs was identified as a safe and necessary 
method of skill acquisition by a qualitative study using two inexperienced NEs (McGrath et al.,
2003). The process of accreditation for endoscopy units is currently underway by JAG (Williams et 
al., 2007).
Endoscopy, as with any invasive procedure that is accompanied by sedation, comes with risks of 
complications, as described in Chapter 5. In 2006, the BSG published guidelines to advise 
endoscopy staff how best to manage patients deemed to be at high-risk of complications including 
cardio-pulmonary problems, infection, bleeding and perforation (British Society of 
Gastroenterology, 2006b). The NCEPOD report looked into the causes of patient death within 30 
days of a Gl endoscopy between Apr 2002 and Mar 2003 and found that of those patients who 
died, 91% presented as emergency cases and 95% had a co-existing medical condition (National 
Confidential Enquiry into Patient Outcome and Death, 2004).
The Global Rating Scale (GRS) was developed by Dr Roland Valori, a consultant 
gastroenterologist at Gloucester Royal Hospital and the national clinical lead for the 18 week 
endoscopy programme to provide an indication of how a patient will experience having an 
endoscopy in an endoscopy unit. It contained 12 items reflecting two dimensions: Clinical quality 
and Quality of patient experience to be completed biannually by participating endoscopy units 
(Williams et al., 2007). Although the web-based tool was voluntary, it has been estimated to have 
been used by more than 90% of endoscopy units in England (Williams et al., 2007). It has not 
been independently evaluated to date so no comments can be made on its impact on NHS 
endoscopy services, although endoscopists speak of the GRS in a favourable manner.
The term “non-medical” is a term that is conventionally used in this field and refers to those 
endoscopists who are not traditionally set in secondary care (GP endoscopists) and also to those 
NHS staff in secondary care who are not qualified gastroenterologists (radiologists, healthcare 
assistants) but who have been trained to perform endoscopy.
6.4.4 “Non-medical” endoscopists
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Primary care-based endoscopy has been introduced in some NHS Trusts to address the increasing 
imbalance between demand for endoscopies and the capacity of medical endoscopists (Barrison et 
at., 2001). In 2004, there were 30 endoscopy units based in primary care (National Audit Office,
2004). A study commissioned by the Primary Care Society for Gastroenterology in 27 sites 
concluded that the use of endoscopy by GPs in primary care was safe (only one fatality in 36455 
cases), resulted in shorter waiting times for both urgently and routinely referred patients and had 
very high levels of patient satisfaction (98% very good or excellent overall) (Primary Care Society 
for Gastroenterology, Galloway et al., 2002). They commented that it should be considered as an 
alternative referral source to hospital endoscopy units where available and when hospital waiting 
lists were extensive.
Swarbrick et al reported the engagement of other non-medical endoscopists including 
radiographers and staff who originated as non-health care personnel who have been educated to 
degree standard as endoscopists, although these non-medical endoscopists are few in number 
(British Society of Gastroenterology Working Party, 2005b).
6.4.5 Specialist clinics
Endoscopy services have evolved since 1997 and now incorporate specialist clinics including 
Barretts specialist clinics (Anagnostopoulos et al., 2006), one-stop dyspepsia clinics (Rutter et al., 
1998, Melleney and Willoughby, 2002), one-stop colorectal clinics (Jones et al., 2001, Goodfellow 
et al., 2003, Badger et al., 2005, Agaba et al., 2006), nurse-led primary care-based clinics 
(Maruthachalam et al., 2006) and one-stop TWR clinics (Smith et al., 2007).
One-stop clinics cover a range of Gl complaints and have been hugely successful in reducing the 
patient journey to just one hospital visit and improving the communication and management of 
patients (Melleney and Willoughby, 2002). They usually involve the patient being assessed by a 
clinician and the investigation required is then carried out by the same clinician or suitably trained 
NE the same day, often in the same appointment. Patient satisfaction with one-stop clinics are 
high (83%), especially for the benefits of being treated the same day (Melleney and Willoughby,
2002) and the median waiting time for these clinics tends to be shorter than the routine waiting time 
(11 days Vs 16.5 weeks respectively) (Melleney and Willoughby, 2002). Jones et al reported that
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they also reduced the number of patients waiting for LGEs from 119 to 63 over a period of six 
months (Jones et al., 2001).
Two studies have reported the success of “paper clinics” (Porrett and Lunniss, 2004, Rao, 2006). 
These clinics involved health professionals meeting to discuss cases and arrange the appropriate 
follow up treatment of specific patients as opposed to the traditional method of following up all 
patients in outpatient clinics as a matter of course. This innovation led to a significant proportion 
(31% for Porrett and Lunniss; 81% for Rao) of patients being discharged because they had no 
need for a follow-up outpatient appointment, which subsequently led to the increased availability of 
outpatient appointments.
Anagnostopoulos et al reported the impact of a Barrett’s specialist clinic gave a more structured 
approach to the management of patients with Barrett’s oesophagus and recommended the 
establishment of these specialist clinics throughout the UK, along with the need for local guidelines 
(Anagnostopoulos et al., 2006).
Another recent development has been the introduction of nurse-led endoscopy clinics in the 
primary care setting. Maruthachalam et al studied the effectiveness of a NE performing FS on 100 
patients in a GP practice in 2004 and found that the clinic resulted in a reduction of the waiting 
times from referral to procedure and diagnosis of CRC and also generated additional capacity for 
endoscopy in secondary care (Maruthachalam et al., 2006).
Evening clinics have been introduced to increase the activity of endoscopy units in response to 
increased demand. Jones et al reported their experiences running a weekly evening one-stop 
colorectal clinic from 6pm to 9:30pm to investigate their impact on waiting times and patient 
experience. They found that the number of patients waiting fell during the study period and rose 
again when the study ended (Jones et al., 2001).
6.4.6 Endoscopy equipment
Endoscopy services require a minimum of six gastroscopes, four colonoscopes, two flexible 
sigmoidoscopies and three side viewing duodenoscopies, as well as accessories, cleaning and
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disinfection equipment (Barrison et al., 2001). Recovery beds are essential to allow the passage of 
patients out of the endoscopy room and increase patient flow whilst still maintaining quality of care 
for the patient until they feel ready to leave. Barrison et al recommend a minimum of eight to ten 
trolley beds and an equal number of reclining chairs with adequate monitoring equipment (Barrison 
et al., 2001).
Lack of functional equipment is another problem for endoscopy activity levels (UK NHS Cancer 
Services Collaborative, 2004). Given the invasive nature of the endoscope, there are strict 
protocols regarding their sterilisation. Any endoscopes that do not meet this standard have to be 
re-sterilised in accordance with BSG standards (British Society of Gastroenterology Working Party 
Report, 2005). This can take time and usually results in at least one procedure being cancelled. 
The quality of the endoscope can also cause problems during the procedure, as old endoscopes 
are more difficult to use, with a higher failure rate. Failures are also common when the Gl tract has 
not been properly evacuated following the inadequate application of bowel preparation, and the 
mismatching of skilled staff to the appropriate procedure type (Ball et al., 2004).
6.5 Changes affecting all aspects of NHS endoscopy services
6.5.1 The Cancer Services Collaborative Improvement Partnership
The Cancer Services Collaborative Improvement Partnership (CSC-IP) was a national NHS-funded 
programme designed to drive improvements in the way cancer services were delivered to patients. 
It did this by providing a practical approach to support local clinical teams to look at their own 
services and make significant improvements for patients by redesigning the way that care is 
delivered. Phasel piloted this approach for breast, lung, bowel, ovarian and prostate cancer with 
nine out 34 cancer networks in November 1999. Phase 2 commenced in April 2001 and was rolled 
out to all 34 cancer networks in England. Phase 3, started in April 2003, with service improvement 
being embedded at cancer network level. Work has expanded across all tumour areas in line with 
local cancer priorities, with continued national and local clinical leadership. An article by Kelly 
reported a local experience of the CSC-IP and how the programme brought ideas and tools that 
were fundamental to identifying problematic areas in their services (Kelly, 2002). Griffiths and 
Turner have published further information on the role of the CSC-IP (Griffiths and Turner, 2004).
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Phase 1 of the CSC was independently evaluated by the Health Services Management Centre at 
Birmingham University. Participants considered it to be a success as it led to a modernisation drive 
to improve every aspect of NHS cancer services (Robert et al., 2003). Of the six key levers for 
change identified by participants, the two most common were the adoption of the patient 
perspective via process mapping and having dedicated project management time.
6.5.2 Multi-Disciplinary Teams
Multi-disciplinary Teams (MDTs) were set up to more effectively manage the care of all patients 
with CRC (National Institute for Clinical Excellence, 2004b). They were made up of a variety of 
health professionals from different specialties with a common interest in cancer patients and would 
meet periodically to discuss specific patient cases (UK NHS Cancer Services Collaborative, 2004, 
National Institute for Clinical Excellence, 2004b). NICE guidance reports have emphasised the 
need for MDTs to continue improving the overall experience of cancer patients due to improved 
communication leading to better continuity and co-ordination of care (National Institute for Clinical 
Excellence, 2004b). A BSG report also advocated their use in patient care (British Society of 
Gastroenterology, 2006a).
A survey of all 183 cancer networks found that 90% had MDTs in operation, although 62% 
admitted experiencing running problems and 32% did not have a dedicated MDT clerk (Kelly et al.,
2003). Of the 150 MDTs in existence at the time, 64% had carried out a patient mapping process, 
64% of which were successful. There has been an increase in the number of NHS Trusts with 
CRC MDTs from 40% in 2002 to 71% in 2006 (Soukop et al., 2007).
Colorectal MDTS have beneficial effects on patient care, training and morale (Sharma et al., 2007). 
However, in two studies evaluating the decision making at MDT meetings, between 10% and 15% 
of decisions were not implemented, mostly due to co-morbid health issues and patient choice 
(Blazeby et al., 2006, Wood et al., 2008). A lack of communication between MDT coordinators and 
both primary care and patients has also been reported (Soukop et al., 2007). Another negative 
aspect of MDTs that featured in the literature was that MDT attendance was not built into job plans 
of colorectal surgeons or nurse specialists (Sharma et al., 2007).
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6.5.3 Analysis of working practices
There is a growing evidence base from endoscopy units reporting on audits performed on their 
services due to the increasing frequency of inspections and reports required by the government. 
They have been performed to investigate the management of Barrett’s oesophagus patients 
(Jeffery, 2005) and to evaluate the effectiveness of nurse-led dyspepsia clinics (Mason, 2005), the 
quality of endoscopy within the unit (Thomas-Gibson et al., 2002, Fasih et al., 2004) and cancer 
waiting times (Lewis et al., 2005). Audits have been successfully introduced into many aspects of 
endoscopy services (Ball et al., 2004, Parmar and Mayberry, 2005, Davies et al., 2007) although 
NCEPOD reported that approximately 42% of their study sites did not hold audit meetings in their 
endoscopy department (National Confidential Enquiry into Patient Outcome and Death, 2004).
The collection of referral, activity and waiting list data highlight discrepancies between the demand 
and supply of NHS services. However, there is evidence to suggest that this data is not routinely 
collected by NHS endoscopy units (Thome et al., 2008). Of a selection of 19 NHS endoscopy units 
in England, nine of which participated in the MES project, only eight sites collected and submitted 
any data and only three of these were MES project sites. Even for these eight sites, the datasets 
were not comprehensive enough to include all four measures requested: referral numbers, number 
of patients waiting, activity and lost appointment slots (Thorne et al., 2008).
Most endoscopists collect some aspect of clinical data corresponding to the quality of their 
expertise, although significantly more physicians and registrars collected data (87% and 95%) than 
surgeons (40%, p < 0.001) (Heamshaw et al., 2007). When surveyed to establish the acceptability 
of distributing quality-related data, most commonly the colonoscopy completion rates, there was a 
high degree of resistance, with most endoscopists considering the publication of their outcome data 
as “fairly unacceptable I not very useful” (Heamshaw et al., 2007).
When an independent evaluation of the CSC was performed in 2000, it came up against significant 
constraints as a result of poor patient-level data availability that restricted its ability to confidently 
evaluate the service quantitatively (Robert et al., 2003). Williams et al published a review 
commissioned by the BSG of the evidence relating to gastroenterology services in the UK in 2007 
where they commented on the lack of high quality health technology assessment and evaluation in
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the service (Williams et al., 2007). This issue of poor research and evaluation was also picked up 
in a 2006 BSG report, which went on to recommend the systematic introduction of good research 
or evaluation relating to initiatives in service delivery (British Society of Gastroenterology, 2006a).
6.5.4 New ways of working
Endoscopy units have attempted to improve the quality of the patient experience by improving the 
quality of the information given about their endoscopy and the consent process. Postal information 
and consent has been widely praised during anonymous patient evaluations with between 87.9% 
and 92.2% reporting the information supplied to be appropriate and useful (Shepherd et al., 2000, 
Sidhu et al., 2006). One of these studies reported the successful implementation of UGE postal 
consent, with 93.1% of patients signing the consent booklet and either returning it by post (55.1%) 
or in person when they attended the appointment (44.9%) (Shepherd et al., 2000).
A multi-centre RCT tested the implementation of patient-oriented self management using IBD 
patients and found that it significantly reduced hospital visits (difference = -1.04 (95% Cl -1.43 to - 
0.65, p < 0.001) whilst maintaining the same degree of quality of life without evidence of anxiety 
about the intervention (Kennedy et al., 2004). The test group also reported a greater confidence in 
being able to cope with their condition. The BSG later published a report advocating the 
introduction of assisted self management by patients (British Society of Gastroenterology, 2006a).
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7. THE “MODERNISING ENDOSCOPY SERVICES”
PROJECT
The NHSMA set up the MES project to improve NHS endoscopy services in line with the targets 
specified in the NHS Cancer Plan (Department of Health, 2000b). It initiated a culture of redesign, 
process mapping and rigorous data capture so that endoscopy staff better understood what was 
happening to the patient during their journey through the unit. It also allowed them to focus 
redesign efforts where they were most needed. The aim of the MES project was for its 
participating sites to achieve the following targets (NHS Modernisation Agency, 2003b):
•  No patient to wait over three months.
•  Increase in effective use of capacity.
•  DNAs below 2%.
•  Cancellations below 5%.
•  Implementation of partial followed by full booking.
•  No suspected cancer patient to wait more than 31 days from GP referral to diagnosis.
•  Four patient-led changes.
•  Locally derived measures.
The team maintained close links with nominated endoscopy staff to facilitate the modernisation 
process, to explain the project requirements and to provide help and advice wherever necessary to 
help sites meet these targets.
7.1 The MES Toolkit
The MES Toolkit was a Microsoft Excel-based macro that allowed the input of specific counts of 
service-related data from the endoscopy unit on a daily or weekly basis, depending on the data 
type. Once data entry was complete, the software allowed the graphic visualisation of data trends
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over time to help staff understand their services. The MES Toolkit was extremely rigorous in its 
data capture requests, insisting on accurate completion of the following counts and timings 
recorded in minutes on a daily basis and in some cases, per session (morning or afternoon):
•  timings of patient entry and exits from procedure rooms (minutes)
•  room turnover times (measured in minutes)
•  referral numbers and types (measured as counts)
•  activity (measured in minutes)
•  potential capacity (measured in minutes)
•  cancellations & DNAs (measured in minutes)
•  endoscopist details (entered as text)
•  waiting list data (measured in minutes and counts)
•  failure rates (measured in minutes)
The MES Toolkit aggregated these data variables to produce total Demand, total Activity, total 
Capacity, total Number of patients waiting and total Lost slots in order to assess endoscopy 
services. These measures were defined as follows:
•  Demand = Referral numbers multiplied by the time taken per procedure requested 
(measured in minutes).
•  Activity = Actual procedure times (measured in minutes)
•  Capacity = Total time available for the session based on endoscopist, room and kit 
availability (measured in minutes)
•  Number of patients waiting = Number of patients on the active and planned waiting list 
(measured as counts)
•  Lost slots = Number of over-runs, under-runs, late starts, cancellations, DNAs and failed 
procedures (measured in minutes).
The MES Toolkit was primarily issued as an Excel file in CD format, accompanied by a user 
manual (NHS Modernisation Agency, 2003b), and was sent to all sites participating in the MES 
project for compulsory use. Later in the study, the CD version was replaced by a web-based MES
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Toolkit, designated the “Webtool”. This version was later revised to make it more user-friendly prior 
to its national roll-out to all endoscopy units in the UK in 2005.
7.2 The MES project
Phase 1 of the MES project began in January 2002 with 12 endoscopy units using the MES Toolkit 
and £10,000 to fund the collection of baseline capacity and demand data for three months to 
identify any relevant issues for service redesign. Following this, they were asked to draft a 
proposal of redesign initiatives that targeted the areas highlighted by the data collection process as 
being in need of improvement. Of these 12, only eight were funded by the NHSMA to implement 
their proposed redesign efforts over the following 12 months.
The MES project identified a number of key issues during the first six months that were common to 
most sites: Identifying strategic support & clinical leadership, understanding the current service by 
mapping and analysing patient processes, seeing the service through patient’s eyes, being clear 
about actual demand and actual capacity, understanding existing backlog, using activity records to 
identify trends over time and promoting new ways of working. These issues formed the framework 
for the revised MES Toolkit, making it a template for undertaking a demand and capacity audit and 
a valuable resource for project leads, clinicians and managers seeking ways of effectively 
improving their endoscopy service.
Phase 2 of the MES project began with all NHS endoscopy units in England being invited to apply 
to participate in the project by submitting a bid containing a detailed description of their services 
and proposals for change in Spring 2002. Of the 99 that applied, only 29 were chosen to 
participate in the preliminary stages of the project based on the scoring of a number of criteria by a 
panel of adjudicators. Sites selected were “sites that we felt would benefit from the funding and 
improve their service” (personal communication with Liz Allen -  MES project lead), and not 
because of any proven modernisation successes that may have artificially improved the effect of 
the MES project.
110
In September 2002, a three month pilot study was initiated in these 29 sites to determine whether 
they could meet the needs of the project. The sites were allocated £10,000 to facilitate the 
collection and analysis of data using the MES Toolkit for three months. Only 26 of the 29 sites 
were invited by the NHSMA to continue with their proposed redesign plans and were allocated a 
further £30,000 to fund them. Once onboard, these sites were encouraged to attend both national 
and local events to learn about and disseminate examples of good practice and service redesign to 
other MES participants.
Of the 70 sites that were unsuccessful in their application to participate in the MES project, all were 
offered access to the MES Toolkit and training in its use by the NHSMA if they wished to initiate 
their own redesign efforts, but no funding was attached and help was only available on request, 
with no monthly upload of data necessary.
During the course of Phase 2, the NHSMA designed and issued their own improvement leaders’ 
guides to help NHS staff find their way through the redesign process including Process Mapping, 
Analysis and Redesign (NHS Modernisation Agency, 2002d), Matching Capacity and Demand 
(NHS Modernisation Agency, 2002b), Measurement for Improvement (NHS Modernisation Agency, 
2002c), Sustainability and Spread (NHS Modernisation Agency, 2002e), Redesigning Roles (NHS 
Modernisation Agency, 2004b), Working in Systems (NHS Modernisation Agency, 2004c) and 
Building and Nurturing an Improvement Culture (NHS Modernisation Agency, 2004a).
7.3 Outcomes of the MES project
A final report of the results of the sites involved in Phase 1 and 2 was published by the NHSMA in 
February and December 2004 respectively (NHS Modernisation Agency, 2004d, NHS 
Modernisation Agency, 2004e). The reports concluded that the MES project was a success and 
described examples of the initial problems identified by the sites. These included extensive waiting 
lists, high levels of DNAs and cancellations, problems in achieving full booking and poor patient 
experiences within the units. These problems were reportedly overcome following a better 
understanding of exactly what was happening in the unit in terms of demand, activity and waiting 
lists. New ways of working were described in case studies and included the pooling and the
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validation of waiting lists, implementing DNA policies, rewriting patient information in “plain 
English", and employing and training NEs. Many sites commented that they were able to secure 
more external funding with business cases that used data collected by the MES Toolkit, an 
unforeseen benefit of the software.
In 2004, the NHSMA also published a report containing their list of “top 20 tips” for NHS endoscopy 
units to take onboard when trying to redesign their services (NHS Modernisation Agency, 2005) 
and included the following issues: Leadership, empowering staff, communication, patient 
involvement, process mapping, identifying and removing constraints, validating and pooling waiting 
lists, analysing demand and capacity data, strategies to tackle lost appointment slots and 
redesigning roles.
According to the NHSMA’s in-house report, the second wave of the MES project was an outright 
success in terms of successful modification of endoscopy units (NHS Modernisation Agency, 
2004e). However, compulsory data collection was terminated in December 2003 so the datasets 
were too limited to sufficiently determine the full extent of any impact on endoscopy services long 
term and whether any improvements were sustained long term. Also, their evaluation did not take 
into consideration the impact of modernisation on the patient journey from the patients’ perspective, 
a major feature of the NHS Plan. Finally, there was no comparison with Non-MES endoscopy units 
to measure the impact of the project as a whole and to assess whether all endoscopy units were 
improving, not just the MES project sites.
With so many unanswered questions and potentially biased or inaccurate statements in the final 
MES reports, it was important that the MES project was independently evaluated. This task was 
undertaken by an independent research group who designed a mixed methods study in order to 
independently evaluate the MES project using quantitative, qualitative and health economics data 
analysis and by comparing the MES sites to a set of sites that had not participated in the MES 
project. This study will be discussed in more detail in the next chapter.
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8. THE “EVALUATING INNOVATIONS IN 
GASTROENTEROLOGY BY THE NHS MODERNISATION 
AGENCY” (ENIGMA) STUDY
The National Institute for Health Research Service Delivery and Organisation (NIHR SDO) 
programme (formally known as the NHS Service Delivery and Organisation (NHS SDO)) was 
established to produce and promote the use of research evidence about how the organisation and 
delivery of services can be improved to increase the quality of patient care, ensure better strategic 
outcomes and contribute to improved public health. In 2003, the NHS SDO funded the EvaluatiNg 
Innovations in Gastroenterology by the NHS Modernisation Agency (ENIGMA) study 
(SDO/46/2003) to perform an independent evaluation of the MES project using mixed methods 
(quantitative and qualitative methodology) and also by introducing a control group of sites that had 
not participated in the MES project for comparative purposes. The NHSMA also contributed a 
small portion of funds for the study.
The project was based at the Centre for Health Information, Research and Evaluation (CHIRAL) at 
Swansea University and collaborator sites included Bangor University and the University of 
Glamorgan. The study team consisted of one quantitative researcher (KT), one qualitative 
researcher and one health economics researcher. Two secretarial assistants were employed to 
manage mail and input data. The study team reported monthly to the project steering group (PSG) 
made up of stakeholders including a consultant gastroenterologist, the quantitative, qualitative and 
health economics leads and the MES project lead.
The ENIGMA study commenced in September 2003 and started recruiting sites in October 2003. 
Ethical approval from the Multi-Centre Research Ethics Committee (MREC) for Wales was granted 
in November 2003 and Local Research Ethics Committees for all study sites were given written 
notification of the study, as directed by the MREC. The approval of the Research and 
Development (R&D) departments in all the NHS Trusts involved in the study took between one day
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and 103 days, depending on the procedures in place at each Trust (Elwyn et al., 2005). 
Researchers held honorary contracts for all study sites prior to commencement of the first wave of 
patient recruitment in all 20 sites in April 2004.
8.1 Background
In brief, 99 endoscopy units in England submitted applications to participate in the MES project. Of 
these, 29 were successful in securing initial funding to analyse their services and prepare a 
redesign plan. Only 26 of these sites went on to fully participate in the next 12 months of the MES 
project -  the redesign implementation phase. The ENIGMA study randomly selected ten MES 
study sites from these 26 sites by interval choice using an assigned random number after ranking 
sites according to bed numbers to ensure stratification by size. A reserve list of replacement sites 
was selected by allocation of one before and one after systematic interval sampling.
Of the 70 sites that were not successful in their application, 27 had indicated to the NHSMA that 
they were still interested in redesigning their services and expressed interest in attending MES 
Toolkit workshops and other NHSMA-led redesign workshops. The ENIGMA study randomly 
selected ten Non-MES study sites from these 27 in the same way as described above. Figure 5 
better illustrates the recruitment of sites in this study. A reserve list of replacement sites was 
selected by allocation of one before and one after systematic interval sampling.
The 20 ENIGMA study sites were invited by letter to participate in the study and were each offered 
£5,000 as an incentive to participate and to cover costs. All endoscopy units were visited in person 
to introduce the study, agree the key contact person and assess the current method of service 
delivery within the unit.
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29 sites selected 70 sites unsuccessful
3 sites 
dropped
26 sites with 
full funding
43 sites with no 
wish to redesign 
independently
10 sites selected by 
the ENIGMA study 
(Non-MES sites)
10 sites selected by 
the ENIGMA study 
(MES sites)
27 sites indicating a 
wish to redesign 
independently
99 endoscopy units who applied 
for the MES project
Figure 5: Flowchart to indicate the selection of MES and Non-MES sites by the ENIGMA study.
8.2 Aims and objectives
The aims of the ENIGMA study, as written in the final proposal to the NHS SDO were:
1. To evaluate, both quantitatively and qualitatively, innovative models of delivery and
organisation of gastroenterology services in general, and endoscopy services in particular,
initiated and co-ordinated by the MES project.
2. To compare the accessibility and acceptability to patients and professionals of the resulting
models of service delivery and organisation with those of other new models.
3. To compare the effectiveness and cost-effectiveness of the resulting models in improving
outcomes assessed by patients and professionals with those of other new models.
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The objectives of the ENIGMA study were:
1. To describe new models of service delivery designed to improve the assessment and 
management of patients with new and continuing Gl disorders. While many of these 
models will arise in experimental sites directly from the MES project, others will arise in 
control sites, either indirectly from the MES or independently of the MES. While some will 
focus narrowly on endoscopy services, others will cover gastroenterology services in 
general.
2. To estimate for both experimental and control models of service delivery:
a. Accessibility and other measures of the quality of the process of care.
b. Acceptability to patients and professionals and their perception of the value of 
these models.
c. Outcome as assessed by patients and professionals.
d. Resources consumed by NHS, patients and society in general.
e. Effects on other aspects of the NHS.
f. To develop methods to evaluate complex heterogeneous interventions designed 
with a common purpose.
8.3 The mixed-methods approach
The ENIGMA study used a variety of methodologies to evaluate the MES project from a secondary 
and primary care perspective using both quantitative and qualitative techniques. Each is discussed 
below in more detail.
8.3.1 Patient quality of life scores
The primary outcome of the ENIGMA study was to measure the effect of innovations implemented 
at each study site on patient QoL scores at three points in time: at the time of the patients’ referral 
using the Baseline Questionnaire (BQ), immediately after their procedure using the Post Procedure 
Questionnaire (PPQ) and 12 months after the procedure using the 12 month Post Procedure 
Questionnaire (12m PPQ). If a procedure had not taken place within one year of referral, a 12 
month Post Referral Questionnaire (12m PRQ) was sent.
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Each of these study questionnaires contained the following sub-sections: the Medical Outcomes 
Study or Short Form 36 (SF-36 v2) questionnaire (www.sf-36.org), the Euroqol-5D (EQ-5D) 
questionnaire (www.euroqol.org) and the Gl Symptom Rating Questionnaire (GSRQ) (Williams et 
al., 2006). A fourth questionnaire, the Gl Endoscopy Satisfaction Questionnaire (GESQ) (Williams 
et al., 2006), was included in the PPQ only.
Patient QoL scores were collected from the questionnaires of all consenting patients from five 
waves of patient recruitment (Spring and Autumn 2004, Spring and Autumn 2005 and Spring 
2006). The questionnaires were scanned using a Canon DR5020 scanner and the scores were 
downloaded into SPSS™ v13 (Lead Technologies Inc. 2004, USA) for statistical analysis.
8.3.2 The analysis of endoscopy unit data
Each endoscopy unit was contacted to determine whether they could provide some basic demand, 
activity and waiting list data. For those sites able to collect the data, forms requesting data for the 
five calendar months coinciding with the five waves of patient recruitment were posted to 
endoscopy units immediately following those months. A reminder form was sent by email if there 
was no response after one month. Retrospective data were also requested for the calendar 
months of January 03, June 03, and December 03, to coincide with the start, middle and end of the 
MES project.
The ENIGMA data collection form asked for the following counts for a specific calendar month, split 
by procedure type (FS, colonoscopy and OGD/Gastroscopy), and by degree of urgency (urgent or 
non-urgent).
1. The number of patients waiting more than 13 weeks for their endoscopy.
2. The %DNA rate.
3. The average time from GP referral to procedure.
4. The number of referrals made to the unit.
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8.3.3 A survey of the views of health professionals
A longitudinal, qualitative evaluation was undertaken to gain some personal insight into the 
structures, processes and outcomes of the planned innovations and how they changed and 
developed over time. One consultant and one change agent from each of the participating sites, 
were interviewed face-to-face during Summer 2004 and Summer 2006 using semi-structured 
interviews that discussed their endoscopy unit’s redesign efforts. If the same person was no longer 
in post when the second interview was due, a suitable replacement was found.
A focus group was also arranged in Spring 2006 with endoscopy specialists from hospitals that did 
not apply for the MES project. These sites were deemed to be completely independent of the MES 
project. The focus group was made up of five consultants and one nurse specialist and they were 
asked to contribute their opinions on themes relating to barriers and facilitators to change within 
their own endoscopy units.
8.3.4 A survey of patient views
Two patients per site, one urgently referred and the other non-urgently referred, were interviewed 
following their procedure. This was done on two separate occasions, one using Wave 2 patients 
recruited in Autumn 04 and the other using Wave 5 patients recruited in Spring 06. The 
interviewees were asked about their views on their referral to the endoscopy unit. The interviews 
were done over the telephone using semi-structured interviews and were recorded with the 
patients’ consent.
8.3.5 The health economics evaluation
A health economics questionnaire (Williams et al., 2006) was also included in all study 
questionnaires to determine how often patients had used any health services in the last three 
months, what medication they were taking, and the prescribed dosage.
The health economics evaluation also estimated the NHS cost of each model of service delivery by 
identifying the NHS resources consumed by patients. Resources were valued in monetary terms 
using standard methods to derive a cost per patient referred. Cost utility analysis was performed 
using the EQ-5D from all three questionnaires and the incremental cost per quality adjusted life
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year was estimated by comparing changes in EQ-5D scores with NHS costs. Cost effectiveness 
analysis was performed by comparing total societal costs with changes in the GSRQ score. The 
health economics researcher also conduct interviews at all sites in winter 2004 to discuss the costs 
involved in the endoscopy service and in any redesign initiatives employed at each site.
8.3.6 Capturing GP views using GP questionnaires
All GPs with patients in the study were sent a questionnaire at the end of Wave 5 asking for their 
perception of the impact of the changes that had occurred in the endoscopy unit participating in the 
study. The questionnaire asked GPs to complete a “yes/no” tick box to indicate whether they 
perceived that specific changes had occurred during the last two years, accompanied by a three- 
point Likert rating scale to reflect their opinion on the impact of the change ranging from better to 
worse. GPs were also invited to make specific comments for qualitative analysis.
9. THE RESEARCH QUESTION
This chapter will discuss the reasons why this research study was conducted, given that the 
ENIGMA study already existed. It will also discuss in detail the research questions being 
addressed, the hypotheses being tested and the basis for those hypotheses. The outcome 
measures used to address the research question are described in detail. The chapter closes with 
the definitive aims and objectives of this study.
9.1 Why was this research study necessary?
The final reports from the NHSMA concluded that the MES project was successful in facilitating the 
improvement of service delivery within participating endoscopy units and presented many case 
studies as evidence (NHS Modernisation Agency, 2004d, NHS Modernisation Agency, 2004e). 
The positive nature of these reports could have a profound effect on the way NHS endoscopy 
services, and possibly NHS services as a whole, modernise in the future by heralding the 
investiture of data collection software, improvement guides and process mapping techniques in 
partnership with the allocation of some financial backing to support redesign plans and achieve 
improvements in service delivery under the supervision of an organisation with redesign expertise.
However, it is important to recognise that the way these reports were analysed brings into question 
their internal and external validity -  there may have been bias in the way data was collected and I 
or analysed, and the results were not easily applicable to all NHS endoscopy units. The reports 
were written by the MESPT and were based on prospectively collected data submitted by each 
study site for the sole purpose of the project. Also, the sites received financial rewards for their 
participation, providing a potential for bias in the data they reported.
It was important to independently evaluate the MES project to examine the occurrence and impact 
of any potential bias in the NHSMA reports prior to this modernisation project being rolled out
120
nationally for NHS endoscopy services or adapted for other NHS diagnostic services. The best 
way to do this was to compare the MES sites with a set of Non-MES sites, as described in Chapter 
8, to determine whether there were any real differences between both site types in terms of their 
ability to successfully redesign their endoscopy services that could be directly attributable to the 
MES project.
The basis of the evaluation by the ENIGMA study focussed primarily on differences between MES 
and Non-MES sites from a patient-centred perspective by analysing patient QoL scores at three 
separate time points during the patient journey. They also examined the effect of the MES project 
on health professionals from primary and secondary care using questionnaires and interviews 
respectively, along with an evaluation of the cost efficiency of the service using health economics 
techniques. One smaller aspect of the ENIGMA study not planned for in the original proposal was 
the collection and analysis of service-related endoscopy data. Even though they later added this 
facet to the study, data were not completed in sufficient quantity or quality for any high quality 
analysis, leaving the option of only descriptive results for the final report. Since the author of this 
thesis viewed this aspect of the evaluation to be of high importance, she proposed an additional 
study within the remit of the ENIGMA study that involved a more comprehensive data collection 
and analysis study as a more appropriate method of evaluating the MES project.
Based on the findings of the literature review in Chapter 6, there was a clear gap in the field on 
independent research evaluating the modernisation of NHS endoscopy services in any way. The 
ENIGMA study will provide answers to the question of how effective the MES project was but it will 
be primarily from the perspective of patients and health professionals. What this research study 
offered was an independent evaluation of the MES and Non-MES sites using data that was 
routinely collected by endoscopy units and corresponded to various aspects of service delivery. 
The outcome measures included as service-related datasets will be described later in this chapter. 
It was felt that this type of data analysis would provide a more relevant and accurate picture of the 
effect(s) of improvement in terms of both the quality of data collected and the analysis of the data 
over time within and between MES and Non-MES sites.
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It was felt that this study design would be a far better tool with which to evaluate the MES project 
because it would use completely unbiased, retrospectively collected data from endoscopy units. It 
would not be subject to recall bias in any way, which was a major limitation of the ENIGMA study, 
which relied upon the memories of patients and health professionals upon which to base their 
evaluations. It was also similar in many ways to the evaluation of the services of MES sites by the 
MESPT using the MES Toolkit, making the results of this study more comparable with the 
NHSMA’s MES project report (NHS Modernisation Agency, 2004e)
9.2 The research question
This study was designed as a longitudinal, observational study to independently evaluate whether 
the recent modernisation drive in NHS endoscopy units in England participating in the MES project 
(the MES sites) had resulted in any significant changes to the delivery of their endoscopy services 
when compared to NHS endoscopy units in England who were not successful in their application to 
participate in the MES project but had indicated their intention to modernise their services 
independently (the Non-MES sites). For the purpose of this study, the term modernisation was 
defined as any changes, both new ways of working and doing more of the same, implemented with 
a view to improving the service.
This study was designed primarily to analyse routinely collected, service-related endoscopy data 
from each individual site to identify trends in data over time. Data were aggregated according to 
Site type into an MES group and a Non-MES group to explore any within-group data trends, to 
determine whether there were any significant differences between the MES and Non-MES group 
datasets and to determine whether any improvements in both groups were sustained. The specific 
outcome measures taken from the service-related endoscopy datasets are discussed later in this 
chapter.
Other facets of this study involved ascertaining the availability of routine data from each study site. 
Additionally, the data submitted for this study would require validation using an appropriate gold 
standard, namely the HES datasets. Finally, a descriptive comparison of the types of innovations 
introduced and the times of their first implementation would be made for MES and Non-MES sites
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to identify whether the MES project had significantly influenced the modernisation plans employed 
by each of the study sites.
9.3 The background to the research question
The MES project advocated the need to collect high quality service-related endoscopy data to 
identify problematic areas in service delivery for a targeted redesign plan. They taught that to 
improve a service, one must first understand it in terms of what is input and what is output. The 
project also highlighted the need for measuring the impact of any improvement plans by collecting 
baseline and follow-up data over a specific period of time to analyse for significant changes over 
time. The MES sites were provided with data collection software for compulsory completion of 
service-related endoscopy unit data and unlimited advice and support during their 12 month 
redesign period. Consequently, the MES sites would have collected high quality service-related 
data during the course of the MES project that was uploaded to the MESPT for analysis that was 
also available to them for their own purposes. The MES sites also had access to £30,000 to fund 
the redesign plans that the NHSMA had approved over a period of 12 months.
The Non-MES sites in this study received no funding from the NHSMA and whilst they were offered 
access to the MES Toolkit and training, it was not compulsory. They were not obliged to complete 
the MES Toolkit in a rigorous manner because the data were not uploaded to the MESPT. It was 
up to the endoscopy staff themselves to accurately collect, input and analyse data to identify 
problem areas in the service to target for redesign.
9.4 The hypotheses being tested
The aims and objectives of this study were to test the hypotheses formulated below and come to a 
conclusion regarding the effectiveness of the MES project on NHS endoscopy services in England 
in terms of its immediate effect on MES sites, and its sustainability over time. This study would 
also determine the effect of modernising independently using the Non-MES sites. Finally, it would 
compare the MES and Non-MES sites to ascertain whether their services were significantly 
different at any point in time.
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To measure how endoscopy services had changed over time, five outcome measures defined as 
"service-related data” variables were selected: Number of referrals (Referral numbers), Number of 
patients waiting more than three months (Wait >3m), Total number of patients waiting at a specific 
point in time {Snapshot), Number of lost appointment slots {Lost slots) and Number of procedures 
performed {Activity). These outcome measures are discussed in more detail later in this chapter. 
Using these outcome measures, this study would test the following hypotheses:
Hypothesis 1 - The MES sites would have a better system of routine data collection 
implemented than the Non-MES sites.
It was hypothesised that since the MES sites had to implement a rigorous data collection regime to 
complete the MES Toolkit in accordance with MES project guidelines they would have a better 
system for routinely collecting service-related data which would have been embedded during 2003 
and maintained following the close of the MES project. It was also hypothesised that the Non-MES 
sites would collect rudimentary data (or possibly no data) in a more haphazard manner and that 
they would not be as proficient in the appropriate analysis of data to identify problematic areas in 
the delivery of their services. The null hypothesis was that there was no difference between the 
MES and Non-MES sites in their data collection practices.
Hypothesis 2 - The MES project would significantly improve various aspects of the 
endoscopy services of the MES sites.
It was hypothesised that over time the MES sites would show statistically significant changes in 
their services, namely increases in Activity mirrored by decreases in the N° patients waiting and 
Lost slots, irrespective of any changes in Referral numbers, as these were some of the targets set 
by the MESPT to be addressed in the redesign plans of the MES sites. It was also postulated that 
these improvements would not only be sustained but that we would see evidence of further 
improvement over time as a result of the embedding of a “modernisation culture” established within 
these sites by the MES project. This “ideal model” was proposed here as the gold standard that all 
MES sites should, in theory, have achieved over time. The model is better illustrated in Figure 6, 
indicating the proposed ideal changes to the endoscopy services of MES sites, both during the 
project and beyond. The null hypothesis was that there was no statistically significant change in 
any aspect of the service-related data from MES sites over time.
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Figure 6: Illustration of the hypothesised changes in service-related data using five outcome measures 
(Referral numbers, Wait >3m, Snapshot, N° lost slots and Activity) over time for MES and Non-MES sites.
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Hypothesis 3 - The Non-MES sites would not have significantly improved their services, 
although some changes would be inevitable due to the natural evolution of their services 
and their intention to redesign independently.
It was hypothesised that the endoscopy services of the Non-MES sites would also show evidence 
of service improvement due both to their intention to modernise and to the “natural evolution” of 
their services over time as a consequence of other independent improvement programmes such as 
the NBAP. However, any improvements identified would not have been large enough to be 
statistically significant. The proposed model of the change in Non-MES site endoscopy services 
over time is illustrated in Figure 6. The null hypothesis was that there was no change whatsoever 
in any aspect of the service-related data from Non-MES sites over time.
Hypothesis 4 - There would be a significant difference in the endoscopy services of the MES 
group and Non-MES group that would increase over time.
It was hypothesised that the degree of improvement in the services of the MES sites, as measured 
by the five outcome measures stated in this chapter, would have been significantly different to the 
degree of improvement (or otherwise) in the services of the Non-MES sites. It was also 
hypothesised that over time, the differences between the MES and Non-MES sites would increase 
significantly. These hypotheses are also illustrated in Figure 6. The null hypothesis was that there 
was no significant difference between the MES and Non-MES sites in their service-related data at 
any point in time.
Hypothesis 5 - The MES sites would have introduced more innovations during the study 
period than the Non-MES sites.
Whilst both MES and Non-MES sites would have implemented a number of redesign initiatives 
during the course of this study, it was hypothesised that the MES sites would have introduced more 
innovations compared to the Non-MES sites due to the earlier implementation of redesign plans 
and the close guidance, support and advice provided by the MESPT. The null hypothesis was that 
there was no difference between the MES and Non-MES sites regarding the number of innovations 
introduced.
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9.5 Study outcome measures
The outcome measures used for this study were based on some aspects of the service-related 
endoscopy data collected by the MES Toolkit from the MES sites. It was thought that if the MES 
project advocated the collection and analysis of demand, activity and capacity data using this 
software on a routine basis, then this evaluation should also be based on as many of the principles 
of the MES Toolkit as was feasible to collect retrospectively.
Since the ENIGMA study did not originally plan this type of data collection, this study was restricted 
to requesting data that was routinely collected by the endoscopy units and was unable to finance 
any retrospective data collection for more detailed data that were not routinely collected. One 
advantage to this was that it was able to get a clear picture of the nature of the data collection 
practices of each site. Unfortunately, capacity measures such as staff numbers and resource 
availability were not routinely collected or easily retrievable by NHS endoscopy units.
The analysis of the service-related endoscopy data were confined to the three most commonly 
requested endoscopies, namely UGEs, FS and colonoscopy. For the purpose of this study, the 
UGE category included both gastroscopies and OGDs because some study sites grouped both 
procedures into “Uppers” whilst others discriminated between the two in their data. From these 
three procedure types, “total procedures" data would be calculated and included as a feature of the 
analysis as well as examining the data split according to individual procedure types (designated 
split procedures data). The reason for this was to identify whether there were any changes in any 
of the five outcome measures that were specifically attributable to a particular procedure which 
would have been hidden when analysing total procedures data. For example, the referral 
guidelines for dyspepsia (National Institute for Clinical Excellence, 2004a) advocated the use of 
diagnostic UGEs, which may have resulted in an increase in UGE N°. patients waiting and Activity 
that may have been obscured in the total procedures data analysis.
A more detailed description of each outcome measure follows, along with the time periods of data 
collection. All subsequent references to the outcome measures in this thesis will refer to them 
according to the titles given below, each of which will be italicised from this point for easier 
identification.
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9.5.1 Referral numbers
This was the number of referrals received by the endoscopy unit for diagnostic and therapeutic 
UGE, FS and colonoscopy procedures made to the endoscopy unit during a specified time period. 
We requested that data be split where possible into referral types, including daycases (outpatients), 
TWR referrals, inpatients, follow-ups and emergencies.
9.5.2 Number of patients waiting more than three months (Wait >3m)
This study requested the number of patients waiting for diagnostic and therapeutic UGE, FS and 
colonoscopy procedures on the active waiting list for more than one month, three months, six 
months and 12 months during a specified time period. Of these, it was the number of patients 
waiting more than three months (designated Wait >3m) that was selected as the main waiting list 
target measure for all subsequent analyses because it was a government target that all NHS 
patients in England should be seen within 13 weeks of a referral by their GP.
9.5.3 Total number of patients waiting (Snapshot)
The total number of patients waiting on the active waiting list for diagnostic and therapeutic UGE, 
FS and colonoscopy procedures at a specific point each month during a specified time period, 
irrespective of how long they had been waiting, was also requested (designated “Snapshot”).
9.5.4 Lost appointment slots (Lost slots)
This was the total number of individual diagnostic and therapeutic endoscopy appointment slots 
“lost” due to patient DNAs and cancellations by both hospital and patient during a specified time 
period. This dataset was not requested split by procedure type as the datasets were not routinely 
compiled in this way.
9.5.5 Number of procedures performed (Activity)
This was the total number of diagnostic and therapeutic UGE, FS and colonoscopy procedures 
performed within the endoscopy unit by endoscopy staff during a specified time period. The 
request did not include any procedures done within an outpatient clinic or theatre unless they were 
done within the remit of the endoscopy unit.
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9.6 Time periods of data collection
All data were requested for specific calendar months to get a better idea of the performance of the 
service over a long period of time. A total of eight separate months were chosen by the ENIGMA 
study, due to their intention to combine this data with their own analyses for their final report. The 
months falling in 2003 corresponded to the start, middle and end of the MES project, whilst all other 
months related to the first five waves of patient recruitment within the ENIGMA study. Where these 
specific dates were not available, data were accepted if within one month.
This thesis refers to each month according to the corresponding time (T) value, indicated in 
brackets: January 2003 (TO), June 2003 (T1), December 2003 (T2), April 2004 (T3), November 
2004 (T4), April 2005 (T5), October 2005 (T6) and April 2006 (T7). The TO data were to be used 
as a baseline measurement against which all subsequent data would be compared. Where TO 
data were not available, the closest time points with data were used instead. Data were 
retrospectively requested in two phases, the first to cover TO to T4 and the second to cover T5 to 
17.
9.7 Study aims and objectives
To summarise, the aims of this study were:
a) To make an independent assessment of the impact of the MES project based on the 
comparative analysis of service-related endoscopy data from MES and Non-MES sites.
b) To determine whether any changes in service-related endoscopy data from both MES and 
Non-MES sites were sustained over time.
c) To comment on the type and extent of innovations implemented as part of the 
modernisation agendas of the MES and Non-MES sites.
This would be achieved by fulfilling the following objectives:
a) To collect routinely collected, service-related endoscopy data from 10 MES and 10 Non- 
MES study sites.
b) To determine whether there were any significant positive changes in service-related 
endoscopy data in the MES sites and the Non-MES sites over time.
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c) To explore whether there were any significant differences in service-related endoscopy 
data from both MES and Non-MES sites at specific points in time.
d) To measure the extent of any changes (in terms of time) in service-related endoscopy data 
from both MES and Non-MES sites.
e) To describe the types of innovations implemented in both MES sites and Non-MES sites 
over time and comment on the “innovativeness” of each site based on the types of 
innovations introduced and when they were first implemented.
To address these aims and objectives in a logical manner, the remainder of this thesis was split 
into individual chapters that would cover the availability of data (Chapter 10), the validation of data 
(Chapter 11), the analysis of data (Chapter 12), and a description of the innovations introduced 
(Chapter 13). Each of these chapters would be structured with a Methods, Results and Discussion 
section. An overall discussion of the study as a whole, including its strengths and weaknesses, 
would be located in Chapter 14, along with a discussion of the results of this study in context, the 
conclusions of the study and any recommendations arising.
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10. THE DATA COLLECTION PROCESS
The principal aim of this study was to ascertain whether the MES project had any significant impact 
on participating sites by comparing specific NHS endoscopy datasets from MES sites with those 
sites who modernised independently. To do this, the study aimed to analyse routinely collected, 
service-related endoscopy data from each study site. For the purpose of this thesis, the term 
“routine” refers to data already collected and used by the endoscopy unit and not retrieved for the 
sole purpose of a research study. This chapter describes the data collection process and the 
datasets received. It also describes how the datasets from each source were assessed for 
compatibility and comparability, prior to the aggregation of the data to form the final dataset used in 
all subsequent analyses. A focussed discussion on the availability (or lack thereof) of routinely 
collected, service-related endoscopy data from the endoscopy units closes the chapter.
10.1 Methods
10.1.1 Hospital recruitment
This study used the same endoscopy units that were randomly selected by the ENIGMA study, as 
described in Chapter 8.
10.1.2 Details of the data requested
The data request consisted of counts for the five study outcome measures previously discussed in 
Chapter 9, namely Referral numbers, Wait >3m, Snapshot, N° Lost slots and Activity. Where 
possible, counts were split according to the three most commonly performed procedure types -  
UGEs, FS and colonoscopies -  for all queries except for Lost slots, which were not generally 
collected according to procedure type. Where the sites were unable to split data by procedure 
type, the total number was accepted but it was noted that this figure would also contain unspecified 
endoscopic procedures, albeit in low numbers, making the data less comparable. All five outcome
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measures were retrospectively requested for the eight calendar months discussed in Chapter 9, 
labelled T0toT7.
10.1.2.1 The endoscopy unit data request
All participating endoscopy units were approached by phone or email in January 2005 to provide 
copies, either electronic or hard copy, of any service-related endoscopy data that had been 
routinely collected. The purpose of the data request was twofold: firstly to find out what type of 
datasets were collected by the endoscopy unit, if any, and secondly to provide datasets at their 
rawest (and probably its truest) levels, free from manipulation or misinterpretation by NHS Trust 
information departments. It was suggested that any other relevant data were also submitted. Units 
sending in-house datasets were asked to provide detailed descriptions of the data and any 
definitions used to make sure datasets were suitable for analysis. The initial data request in 
January 2005 retrospectively collected data pertaining to TO to T4. Follow-up datasets to cover T5 
to T7 were retrospectively requested in June 2006. The deadline for final data collection was 
January 2007.
Routinely collected data were specified for four reasons: (1) The ENIGMA sites had not agreed to 
collect any service-related data for this study as it was not part of the ENIGMA study’s original 
remit, (2) the retrospective nature of the data request, (3) the fact that no financial incentive was 
made available to the units to fund the manual retrieval of these datasets if they were not routinely 
available, and (4) it would indicate what type of data were considered to be important enough to be 
collected by the endoscopy units.
Following the submission of all endoscopy unit datasets, Mann-Whitney U tests were used to 
determine whether there was a significant difference in the time taken by the endoscopy units of 
MES and Non-MES sites to return their datasets. Statistical tests were done using SPSS version 
13 (Lead Technologies Inc, USA). A p-value of ^  0.05 was considered to be statistically significant.
10.1.2.2The NHS Trust Information Services endoscopy data request
To ensure that this study had complete datasets for each time period and each outcome measure, 
equivalent datasets were also requested from the corresponding Trust Information Services (TIS)
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departments of each study site’s NHS Trust. In April 2005, the TIS managers of all 20 study sites 
were contacted by letter to ask whether they would be prepared to release copies of any service- 
related data that they routinely collected corresponding to the endoscopy unit of the hospital 
involved in ENIGMA within the Trust. Where no response to the original data collection request 
was received after six weeks, a second letter was sent. This time, the letter was addressed to a 
specific person in the TIS department identified by a contact based at HES. Where no response 
was received to the second letter, efforts were made to communicate with the person by email and 
telephone on a minimum of five separate occasions before the request was abandoned. Where 
other Trust sources of data were identified by the ENIGMA contact, such as IT departments, the 
named contact was approached by Email or phone in the same way. The initial data request in 
April 2005 retrospectively collected data pertaining to TO to T4. Follow-up datasets to cover T5 to 
T7 were retrospectively requested in June 2006. The deadline for final data collection was January 
2007.
Since TIS datasets were likely to be extensive if collected at the patient-level, the TIS contacts 
were also offered the option of a data collection proforma for completion designated the TIS form. 
The proforma was designed as an Excel-based spreadsheet that consisted of four pages 
requesting data on Referral numbers (Form A), N° patients waiting (Form B), N° Lost slots (Form 
C) and Activity (Form D) respectively, with the sub-variables described in Chapter 9 incorporated 
within the form (see Appendix 16.3). The TIS form was accompanied by a comprehensive 
instruction sheet to ensure its completion was accurate, comparable and related only to the 
hospital specified, not the Trust as a whole. The instructions also asked for the data request to be 
completed using the Office for Population Censuses and Surveys-4 (OPCS-4) coding system used 
by HES:
•  Endoscopic operations on the oesophagus (G16 to G19) using OGD or gastroscopy.
•  Endoscopic operations on the upper Gl tract (G43 to G45) using OGD or gastroscopy.
•  Endoscopic operations on the colon using colonoscopy (H20 to H22).
•  Endoscopic operations on lower bowel using FS (H23 to H25).
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TIS departments sending their own in-house datasets were asked to provide a detailed description 
of the data types and definitions used to ensure they were comparable with TIS form datasets. The 
TIS form was piloted in one study site endoscopy unit prior to being sent to those TIS contacts 
requesting a proforma.
Following the submission of all endoscopy datasets from the TIS contact, Mann-Whitney U tests 
were used to determine whether there was a significant difference in the time taken by the TIS 
departments of both MES and Non-MES sites to return their datasets. Statistical tests were done 
using SPSS version 13 (Lead Technologies Inc, USA). A p-value of < 0.05 was considered to be 
statistically significant.
10.1.2.3Endoscopy data from the ENIGMA study
As previously mentioned in Chapter 8, the ENIGMA study requested the retrospective completion 
of a rudimentary ENIGMA data collection form by each site with the datasets corresponding to the 
same time points as used in this study (TO to T7). These datasets were available for this study, if 
necessary.
10.1.3 Assessment of endoscopy data collected
All data received were assessed following discussions with site contacts (endoscopy unit and/or 
TIS contacts), using the definitions provided and by using observational comparisons to determine 
their accuracy and comparability with other datasets. The TIS form was used as a proforma for the 
extraction of in-house, routinely collected data provided by both endoscopy units and the Trust to 
structure comparable datasets. The exclusion criteria described below were imposed following the 
first data request (TO to T4) and where data were not suitable, it was not requested for T5 to T7. 
More suitable replacement datasets were requested wherever possible.
During the data extraction process, datasets were assessed for its compliance to strict 
specifications and in accordance with the instruction sheet accompanying the TIS Form. Data 
were excluded whenever they did not conform to the request in either content or output style (e.g. 
Trust-wide data, planned and active waiting list data combined, percentages, etc). Data were also 
excluded when not split according to procedure type because it was likely to include additional
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endoscopic procedures, albeit small, artificially inflating the total procedures figures, thereby 
making the dataset inaccurate for comparison.
10.1.4 Validation of endoscopy data collected
Where data were extracted from routinely collected, in-house data to complete the TIS forms, it 
was validated by selecting approximately 20% of the datasets by randomly selecting site numbers 
and TIS forms using SPSS version 13 software (Lead Technologies Inc, USA) and re-completing 
them based on the original data. Any discrepancies resulted in the appropriate corrections being 
made and another 20% of the data being validated until no errors occurred.
Following this, all data from the verified TIS forms were input into SPSS. Data entry was validated 
by selecting 20% of the data in the file for re-entry. Any discrepancies resulted in the appropriate 
corrections being made and another 20% of the data being validated until no errors occurred.
10.2 Results
10.2.1 Hospital recruitment
All hospitals originally participating in the ENIGMA study were allocated unique identification (ID) 
numbers from one to 20 according to the order in which they agreed to participate in the ENIGMA 
study. The same numbers have been used in this thesis and they appear in brackets wherever 
reference is made to a specific site. A description of each study site according to its Site ID can be 
found in Table 8.
During the early stages of the ENIGMA study the PSG agreed to withdraw two study sites, one 
MES site (18) and one Non-MES site (10), because they were unable to comply with the strict 
patient recruitment criteria. These sites were not replaced because the ENIGMA study had already 
begun. The Non-MES site indicated that they were willing to participate in this study whilst the 
MES site chose to withdraw from all active participation. This meant that for this study, there were 
only 19 endoscopy units actively participating in service-related data collection. The withdrawn 
MES site was not contacted for this study, and data were only requested from the TIS department 
for that site.
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Site ID Site type Unit type f  
(at first visit)
Population served 
by the Trust
N°. hospital 
beds*
N°. endoscopy rooms in 
unit in ...
2003 2006
1 MES 1,4 250,000 547 2 2
2 Non-MES 1,4 500,000 1100 2 2
3 Non-MES 1,3 300,000 357 2 2
4 MES 1,4 500,000 512 2 2
5 Non-MES 2,4 500,000 520 2 2
6 MES 1,4 183,000 396 1 2
7 MES 1,3 250,000 413 2 2
8 MES 1,4 1,500,000 1048 2 2
9 Non-MES 2,3 265,000 968 2 2
10 Non-MES 1,4 600,000 610 4 4
11 MES 1,3 400,000 203 2 2
12 Non-MES 2,4 300,000 450 1 2
13 MES 2,3 500,000 519 3 4
14 Non-MES 1,4 640,000 368 1 2
15 Non-MES 1,4 350,000 430 3 3
16 MES 1,4 138,500 320 2 2
17 Non-MES 1,3 750,000 650 3 3
18 MES 1,4 350,000 720 3 3
19 MES 2,4 157,000 453 2 2
20 Non-MES 1,3 550,000 427 3 3
Table 8: Description of each endoscopy unit in the study.
* The number of beds was taken from the ENIGMA study and was the basis of the sampling strategy that 
selected those 20 sites. |Key: 1 = self-contained; 2 = part of another specialty; 3 = modem/new unit; 4 =
older/original unit.
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10.2.2 The availability of service-related endoscopy data
10.2.2.1 Endoscopy unit service-related endoscopy data
Only eight of the 19 endoscopy units were able to provide copies of any service-related data for 
any of the time periods requested, of which three were MES sites and five were Non-MES sites. 
The data submitted by these eight sites consisted of seven Excel files (5, 7,10,12,17 and 19), two 
internal written reports (10 and 19) and two Excel-based MES Toolkit files (1,2).
Whilst one of the MES Toolkit files had been submitted by a Non-MES site, it was confirmed that 
they had legitimately secured a copy from the NHSMA but were not required to complete or submit 
any of their data to the NHSMA. Closer examination of the dataset confirmed that they were only 
interested in completing specific aspects of the MES Toolkit as some tabs were left blank.
One of these sites (1) agreed to pilot the TIS form by searching their PAS to extract the relevant 
data. The subsequent richness of the data on the form meant that it was far superior to the original 
dataset - a printout of part of the MES Toolkit for January 2003 only -  and so, it was used in 
preference to the original, routinely collected data in order to have a more complete dataset for this 
site covering all eight time periods.
Of the remaining 11 sites, two submitted the TIS forms originally sent to the TIS contact because 
they had liaised with them for their completion but returned it themselves (4 and 6) and so, were 
classified as “mixed source” datasets. A further two sites claimed that they collected their own data 
but they refused to submitted copies for this study due to excessive staff workloads (9 and 15). 
The remaining seven reported that they did not routinely collect any service-related data within the 
unit and relied on their liaison at the TIS to extract and compile data whenever necessary (3,8,11, 
13, 14, 16 and 20). When asked for copies of data collated following these requests, they had 
either not been kept or they were not relevant to this data request. In sites with no data, this was 
documented and no further requests were made unless, during the course of the ENIGMA study, 
they mentioned the intention to initiate data collection.
Of the eight sites providing routinely collected, service-related endoscopy data, not all of the 
outcome measures were collected. When examining the data more closely, the Non-MES sites
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provided data for more outcome measures than the MES sites. When looking at all five outcome 
measures in this study, one MES site provided all five data types (1), whilst the other two were only 
able to provide one (7 and 19). One Non-MES site provided four data types (2), two provided three 
(5 and 12), one provided two (17) and only one provided just one data type (10). A breakdown of 
whether data for each outcome measure was provided by each endoscopy unit is illustrated in 
Table 9.
Table 10 shows the median time in weeks taken for the endoscopy units to return data in response 
to the first data request (TO to T4), which varied for each site from zero to 38 weeks (median = 3). 
This figure did not include the two occasions when forms had been jointly completed by the 
endoscopy unit and TIS department in Sites 4 and 6. There were no significant differences in the 
response times of MES and Non-MES sites (p > 0.05, Mann-Whitney).
This study was designed on the basis that all NHS endoscopy units, especially the MES sites, 
would routinely collect some degree of service-related endoscopy data that would be available to 
this study for independent analysis. However, this soon proved to be untrue, with a number of sites 
reporting that they did not routinely collect any service-related endoscopy data.
Site ID Site type Referral
Numbers
Wait >3m Snapshot Lost slots Activity Earliest time 
period with data
1 MES Yes Yes Yes Yes Yes Jan 2003
7 MES No No Yes No No Jan 2003
19 MES No No No No Yes Jan 2003
2 Non-MES Yes Yes Yes Yes No Dec 2003
5 Non-MES Yes No No Yes Yes Apr 2004
10 Non-MES No No Yes No No Apr 2004
12 Non-MES Yes No Yes No Yes Dec 2003
17 Non-MES Yes No No No Yes Dec 2003
Table 9: Description of outcome measures provided by the eight endoscopy units submitting routinely
collected, service-related data for this study.
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Site ID Site type Time (weeks) taken by...
Endoscopy unit Trust
1 MES 35 No data submitted
2 Non-MES 3 12
3 Non-MES No data submitted 31
4 MES 66
5 Non-MES 3 10
6 MES 52
7 MES 3 No data submitted
8 MES No data submitted 67
9 Non-MES No data submitted 4
10 Non-MES 1 5
11 MES 0 32
12 Non-MES 1 8
13 MES No data submitted 19
14 Non-MES No data submitted 24
15 Non-MES No data submitted 22
16 MES No data submitted 46
17 Non-MES 3 22
18 MES Not requested 3
19 MES 38 3
20 Non-MES No data submitted 46
Median (range) 3(0 to 38) 22 (3 to 67)
Table 10: Description of the time taken in weeks to receive data pertaining to TO to T4 from the endoscopy 
units and the corresponding Trusts of MES and Non-MES sites. Data from Sites 4 and 6 were completed 
jointly by the endoscopy unit and Trust. Data from Site 18 was not requested from the endoscopy unit.
With this in mind, the methodology of the study was altered to capture sufficient data from as few 
sources as possible to reduce the variation in data and allow a tentative comparison, so long as 
any conclusions would bear in mind the different sources of data making up the datasets being 
analysed. For this reason, the corresponding TIS departments of each study site were contacted 
to provide the same data as were requested from the endoscopy units.
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10.2.2.2NHS TIS department service-related endoscopy data
Of the 20 TIS departments contacted to provide data files, responses were received from 19, 
including one IT department (3). One contact (7) did not respond to any attempts to get in touch 
with them by email, phone or letter. Eleven Trusts were able to send electronic copies of their data 
or reports (1, 2, 5, 9,10, 12, 14, 16, 17,18 and 19), while six sites completed the TIS forms and 
returned them electronically or by post (3, 8 ,11 ,13 ,15  and 20). Another two TIS contacts liaised 
closely with the endoscopy unit for TIS form completion but the forms were submitted ultimately by 
the endoscopy unit so they were included as endoscopy unit data sources (4 and 6).
One TIS contact (12) submitted the same file as was submitted by the corresponding endoscopy 
unit, whilst another TIS contact (1) submitted a report but advised this author to consult with the 
corresponding endoscopy unit, commenting that they deferred to the endoscopy staff for accurate 
data collection from PAS.
Table 10 also shows the median time in weeks taken for the TIS contacts to return the service- 
related endoscopy data in response to the first data request (TO to T4), which varied for each site 
from three to 67 weeks (median = 22). This figure did not include the two occasions when forms 
had been jointly completed in Sites 4 and 6. There were no significant differences in the response 
times of MES and Non-MES sites (p > 0.05, Mann-Whitney).
10.2.2.3 ENIGMA study endoscopy data
The ENIGMA study’s retrospective data collection forms were available for this study. Fourteen of 
the 19 ENIGMA sites returned forms to correspond to one time point between TO and T7 (1 ,2,3 ,4, 
6, 7, 8 ,11 ,12,13,14,16,17 and 20). A further two indicated early on that data were not routinely 
collected and they were not pursued any further during the ENIGMA study (5 and 10). Three sites 
reported that they collected data but did not complete the forms due to time and resource 
constraints (9,15 and 19).
Of the 14 sites with forms, five stopped returning them for T6 and T7 (4, 6, 7, 8 and 14) and a 
further three did not return the final form corresponding to T7 only (2,13 and 16). This may have 
been because sites had been asked to submit their routine datasets at this time and did not wish to
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continue with completing the forms as well. Completed forms were not of particularly high quality, 
with many sites unable to split data by procedure type or degree of urgency. They also found it 
extremely difficult to complete the average time from GP referral to procedure.
Once this study had been acknowledged by the PSG to be of superior design to the rudimentary 
data collections forms drafted by the ENIGMA study, they were happy for the sites to “drop out” of 
completing their forms in favour of this study.
10.2.3 Categorisation of datasets
Based on discussions with site contacts (endoscopy unit and/or TIS contacts), the definitions 
provided and the observational comparisons, it was decided that data from endoscopy units would 
be used in preference to Trust-held datasets because some TIS contacts had commented that they 
were often unable to discriminate between endoscopies performed within and outside the 
endoscopy unit. There were also issues with a few TIS datasets concerning a change in coding 
practices for endoscopies, making their data less accurate when analysing for trends over time, 
although there was no published evidence of this occurring. TIS data were only used in the 
complete absence of any routinely collected endoscopy unit data and where possible, it was 
ensured that the data submitted was the same as the data sent to the endoscopy unit.
In all, four types of data were available from three sources for this study. Each was ranked 
according to its accuracy based on discussions with various endoscopy unit and Trust personnel. 
Whilst data completed by the endoscopy unit was considered to be most accurate by all
questioned, the ENIGMA data collection forms were not completed very rigorously and as a
consequence, they were not used unless all other data sources were exhausted.
The final data rankings used for this thesis were:
1. Routinely collected in-house endoscopy unit data.
2. TIS forms completed by the Trust.
3. Routinely collected Trust in-house data.
4. ENIGMA data collection forms.
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Where possible, the same data source was used for all four TIS forms to allow consistency and 
enhance comparability. Data sources were allowed to vary between TIS forms where necessary, 
but not within the TIS forms or else data it would not be feasible to analyse the data over time.
10.2.4 Exclusion of datasets
Data were excluded because they did not conform to the request made, either in format or in the 
specification for it to be split according to procedure type. In one site (15), data were only available 
from the TIS and those datasets were all subsequently excluded because there was doubt cast 
upon their accuracy because they included a number of zeros. The TIS contact commented on 
changes in coding practices over the time period requested that, in her opinion, made the dataset 
unsuitable for analysis over time.
Referral numbers data were also excluded from Sites 14 and 19 because the data were not split 
according to referral type (14) or procedure type (19). N° patients waiting data were excluded from 
Sites 5,11,13 and 17. One site did not split their waiting list data according to procedure type (5), 
one site provided waiting list data but it was recorded in minutes rather than counts (17), and two 
sites submitted waiting list datasets that included both their active and planned waiting lists (11 and 
13). Lost slots data were excluded from Sites 14,16,17 and 19 because two sites did not include 
hospital cancellations (14 and 16), one site did not include patient cancellations (17) and one site 
submitted only DNA counts (19). Activity data were excluded from Sites 7 and 14 because neither 
had split their data according to procedure type.
10.2.5 Formation of final datasets
The final datasets used for analyses in this study used a mixture of endoscopy unit data, Trust data 
and ENIGMA data. Table 11 shows the breakdown of the best sources of each dataset provided, 
and which datasets were subsequently excluded to produce the final dataset used by this study 
split according to Site ID, time and outcome measure. The numbers within the table corresponded 
to the best source of that data item, as described in the key. Grey-shaded cells highlight those 
datasets that were later excluded. Black cells indicated that no data were available from any 
source.
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10.3 Discussion
It appears that data were not routinely collected by NHS endoscopy units. Only four of the nine 
MES sites approached submitted any routinely collected, service-related data, and one of those 
was only for one time period in 2003 (1). This lack of data availability was surprising, considering 
the MES project based its redesign principles on the collection and analysis of accurate, 
measurable service-related data for the analysis and evaluation of endoscopy service pre- and 
post-modernisation. It also advocated the routine collection of this data by the endoscopy units 
themselves using data collection software, in preference to liaising with TIS departments. The 
author expected, at the very least, to obtain data for all three time periods in 2003 if nothing else, 
but even this was beyond the scope of the MES sites.
It was clear that the key issue of the importance of high quality data collection and analysis 
advocated by the MES project was not taken on board by many MES sites. This may be explained 
by the fact that datasets were uploaded to the MESPT on a monthly basis and even though the 
staff attended MES Toolkit training sessions, they may not have understood how to analyse and 
understand the data at the ground level and may not have realised its true potential.
Informal discussions with some MES site contacts during the data collection phase highlighted the 
difficulties they experienced in collecting, using and extracting any meaningful datasets from the 
MES Toolkit. Since the data collection process was so labour-intensive, sites may have found it 
impossible to maintain this level of data acquisition in accordance with the strict deadlines imposed 
by the MESPT whilst also inputting data into a second database that was more appropriate for their 
purposes so the MES Toolkit would have taken priority. Many contacts from the MES sites also 
expressed their frustrations at having to collect such detailed datasets when, in their minds, they 
were able to analyse their services equally well with less complex, easier to collect data. However, 
this study showed that even the less complex service-related data was not routinely collected by 
the MES sites. They also commented on the fact that they had used some of the MES funding to 
pay for a data entry clerk to input data and when the funding ended, so did the data collection.
Problems with data collection and uploading to the MESPT were further exacerbated with the 
change from the Excel-based version to the web-based version (the MES Webtool) mid-way 
through the MES project. They commented that they were less able to manipulate their data for
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their own purposes than before and viewed the Webtool as even more disadvantageous when 
compared to the Excel- based MES Toolkit.
Even with all the negative comments from sites regarding the data collection process, all MES sites 
agreed that some form of data collection was necessary and acknowledged the value of the MES 
Toolkit, not so much as a data collection tool but as an instigator for their own in-house data 
collection ideas. Unfortunately, this study suggests that routine data collection processes did not 
flourish in the same way that they were spoken about, although the reasons for this were unknown. 
Consequently, the definition of routinely collected data used in this study had to be adapted to 
encompass the use of the TIS datasets which, whilst routinely collected within their department, did 
not strictly adhere to the original definition of routine stated in the opening paragraph of this 
chapter. Instead, routinely collected data would encompass data routinely collected by the 
endoscopy unit and data collected by the Trust prior to it being manipulated for export into HES via 
central returns. It would not include HES datasets.
Another surprising aspect of this study was that half the Non-MES sites had initiated their own, in- 
house data collection protocols, although these were instigated during the latter part of 2003 or 
early 2004. The Non-MES sites were all aware of the MES project because they had originally 
applied to take part but had been rejected. They were offered the opportunity to be trained in the 
use of the MES Toolkit, if they so desired but only one Non-MES site took advantage of this 
opportunity (2) and used the Excel-based version of the MES Toolkit to collect some elements of 
endoscopy service-related data on a monthly basis. As a result, they were able to provide data for 
most outcome measures for all of the time periods requested by this study.
It is possible that the messages of accurate data collection advocated by the MES project were 
disseminated to these sites and they began their own data collection procedures, albeit later on. 
The raw datasets provided by the Non-MES sites covered more of the outcome measures 
requested than those of the MES sites. It is feasible that having access to view and use the MES 
Toolkit, they took on board the idea of data collection but did so in a rudimentary manner with basic 
counts of the relevant aspects of the service collected in Excel software and as a result, were more 
motivated to capture these simpler datasets over a prolonged period.
It was concerning to hear from some TIS personnel about the degree of potential coding 
ambiguities in their own endoscopy datasets, although there was no published evidence retrieved
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in the field of endoscopy to support this. For the sites that relied on Trust-held data, it is 
questionable whether the data they were being given was truly accurate. However, it was not part 
of the remit of this study to investigate how aware the endoscopy staff were of the quality of their 
data, although it was evident that Trust data were used by the units in the absence of anything 
else, irrespective of its potential inaccuracies.
The need for good quality, routinely collected data in the NHS has been widely acknowledged 
based on independent assessment of current data collection practices (Benneyan et al., 2003, 
Audit Commission, 2002, Audit Commission, 2004, Thorne et al., 2008). However, there is 
currently no national impetus to collect routine data in NHS endoscopy services, even in light of the 
MES project report that described significant improvements in the services of MES sites based, in 
part, on high quality data collection and analysis (NHS Modernisation Agency, 2004e).
With increasing demands on NHS endoscopy services from initiatives including TWR referrals and 
the NBCSP, it is difficult to understand how NHS endoscopy services hope to become more 
efficient if they do not understand how they work and where underlying problems may exist in order 
to target any redesign plans effectively. This may explain why the service is only able to achieve 
TWR targets at the expense of the routine waiting list (Thorne et al., 2006). Even the most basic 
understanding of the demand, capacity and activity within the endoscopy unit can identify seasonal 
effects, underused resources and potential problems for further investigation, as well as providing 
an essential baseline measurement against which to measure the impact of any change(s) to the 
service. It can also provide an invaluable source of evidence when submitting bids for funding, all 
of which make the effort of establishing even a basic data collection regime worthwhile.
A possible lack of business experience in some NHS managers may go some way towards 
explaining the ineffective working practices of many NHS services, not just endoscopy, as many 
NHS managers may not be properly trained in the redesign concepts covered in Chapter 3, all of 
which advocate data collection and analysis as the basis for improving a process. Even though the 
NHSMA was established to bridge the gap between redesign theory and its practical 
implementation in the NHS, the message of continuous data collection and analysis did not appear 
to be fully understood and embraced by the MES sites used in this study. The Audit Commission 
have recently published a report aimed at public services to improve the quality of their data (Audit 
Commission, 2007). If this could be used as a framework for the NHS to initiate an improved data 
collection strategy, the quality of NHS services may improve in line with its datasets.
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11. VALIDATION OF THE STUDY DATA
Since the data compiled for this study was retrieved from up to three separate data sources (the 
endoscopy unit, the TIS department associated with each study site and the ENIGMA study), it was 
necessary to validate the final study datasets to ensure that any significant findings could be 
reported with confidence. HES is the national statistical data warehouse for England of the care 
provided by NHS hospitals and for NHS hospital patients treated elsewhere. Whilst tailor-made 
data requests can be made at a cost, there are also freely available datasets online at 
www.hesonline.orq.uk/.
HES data has been used in many health services research studies in NHS trusts in England 
associated with Gl disorders (Pollock and Vickers, 1998b, Pollock and Vickers, 1998a, Kang et al., 
2003, Parry et al., 2004, Al-Sarira et al., 2007) although there was only one reported case to date 
of its use in investigating NHS endoscopy services (Williams and Mann, 2002). Given its wide 
application for the measurement of NHS management patterns, HES datasets were considered to 
be the most appropriate and best available datasets against which to validate the data submitted 
by each site for this study. Details of the validation process and the results of the comparison are 
presented and discussed in this chapter.
11.1 Methods
Since HES data was most commonly collected at the Trust-level and not at hospital-level, it 
contained data combined from each endoscopy unit within a Trust. It was not appropriate to 
include all 20 study sites in a comparative analysis, since all study sites had submitted data 
corresponding to one endoscopy unit and not for the Trust as a whole and so, where there were 
two or more endoscopy units within a Trust, the study data for that site could not be compared with 
the corresponding HES data. Only those sites that were the only endoscopy unit within their Trust 
were eligible for comparison. Of the 20 sites in this study, eight were the only endoscopy unit in 
the Trust and of these there were equal proportions of MES (6,16,18 and 19) and Non-MES (2,3, 
9 and 12) sites.
147
The most complete dataset collected by this study that was comparable with a HES dataset was 
for Activity. Details of the source of the Activity data for each of the eight study sites can be found 
in Chapter 10, whilst the actual data can be found in Appendices 16.5 -16 .8 .
A request was submitted to the Health Information Research Unit (HIRU) based at Swansea 
University for HES Activity data split according to procedure type using OPCS-4 codes G16-G19, 
G43-G45 and H20-H25 for the following time periods: Jan 03, Jun 03, Dec 03, Apr 04, Nov 04, Apr 
05, Oct 05 and Apr 06.
Where both “HES data” and “Study data” were available, the differences between the two datasets 
were calculated using Formula A to determine the Difference and Formula B to determine the % 
Difference between them.
Formula A: Difference = HESdata -  STUDYdata
HESdata-STUDYdata
Formula B: %Difference = -------------------------------------
STUDYdata
The datasets were compared using independent samples t-tests to identify whether there were any 
statistically significant differences between them at each time point. Both datasets were compared 
in their entirety before the data were split according to Site type, Time (TO to T7) and procedure 
type (UGEs, FS and colonoscopy). Statistical tests were done using SPSS version 13 (Lead 
Technologies Inc, USA). A p-value of ^  0.05 was considered to be statistically significant.
11.2 Results
HIRU were able to provide all HES datasets requested at a cost of £315 which was paid for the by 
ENIGMA study. The data is available in Appendix 16.4. The results of applying Formulae A and B 
to the datasets are shown in Table 12 for the MES sites and Table 13 for the Non-MES sites. Any 
% Difference values > ± 50% are illustrated in bold. A negative % Difference indicated that the 
HES data was lower than the Study data and vice versa.
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It was clear from Table 12 that Sites 16 and 18 had HES data that were a gross under-estimate of 
the Study data, with % Difference between the HES data and Study data reaching as high as - 
96%. When the actual Difference values are examined for these two sites, it is clear that for 
procedure 3 (FS) the counts are low anyway which explains why the % Difference was large. 
However, when looking at each procedure type, the actual Difference values are also high, 
indicating a true large % Difference between the two datasets.
Closer examination of the HES data from Sites 16 and 18 revealed extremely low counts for UGEs 
and colonoscopies for all time points requested when compared to the Study data (see Table 14), 
so low as to cause serious concerns regarding their accuracy. Further interrogation of the HES 
database in collaboration with a HIRU data analyst revealed that the data was correct and was not 
the fault of any incorrect queries. It became apparent that it was the number of daycases being 
reported that was problematic, with Site 16 reporting three endoscopy daycases in total for 2003/04 
and six for 2005/06, whilst Site 18 reported 21 endoscopy daycases in total for 2003/04 and 30 
daycases for 2005/06. The reason for this discrepancy was not obvious, since the Study data from 
these two sites had both come from the Trust.
Site ID Data source Procedure type TO T1 T2 T3 T4 T5 T6 T7
16 HES U G E s 29 25 37 26 25 22 34 19
C o lo n o s c o p y 10 16 16 14 14 21 25 13
S tudy U G E s 60 126 138 169 171
• ' { ::
C o lo n o s c o p y 150 354 358 364 330
18 H ES U G E s 50 43 51 53 42 48 38 55
C o lo n o s c o p y 15 23 22 29 28 33 20 17
S tud y U G E s 340 394 323 344 40 0 382 357 192
C o lo n o s c o p y 293 357 376 363 362 436 494 230
Table 14: Comparison of HES data and Study data for Sites 16 and 18 for UGEs and colonoscopy.
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When the TIS contacts were questioned about the anomalies in the datasets they reported that it 
used to be Trust policy to record their endoscopies as outpatient procedures, not daycases. This 
meant that they were not reported to HES, since the HES database did not require the compulsory 
inclusion of outpatient procedures until more recently.
The first stage of the analysis using independent samples t-tests were done using the datasets 
from all eight sites, since the reason for the analysis was to determine whether there were 
significant differences between the HES data and the Study data overall. However, it was also 
important for the sites with the two anomalous HES datasets to be excluded from subsequent 
analyses and for it to be repeated using just six site’s datasets, only two of which would be MES 
sites.
11.2.1 Preliminary analysis
When examining the two sets of eight datasets as a whole, there was a significant difference (T = 
2.41, p = 0.017) between the HES data (mean = 110.6) and the Study data (mean = 141.25). 
When this was further investigated by splitting the data according to Site type, this was only true for 
the MES group (HES mean = 69.89, Study mean = 155.21, T = 5.21, p < 0.001). There were no 
significant differences between the HES data and the Study data at each time point (TO to T7) but 
there was a significant difference for the reporting of colonoscopies (HES mean = 73.09, Study 
mean = 141.96, T = 3.851, p<  0.001).
11.2.2 Final adjusted analysis
Following the exclusion of the data from Sites 16 and 18 from the analysis, there was no significant 
difference between the HES data (mean = 138.56) and the Study data (mean = 120.22) when all 
data points from all sites were combined (T = -1.398, p = 0.163). When the analysis was split 
according to Site type, there was no significant difference between HES data and Study data for 
the MES sites (HES mean = 113.95, Study mean = 106.6, T = -0.521, p = 0.603), or the Non-MES 
sites (HES mean = 151.32, Study mean = 127.28, T = -1.308, p = 0.193).
There was also no significant difference in HES data and Study data when the analysis was split by 
Time (TO to T7). However, when the analysis was split by procedure type, there was a significant
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difference between HES data and Study data for FS (HES mean = 51.61, Study mean = 67.12, T = 
-2.05, p = 0.044). When this was further investigated by splitting the data into Site type and 
procedure type, the significant difference was from Non-MES sites (HES mean = 55.81, Study 
mean = 34.81, T = -3.579, p = 0.001). It may be that the low values reported for FS from sites may 
have affected the statistical tests.
11.3 Discussion
There was a large significant difference between the HES data and the Study data from the eight 
endoscopy units. Further analysis indicated that the difference was isolated to the MES sites. 
Sites 16 and 18 had a significant impact on the comparison of HES and Study data due to the 
gross under-estimation of data from the corresponding HES datasets. When these two sites were 
excluded from the analysis, there was no longer any significant difference between HES data and 
Study data. This was also true when data were split by Site type and Time, but splitting the data by 
procedure type indicated that there was a significant difference in the reporting of FS between HES 
data and Study data, in particular for Non-MES sites.
The similarity of the data (following the exclusion of the two anomalous datasets) was to be 
expected, given that half of the data sources used in the Study dataset originated from the TIS 
department (Sites 2, 3 and 9) and of these, all were Non-MES sites. The other three data sources 
were from the endoscopy unit, with two submitting routinely collected data (12 and 19) whilst the 
other site’s data came from the ENIGMA data collection forms (6).
In most cases, the mean Study data were lower than the mean HES data, as reflected by the 
positive % Difference values. This may be because the HES data were more rigorous in its data 
requests and the routinely collected datasets from the endoscopy units may not have included as 
many counts. It is also possible that the restriction in the OPCS codes given to the TIS contacts for 
the Study data request may have missed a particular aspect of Activity that was captured in the 
HES data. Alternatively, the HIRU request may not have been refined enough to block some of the 
procedures not included in the Study data request.
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Only a partial validation of the Study data was possible as only the Activity dataset could be 
compared with the HES data. Consequently, only the Activity data could be confidently analysed, 
although it was hoped that the other datasets would be equally accurate, given the identical source 
of those datasets.
However, it also brings into perspective the need to be vigilant when using HES data for evaluating 
endoscopic procedures in NHS Trusts, since some Trusts did not record them as day cases but 
rather as outpatient procedures. Researchers intending to use HES data to examine the nature of 
NHS endoscopy services retrospectively should clarify with each Trust how they reported their 
endoscopy data to HES to ensure the HES dataset provides an accurate count. This, along with 
the more rigorous guidelines for Trusts concerning the completion of their data returns to HES 
means that this problem should not arise as often using current datasets but caution should be 
used when using older datasets, as was the case in this study.
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12. THE EVALUATION OF ENDOSCOPY SERVICES
USING ROUTINELY COLLECTED, SERVICE-RELATED 
ENDOSCOPY DATA
The primary aim of this study was to ascertain whether the MES project had any significant impact 
on participating sites by comparing specific endoscopy service-related datasets from MES sites 
with those sites who modernised independently at eight separate time points between January 
2003 and April 2006. The study also aimed to examine the sustainability of any changes in data 
over time.
This chapter discusses how five outcome measures - Referral numbers, Wait >3m, Snapshot, Lost 
slots and Activity - were analysed to address the aims and objectives of this thesis and answer the 
research question conclusively. The chapter opens with a comprehensive description of the 
finalised datasets, followed by the data analysis section. A “within-groups” analysis determined 
whether there were any changes in data from the MES group and from the Non-MES group 
separately over time, whilst a “between-groups” analysis identified any significant differences 
between MES and Non-MES groups at each time point for each outcome measure. The chapter 
closes with a focussed discussion of the results.
12.1 Methods
12.1.1 Exploratory data analysis of data from both MES sites and Non-MES sites 
Once the final dataset had been formed and validated in SPSS, the next step was to calculate the 
total procedures data from the sum of the data provided for all three procedure types.
Exploratory data analysis (EDA) was performed using SPSS on the total procedures data 
calculated for each individual study site to identify any outlying data points and to explore any site-
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level data trends at individual time points. This involved plotting the data from each site on a line 
graph according to Site type and outcome measure. The MES and Non-MES group means were 
also plotted for reference and any sites with data deviating from the corresponding group mean 
were described in the text.
The data from each site was also analysed by comparing Demand and Activity to determine the 
Variance (defined as Activity minus Demand) within each site to identify whether there were any 
backlogs in the service due to Demand exceeding Activity, which would be illustrated by negative 
Variance values. For the purpose of this study, the Demand variable was defined as Referral 
numbers, the only outcome measure capable of indicating the “active” Demand on the service. 
The combination of either Wait >3m or Snapshot data with Referral numbers to produce an overall 
Demand value was not feasible because there were too many sites with these outcome measures 
missing.
12.1.2 Exploratory data analysis of data from the MES group and Non-MES group 
All data from MES sites were aggregated to form a MES group dataset. The same was done for 
the Non-MES sites to create a Non-MES group dataset.
Due to the lack of data for many early and late time periods, it was also necessary to aggregate the 
data from individual time periods according to the corresponding year (2003,2004,2005 and 2006) 
for further analysis to improve the accuracy of the data. Since there was only one time period for 
2006 and this had missing data for many sites, the data for 2005 and 2006 was merged to become 
2005/06.
Graphical EDA using graphs with error bars indicating the 95% Cl and stacked bar graphs were 
used to describe total procedures and split procedures data for the MES and Non-MES groups to 
identify outlying data points and to examine data trends at individual time points and for data 
aggregated according to year.
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12.1.3 Correlation of outcome measures in the MES and Non-MES groups 
Correlation was used to determine whether there were any significant linear relationships between 
any of the five outcome measures within both the MES and Non-MES groups and if so, to identify 
the strength and direction of the association. Spearman’s correlation was chosen as the best test 
due to low sample numbers and the non-normal distribution of the data highlighted in previous 
EDA, since this test was based on ranked data rather than the actual data. This analysis was done 
for each Site type using only total procedures data for data aggregated according to year.
12.1.4 Two-way Analysis of Variance
A two-way analysis of variance (ANOVA), also known as a mixed between-within groups ANOVA, 
was performed using SPSS to determine the impact of Site type and Time using data aggregated 
according to year (2003, 2004 and 2005/06) on each outcome measure using both total 
procedures and split procedures data. A p-value < 0.05 was considered to be statistically 
significant.
This test was able to concurrently perform a between-groups analysis to compare data from the 
MES and Non-MES groups whilst also comparing changes in data over Time within each Site type 
using within-group, repeated measures analysis. The test would also identify any significant 
interaction effects between Site type and Time whereby the rate or degree of change in data in one 
Site type was significantly different to the rate or degree of change of the data in the other Site 
type. As well as its significant p-value, a significant interaction effect could be illustrated 
graphically whereby the two lines plotted for the means of each Site type are non-parallel.
By using a two-way ANOVA, we reduce the number of statistical tests being done. This is vital, 
since evidence shows that a test with a p-value of 0.05 has a one in 20 chance of occurring by 
chance, so the more tests done, the more likely the possibility of a Type 1 error where we falsely 
reject the null hypothesis that states no significant difference (Bland and Altman, 1995). Ideally, a 
non-parametric equivalent to the two-way ANOVA would have been used, given the low sample 
numbers involved and its non-normal data distribution, but on seeking statistical advice from a 
statistics consultant, the author was advised that it was not within the capabilities of the statistical 
software (SPSS v13) to facilitate this type of analysis. Instead, the Friedman test was used to
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investigate any significant differences in data within MES and Non-MES sites over time as this was 
the non-parametric equivalent to the repeated measures ANOVA.
In all cases, where Mauchly's test of sphericity was not significant (p > 0.05), the “sphericity 
assumed” p-value displayed by SPSS was used. A significant p-value led to using the 
“Greenhouse-Geisser” p-value instead, since it is more conservative in nature and is suitable for 
smaller sample sizes. Any significant differences in Time were investigated a posteriori using post 
hoc methods. Where a significant difference was found for Site type, no post hoc analysis was 
necessary, since there were only two categories being tested.
12.2 Results
12.2.1 Description of MES and Non-MES site datasets
In the case of total procedures data, Referral numbers were available for nine MES sites and 
seven Non-MES sites. Wait >3m data were available for six MES sites and four Non-MES sites. 
Snapshot data were available for four MES sites and five Non-MES sites. Lost slots data were 
available for five MES sites and four Non-MES sites. Activity data were available for nine MES 
sites and eight Non-MES sites.
Availability of the Split procedures data were identical, since it was calculated from the data for all 
three procedure types. The actual datasets used for this study can be found in Appendices 16.5 -  
16.8, split according to total procedures data and split procedures data, namely FS, colonoscopy 
and UGE datasets respectively.
12.2.2 EDA for data from MES sites and Non-MES sites
The following section described the data trends over time for each outcome measure from each 
study site, split according to Site type. Data are represented graphically according to Site type 
using total procedures data at individual time points, with individual sites’ data plotted using 
different coloured lines. The MES group mean and the Non-MES group mean were also included 
in each corresponding graph for comparative purposes. The MES site and Non-MES site graphs 
did not have matching scales because the data were better illustrated this way and also, because
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they were not meant for comparative purposes at this point. This issue will be dealt with later in the 
chapter.
Referral numbers for MES sites and Non-MES sites are plotted in Figures 7 and 8 respectively. 
The data trends of both MES sites and Non-MES sites appeared to be highly variable over time, 
although the variability of the MES group mean was less than the Non-MES group mean. Many 
sites deviated from the corresponding group means, particularly Site 18 (MES) and Site 17 (Non- 
MES). When examining the data from the earliest to the latest available individual time points, two 
MES sites (1 and 13) and two Non-MES sites (5 and 12) showed increases in Referral numbers 
over time, whilst seven MES sites (4, 6, 7, 8,11, 16 and 18) and five Non-MES sites (2, 3, 9,17 
and 20) showed decreases in Referral numbers over time.
Wait >3m data for MES and Non-MES sites are plotted in Figures 9 and 10 respectively. Data 
were limited, especially from Non-MES sites. The trends of both the MES and Non-MES sites 
appeared to be fairly constant over time, with the exception of two MES sites (4 and 18) and one 
Non-MES site (14), which dramatically deviated from the Non-MES group mean after T2, causing 
the group mean to rise unexpectedly. When examining the data from the earliest to the latest 
available time points, one MES site (18) and one Non-MES site (14) showed increases in Wait >3m 
over time, whilst four MES sites (4, 6, 7, 8 and 19) and three Non-MES sites (2,3 and 20) showed 
decreases. One MES site’s data remained unchanged (6).
Snapshot for MES and Non-MES sites are plotted in Figures 11 and 12 respectively. Data were 
extremely limited from both Site types. The trends of both Site types were highly variable over 
time. The MES group mean was not representative of any of the individual sites, although none 
seemed to deviate far from the mean to any extent, whilst the Non-MES group mean showed a 
similar trend to many of its constituent sites. Site 9 showed extensive deviation from the Non-MES 
group mean after T1 as it was double the mean value. When examining the data from the earliest 
to the latest available time points, one MES site (18) and four Non-MES sites (9, 10, 11 and 12) 
showed increases in Snapshot over time, whilst three MES sites (1, 8 and 19) and one Non-MES 
site (2) showed decreases.
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Figure 7: Total procedures Referral numbers for each MES site and the MES group mean.
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Figure 8: Total procedures Referral numbers for each Non-MES site and the Non-MES group mean.
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Figure 9: Total procedures Wait >3m for each MES site and the MES group mean.
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Figure 10: Total procedures Wait >3m for each Non-MES site and the Non-MES group mean.
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Figure 11: Total procedures Snapshot for each MES site and the MES group mean.
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Figure 12: Total procedures Snapshot for each Non-MES site and the Non-MES group mean.
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Lost slots for MES and Non-MES sites are plotted in Figures 13 and 14 respectively. Data were 
limited from both Site types. The data trends of both MES sites and Non-MES sites appeared to 
be fairly constant over time, as reflected in the corresponding group means. Site 18 was generally 
double that of the MES group mean and the same trend was seen for Site 9 compared to the Non- 
MES group mean from T2 onwards. When examining the data from the earliest to the latest 
available time points, no MES sites showed increases in Lost slots whilst two Non-MES sites did (2 
and 5). All five MES sites (1, 6, 11, 13 and 18) showed decreases in their Lost slots over time 
compared with only two Non-MES sites (3 and 9).
Activity for MES and Non-MES sites are plotted in Figures 15 and 16 respectively. Data were 
available from the majority of sites. The trends of both MES and Non-MES sites appeared to be 
fairly constant over time, as reflected in the corresponding group means. Site 18 deviated from the 
MES group mean, whilst Site 17 appeared to deviate from the Non-MES group mean although the 
degree of difference for both compared to the group means was actually quite small in terms of 
actual numbers. When examining the data from the earliest to the latest available time points, two 
MES sites (16 and 19) and four Non-MES sites (2, 12, 17 and 20) showed increases in Activity, 
whilst seven MES sites (1,4, 6 ,8 ,11,13 and 18) and four Non-MES sites (3, 5 ,9  and 10) showed 
decreases.
As well as a graphical illustration of the data trends in each site over time, the actual changes in 
data were calculated using total procedures data for each individual study site to determine 
whether it had increased, decreased or remained relatively constant from the earliest time point to 
the latest time point with data submitted by that site. The calculation was done using data from 
individual time points and data aggregated by year to cover the difference in the corresponding 
months (TO to T7) and the mean values for the corresponding years (2003 to 2005/06), to ensure 
there was no obvious difference in the two time scales. The findings of this analysis are 
summarised in Table 15 with the actual difference in the data illustrated numerically, along with 
arrows to illustrate the direction of the differences as an increase or decrease.
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Figure 13: Total procedures Lost slots for each MES site and the MES group mean.
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Figure 14: Total procedures Lost slots for each Non-MES site and the Non-MES group mean.
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Figure 15: Total procedures Activity for each MES site and the MES group mean.
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Figure 16: Total procedures Activity for each Non-MES site and the Non-MES group mean.
900 —
8 0 0 -
7 0 0 -
6 0 0 -
5 0 0 -
400  —
3 0 0 -
2 0 0 -
165
Site ID Site type Time Period Referral
numbers
Wait >3m Snapshot Lost slots Activity
MES T0-T7 T (44) No data 1(848) 1(62)
2003 - 2005/06 1 (602) 1(23)
1(98)
1 (20)
Non-MES T0-T7 1(83) 1(25) 1(251)
2003 - 2005/06 T (36) 1(27) 1 (242) T (12)
T (60)
T (42)
Non-MES T0-T7 1 (6) 1 (196)
2003 - 2005/06 1(51) 1(90)
MES T0-T7 1 (128) 1(154)
2003 - 2005/06 1(97) 1(154)
Non-MES T0-T7 
2003 - 2005/06
T (30) No data No data
MES T0-T7 1(83) No change
2003 - 2005/06 1 (88) T(4)
MES T0-T7 1 (8) 1(82) No data
2003 - 2005/06 T (37) )3 data ■ m
MES T0-T7 1 (438) 1(36) 1 (68)
2003 - 2005/06 1(191) T (14) 1(28)
v  a 1 (393)
1 (176)
Non-MES T0-T7 1(73) No T (1653) 1(78)
2003 - 2005/06 No 2005/06 data T (882) 1 (10)
1(93)
1(61)
10 Non-MES T0-T7
2003 - 2005/06
No data T (500) No data
No 2003 data 1(15)
11 MES T0-T7 i m .
2003 - 2005/06 1(31)
No data JJ251 M .
1(15)
12 Non-MES T0-T7 T (77) i m
2003 - 2005/06 T (41) T (90)
I M .
T (50)
13 MES T0-T7 T (373) No i No data 1(24)
2003 - 2005/06 t  (249) 1 (12)
1 (112)
1(106)
14 Non-MES T0-T7 No data T (737) T (826)
2003 - 2005/06 T (823) T (930)
No data No data
15 Non-MES T0-T7
2003 - 2005/06
No data No data No data No data
T0-T7
2003 - 2005/06
Non-MES T0-T7
2003 - 2005/06 1(41) T (119)
18 MES T0-T7 1 (492) T (269) T (293) 1(79) 1 (258)
2003 - 2005/06
T0-T7
2003 - 2005/06
Non-MES T0-T7
2003 - 2005 06
Table 15: Summary of the trend of data for Referral numbers, Wait >3m, Snapshot, Lost slots and Activity 
over time. Data illustrates the difference in counts for each outcome measure from (i) TO to T7 (or the 
closest time point with data) and (ii) 2003 to 2005/06. Key: |  = increase in counts; j  = decrease in counts. 
The number within the brackets signified the actual difference in counts.
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Further evaluation of the service in each site compared Demand with Activity to produce a 
Variance (defined as Activity minus Demand) plot for each site over time. The results for each site 
are plotted in Figure 17 for the MES sites and Figure 18 for the Non-MES sites. Full data (namely 
Referral numbers and Activity) was only available for eight MES sites and seven Non-MES sites to 
calculate Variance over time and of these, only one MES site had missing start or end point 
Variance data (16) compared with six Non-MES sites (2 ,5 ,9 ,12,17 and 20).
Overall the MES sites seemed to have more positive Variance values than negative, indicating that 
Activity exceeded Referral numbers at those times, whilst the Non-MES sites seemed to display 
the opposite, with more negative Variance than positive at specific points in time, indicating that 
Referral numbers exceeded Activity. The MES sites tended to have positive Variance values that 
ranged further from zero than those of the Non-MES sites, as indicated by the scales used on each 
graph. They also showed far more variability over time than those of the Non-MES sites.
Four MES sites had the majority of their data as positive values (1,13,16 and 18) and one had its 
Demand exactly matching its Activity for TO to T6 (8). Of those MES sites with negative Variance 
at the earlier time points, three showed a change in the data into positive Variance values over 
time (4, 6 and 18), whilst two showed the occurrence of a backlog indicated by increasingly 
negative Variance over time (11 and 13). Only three Non-MES sites showed any improvement in 
their Variance values over time (2, 9, 17 and 20) although the difference was extremely small for 
one (9). The remaining three showed the occurrence of a backlog shown by negative Variance 
overtime (3,5 and 12).
12.2.3 EDA of the MES group and Non-MES group data
The mean values of each outcome measure at each individual time point and for data aggregated 
by year were tabulated for MES and Non-MES groups using total procedures data (see Table 16) 
and split procedures data (see Tables 17 and 18). Trends for each mean data variable were 
discussed according to total procedures data and then split procedures data, according to the 
timescale used (individual time points or data aggregated by year).
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Figure 18: Variance within each Non-MES site.
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Site type Time Time Outcome measure
Referral N°s (n) Wait >3m (n) Snapshot (n) Lost slots (n) Activity (n)
MES Individual TO 483 ±238 (8) 135 ±123 (5) 818 ±289 (4) 94 ±86 (5) 454 ±170 (9)
time points T1 458 ±207 (8) 136 ±180 (5) 673 ± 350 (4) 115 ± 112 (5) 494 ±181 (9)
T2 446 ±187 (9) 131 ±189 (5) 565 ±133 (4) 137 ±109 (5) 460 ±166 (9)
T3 460 ±172 (9) 118 ±140 (6) 602 ±133 (4) 145 ± 79 (5) 463 ±162 (9)
T4 434 ±157 (9) 115 ±105 (6) 576 ± 145 (4) 110 ±91 (5) 505 ±162 (9)
T5 457 ±177 (9) 119 ±128 (6) 548 ±126 (4) 113 ± 114 (5) 474 ± 173 (8)
T6 417 ±133 (8) 91 ±91 (5) 472 ±106 (4) 159 ±147 (5) 495 ±187 (7)
T7 387 ±129 (7) 174 ±235 (4) 767 ±660 (2) 56 ±60 (5) 349 ±80 (7)
Data by year 2003 462 ± 202 (25) 134 ±154 (15) 685 ±270 (12) 116 ±97 (15) 469 ±167 (27)
2004 447 ±160 (18) 116 ± 118 (12) 589 ±130 (8) 127 ±82 (10) 484 ±159 (18)
2005/06 423 ±147 (24) 124 ±145 (15) 561 ±266 (10) 109 ±113 (15) 441 ± 161 (22)
Non-
|
Individual TO 358 ±100 (2) 278 ±107 (2) 840 ±219 (2) 143 ±104 (2) 333 ±133 (5)
| MES time points T1 460 ±5  (2) 253 ± 233 (2) 1379 ±913 (2) 103 ±50 (2) 357 ±124 (5)
I T2 514 ±178 (5) 37 ± 37 (2) 1007 ±653 (4) 57 ±47 (3) 363 ±140 (7)
T3 396 ±170 (6) 153 ±164 (3) 1026 ± 584 (5) 62 ±54 (4) 360 ±117 (8)
I
T4 502 ±198 (7) 230 ± 385 (4) 1073 ±659 (5) 70 ±48 (4) 419 ±166 (8)
T5 450 ± 147 (6) 297 ±530 (4) 1237 ±623 (5) 74 ±54 (4) 412 ±150 (8)
T6 527 ± 247 (6) 6 ± 7 (3) 1501 ±1105 (3) 80 ±50 (4) 419 ±155 (6)
T7 438 ±170 (4) 19 ±29 (3) 1608 ± 1472 (2) 72 ±60 (3) 362 ±140 (5)
Data by year 2003 467 ± 147 (9) 167 ±163 (7) 1058 ±594 (8) 94 ± 67 (7) 352 ±126 (17)
i
2004 453 ±186 (13) 197 ±291 (7) 1049 ±588 (10) 66 ±48 (8) 390 ±142 (16)
i
2005/06 476 ±187 (16) 127 ± 340 (10) 1390 ± 844 (10) 75 ±49 (11) 401 ±143 (19)
I
Table 16: Mean values with standard deviations of each outcome measure for total procedures data at 
individual time points and according to year for the MES and the Non-MES group.
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Procedure Time Time Outcome measure
type Referral N°s (n) Wait >3m (n) Snapshot (n) Activity (n)
Flexible Individual time TO 79 ±59 (8) 22 ±29 (5) 150 ±107 (4) 77 ± 56 (9)
sigmoidoscopy points T1 72 ±41 (8) 16 ±25 (5) 136 ±92 (4) 82 ±61 (9)
T2 72 ± 57 (9) 20 ±25 (5) 129 ±112 (4) 68 ± 63 (9)
T3 76 ±45 (9) 17 ±13 (6) 124 ±110 (4) 76 ±67 (9)
T4 74 ±53 (9) 14 ±14 (6) 139 ±155 (4) 73 ± 55 (9)
T5 79 ±54 (9) 11 ±11 (6) 101 ±92 (4) 80 ±53 (8)
T6 86 ±57 (8) 9 ±10 (5) 104 ±105 (4) 77 ± 53 (7)
T7 79 ±61 (7) 12 ±10 (4) 20 ±13 (7) 66 ±45 (7)
Data by year 2003 75 ± 51 (25) 19 ±25 (15) 138 ±95 (12) 75 ±58 (27)
2004 75 ±47 (18) 15 ±13 (12) 131 ±124 (8) 74 ±60 (18)
2005/06 81 ± 55 (24) 11 ±10(15) 86 ±88 (10) 75 ±48 (22)
Colonoscopy Individual time TO 121 ±93 (8) 69 ± 93 (5) 255 ±192 (4) 117 ±77 (9)
points T1 144 ±150 (8) 74 ±91 (5) 220 ±173 (4) 153 ±118 (9)
T2 121 ±83 (9) 53 ± 66 (5) 184 ±118(4) 143 ±129 (9)
T3 129 ±102 (9) 47 ± 55 (6) 220 ±129 (4) 146 ±125 (9)
T4 139 ±92 (9) 57 ± 60 (6) 162 ±56 (4) 163 ±108 (9)
T5 145 ± 97 (9) 61 ±70 (6) 161 ±79 (4) 140 ±121 (8)
T6 119 ±60 (8) 51 ± 53 (5) 149 ± 52 (4) 150 ±154 (7)
T7 105 ±36 (7) 69 ±86 (4) 246 ±160 (2) 102 ±64 (7)
Data by year 2003 128 ± 107 (25) 65 ±79 (15) 219 ±152 (12) 138 ±107 (27)
2004 134 ±94 (18) 52 ±55 (12) 191 ±97 (8) 155 ±114 (18)
2005/06 125 ± 70 (24) 60 ±65 (15) 173 ±86 (10) 131 ±155 (22)
UGEs Individual time TO 283 ±130 (8) 44 ±61 (5) 413 ±175 (4) 259 ±105 (9)
points T1 242 ±82 (8) 46 ±86 (5) 318 ±229 (4) 259 ± 101 (9)
T2 253 ±115 (9) 59 ±108 (5) 252 ±47 (4) 249 ±82 (9)
T3 254 ±102 (9) 55 ±84 (6) 258 ±86 (4) 241 ± 106 (9)
T4 220 ±94 (9) 44 ±45 (6) 275 ±74 (4) 269 ± 87 (9)
T5 234 ±113 (9) 47 ±70 (6) 286 ±85 (4) 254 ±73 (8)
T6 213 ±98 (8) 31 ±40 (5) 220 ±55 (4) 268 ±68 (7)
T7 203 ±67 (7) 93 ±153 (4) 502 ±514 (2) 180 ±37 (7)
(... Cont’d)
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(... Cont’d)
Procedure
type
Time Time Outcome measure
Referral N°s (n) Wait >3m (n) Snapshot (n) Activity (n)
UGEs Data by year 2003 259 ± 107 (25) 50 ±81 (15) 328 ±167 (12) 256 ±93 (27)
2004 237 ±97 (18) 49 ±65 (12) 266 ±75 (8) 255 ±95 (18)
2005/06 218 ±93 (24) 54 ±89 (15) 303 ±212 (10) 235 ± 71 (22)
Table 17: Mean values with standard deviations of each outcome measure for FS, Colonoscopy and UGE 
procedures at each at individual time points and according to year for the MES group.
Procedure Time Time Outcome measure
type Referral N°s (n) Wait >3m (n) Snapshot (n) Activity (n)
Flexible Individual time TO 9 ± 4 (2) 17 ± 2  (2) 15 ±16 (2) 28 ± 22 (5)
sigmoidoscopy points T1 24 ±28 (2) 9 ± 6 (2) 17 ±4  (2) 33 ± 24 (5)
T2 56 ± 56 (5) 1 ± 2 (3) 61 ±62 (4) 48 ±36 (7)
T3 73 ±63 (6) 5 ± 5 (3) 225 ± 342 (5) 59 ±41 (8)
T4 98 ±71 (7) 9 ± 14 (4) 75 ± 34 (5) 69 ±58 (8)
T5 97 ±65 (6) 19 ±23 (4) 89 ±44 (5) 65 ± 53 (8)
T6 100 ±53 (6) 2 ± 3 (3) 118 ±41 (3) 77 ± 60 (6)
T7 81 ±69 (4) 5 ± 9 (3) 72 ±3  (2) 76 ± 70 (5)
Data by year 2003 38 ±46 (9) 8 ± 8 (7) 38 ±48 (8) 38 ±29 (17)
2004 86 ±66 (13) 7 ±11 (7) 150 ±243 (10) 64 ±49 (16)
2005/06 94 ±58 (16) 10 ±16 (10) 94 ±39 (10) 72 ±57 (19)
(Cont’d...)
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(...Cont’d)
Procedure Time Time Outcome measure
type Referral N°s (n) Wait >3m (n) Snapshot (n) Activity (n)
Colonoscopy Individual time TO 91 ±9 (2) 199 ±116 (2) 549 ±135 (2) 66 ±25 (5)
points T1 146 ±5  (2) 211 ±204 (2) 794 ±361 (2) 76 ±19 (5)
12 148 ± 39 (5) 24 ±20 (3) 474 ± 404 (4) 87 ±38 (7)
T3 109 ±39 (5) 95 ±92 (3) 250 ±178 (5) 80 ±32 (8)
T4 133 ±53 (7) 139 ±233 (4) 527 ±451 (5) 101 ±53 (8)
T5 120 ±58 (6) 179 ± 334 (4) 573 ± 424 (5) 121 ±80 (8)
T6 155 ±98 (6) 4 ± 5 (3) 654 ±516 (3) 112 ±67 (6)
T7 116 ±54 (4) 12 ±18 (3) 740 ±722 (2) 89 ±48 (5)
Data by year 2003 135 ±37 (9) 127 ±137 (7) 573 ± 333 (8) 78 ±30 (17)
2004 122 ±47 (13) 120 ±175 (7) 388 ±355 (10) 90 ±44 (16)
2005/06 132 ±73 (16) 76 ±213 (10) 631 ±449(10) 110 ±66 (19)
UGEs Individual time TO 259 ±96 (2) 62 ±7  (2) 277 ±100 (2) 240 ±110 (5)
points T1 291 ±18 (2) 33 ±24 (2) 568 ± 556 (2) 248 ±122 (5)
T2 310 ±121 .(5) 12 ±16 (3) 472 ± 270 (4) 228 ±113 (7)
T3 214 ±100 (6) 53 ±71 (3) 551 ± 344 (5) 221 ± 94 (8)
T4 270 ±113 (7) 83 ±139 (4) 471 ± 244 (5) 250 ± 98 (8)
T5 233 ± 86 (6) 99 ±192 (4) 575 ± 238 (5) 226 ±94 (8)
T6 272 ± 140 (6) 1 ± 2 (3) 729 ± 593 (3) 230 ± 59 (6)
T7 242 ± 86 (4) 2 ± 2 (3) 796 ± 747 (2) 197 ±33 (5)
Data by year 2003 294 ±95 (9) 32 ±26 (7) 447 ± 299 (8) 237 ±107 (17)
2004 244 ±107 (3) 70 ±107 (7) 511 ±284(10) 236 ±94 (16)
2005/06 250 ±104 (16) 41 ±122 (10) 665 ±418 (10) 220 ±70 (19)
Table 18: Mean values with standard deviations of each outcome measure for FS, Colonoscopy and UGE 
procedures at each at individual time points and according to year for the Non-MES group.
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Additonally, the group mean for each outcome measure was plotted graphically according to Site 
type and time scale used, using error bars marking the 95% Cl for the mean total procedures data 
and stacked bar graphs for the mean split procedures data using UGEs, FS and colonoscopy data.
12.2.3.1 Referral numbers
The mean total procedures Referral number trend for the MES group fell from 483 to 387 between 
TO and T7 whilst the Non-MES group mean increased from 358 at TO to 438 at T7 (see Figure 19). 
The Non-MES group mean showed more variability over time than the MES group mean. There 
were missing data for TO in the Non-MES group, resulting in a larger 95% Cl for that time point. 
When data were aggregated by year, the MES group mean decreased from 462 at 2003 to 423 at 
2005/06 (see Figure 20). The Non-MES group mean showed a minor dip in Referral numbers for 
2004 but overall, there was a slight increase from 467 at 2003 to 476 at 2005/06.
When the data were split by procedure type, the MES group means for FS and colonoscopy were 
relatively constant from TO to T7 (see Figure 21) and 2003 to 2005/06 (see Figure 22) and only 
small decreases were seen in UGEs over time. Data for all three procedure types for the Non-MES 
group were more variable over time for TO to T7 and 2003 to 2005/06, with increasing numbers of 
FS and decreasing numbers of UGEs whilst colonoscopy remained relatively stable.
12.2.3.2Wait >3m
The mean total procedures Wait >3m data showed an overall increase from 135 at TO to 174 at 17 
(see Figure 23) due to a similar sharp increase in Site 18 data. The Non-MES group mean showed 
an overall decrease from 278 at TO to 19 at T7, with the rise at T5 greatly influenced by Site 14 
data. Missing data from the Non-MES sites contributed to larger 95% CIs than seen for the MES 
group. When data were aggregated by year, the MES group mean showed a slight decrease from 
134 at 2003 to 124 at 2005/06. The Non-MES group mean showed a peak for 2004 but overall, it 
slightly decreased from 167 at 2003 to 127 at 2005/06 (see Figure 24).
When data were split by procedure type, the MES group mean for each procedure were relatively 
unchanged until T7, when there was an increase in UGEs (see Figure 25), although the 
aggregation of data meant that this increase was not seen in the 2005/06 dataset (see Figure 26).
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Figure 19: Mean total procedures Referral numbers for the MES and Non-MES group datasets for 
individual time points (TO to T7) with error bars (95% Cl).
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Figure 20: Mean total procedures Referral numbers for the MES and Non-MES group datasets for data,
aggregated by year (2003, 2004 and 2005/06) with error bars (95% Cl).
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Figure 21: Mean split procedures Referral numbers for the MES and Non-MES group datasets for
individual time points (TO to T7).
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Figure 22: Mean split procedures Referral numbers for the MES and Non-MES group datasets for data,
aggregated by year (2003, 2004 and 2005/06).
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re 23: Mean total procedures Wait >3m for the MES and Non-MES group datasets for individual time 
points (TO to T7) with error bars (95% Cl).
T o ta l p ro c e d u re s  
M E S  g ro u p  N o n -M E S  g ro u p
5 0 0 -
400 —
3 0 0 -
200 -
100 -
0 -
- 1 0 0 -
- 2 0 0 -
2005/062003 2004
T im e
2004 2005/062003
T im e
Figure 24: Mean total procedures Wait >3m for the MES and Non-MES group datasets for data,
aggregated according to year (2003,2004 and 2005/06) with error bars (95% Cl).
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Figure 25: Mean split procedures Wait >3m for the MES and Non-MES group datasets for individual time
points (TO to T7).
M E S  g r o u p N o n -M E S  g r o u p
Eco
A
2 0 0 4
T  im e T im e
□  F S
□  C o lo n o sc o p y
□  UGE
Figure 26: Mean split procedures Wait >3m for the MES and Non-MES group datasets for data,
aggregated by year (2003, 2004 and 2005/06).
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Data for all three procedures for the Non-MES group was highly variable over time for TO to 17, 
especially for colonoscopy figures. This variability was less obvious when data was aggregated 
according to year, although colonoscopy and UGE figures showed a decreasing trend over time 
due to the influence of the extremely low figures reported in 12, T6 and T7 which affected the 2003 
and 2005/06 data. FS figures were low and remained so throughout.
12.2.3.3Snapshot
The mean total procedures Snapshot data for the MES group fell from 818 at TO to 767 at T7, 
whilst the Non-MES group mean increased from 840 at TO to 1608 at T7 (see Figure 27). Both the 
MES and the Non-MES group mean showed constant trends over time, although the extremely 
large 95% Cl for the Non-MES group at T7 meant that the scales used for these plots were large 
enough that they may have obscured any real trends in the data. The aggregated data for the 
MES group mean decreased from 685 at 2003 to 561 at 2005/06 and the Non-MES group mean 
increased from 1058 at 2003 to 1390 at 2005/06 (see Figure 28).
When data were split by procedure type, the MES group means for each procedure decreased 
from TO to T6 but increased in T7 for UGEs and colonoscopy but not for FS (see Figure 29). When 
data was aggregated by year, this was not visible in the 2005/06 bar (see Figure 30). Data for all 
three procedures for the Non-MES group were more variable over time for TO to T7 and 2003 to 
2005/06, with no obvious pattern emerging in either timescale.
12.2.3.4Lost slots
The mean total procedures Lost slots trend for the MES group fell from 94 at TO to 56 at T7, whilst 
the Non-MES group mean showed an overall decrease from 143 at TO to 72 at T7 (see Figure 31). 
Both the MES and the Non-MES group mean showed remarkably constant trends over time that 
were also highly comparable, although the extremely large 95% Cl for the Non-MES group at T1 
meant that the scales used for these plots were large enough that they may have obscured any 
details in the trends. When data were aggregated by year, the MES group mean showed a slight 
decrease from 116 at 2003 to 109 at 2005/06 and the Non-MES group mean showed a decrease 
from 94 at 2003 to 75 at 2005/06 (see Figure 32). Lost slots data were not split by procedure type 
so no further analysis was possible.
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Figure 27: Mean total procedures Snapshot for the MES and Non-MES group datasets for individual time
points (TO to T7) with error bars (95% Cl).
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Figure 28: Mean total procedures Snapshot for the MES and Non-MES group datasets for data,
aggregated according to year (2003, 2004 and 2005/06) with error bars (95% Cl).
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Figure 29: Mean split procedures Snapshot for the MES and Non-MES group datasets for individual time
points (TO to T7).
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Figure 30: Mean split procedures Snapshot for the MES and Non-MES group datasets for data,
aggregated according to year (2003, 2004 and 2005/06).
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Figure 31: Mean total procedures Lost slots for the MES and Non-MES group datasets for individual time
points (TO to T7) with error bars (95% Cl).
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Figure 32: Mean total procedures Lost slots for the MES and Non-MES group datasets data, aggregated
according to year (2003, 2004 and 2005/06) with error bars (95% Cl).
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12.2.3.5Activity
The mean total procedures Activity trend for the MES group fell from 454 at TO to 349 at T7, whilst 
the Non-MES group mean increased from 333 at TO to 362 at T7 (see Figure 33). Both the MES 
and the Non-MES group mean showed small variations in data over time, which were exaggerated 
in the graph due to the smaller scales used as a result of smaller 95% Cl values for both Site types. 
When data were aggregated by year, the MES group mean showed a decrease from 469 at 2003 
to 441 at 2005/06 and the Non-MES group mean showed an increase from 352 at 2003 to 401 at 
2005/06 (see Figure 34).
When data were split by procedure type, the MES group data for all three procedure types 
remained relatively constant over time for TO to T6 with only a decrease in UGEs and colonoscopy 
in T7 (see Figure 35). The aggregated data was less varied over time, although a minor decrease 
in UGEs for 2005/06 was evident (see Figure 36). The Non-MES group means for each procedure 
showed gradual increases over time from TO to T6 with a slight decrease in T7 for UGEs and 
colonoscopy although this was not evident in the 2005/06 bar.
12.2.4 Correlation
Significant relationships between combinations of each outcome measure were identified using 
Spearman’s correlation (rho). Only significant results were discussed in detail (p < 0.05). 
Correlation values between 0.5 and 1 were considered to be strong relationships, whilst those 
between 0.3 and 0.49 were of medium strength and those between 0.1 and 0.29 were considered 
to be only weakly related.
Significant positive correlation indicated that an increase in one variable was associated with an 
increase in the other variable, although the result would not indicate which variable was the 
causative one (if either -  a third confounding variable may have a causative effect on both 
variables being correlated), whilst significant negative correlation indicated that an increase in one 
variable was associated with a decrease in the other. Again, the results would not explain which 
variable was the causative one.
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Figure 33: Mean total procedures Activity for the MES and Non-MES group datasets for individual time
points (TO to T7) with error bars (95% Cl).
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Figure 34: Mean total procedures Activity for the MES and Non-MES group datasets for data, aggregated
according to time (2003,2004 and 2005/06) with error bars (95% Cl).
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Figure 35: Mean split procedures Activity for the MES and Non-MES group datasets for individual time
points (TO to T7).
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Figure 36: Mean split procedures Activity tor the MES and Non-MES group datasets for data, aggregated
according to time (2003, 2004 and 2005/06).
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For the MES group, there was strong positive correlation between Referral numbers and 
Activity for 2003 (p = 0.006), 2004 (p = 0.02) and 2005/06 (p < 0.001) that grew in strength over 
time, indicating a successful and sustained response to any increased demand by increasing 
Activity (see Table 19). Lost slots and Activity also showed strong positive correlation for 2003 
(p = 0.006), 2004 (p = 0.03) and 2005/06 (p = 0.009), although the strength of the relationship 
decreased slightly over time, indicating that either the sites increased their Activity in response 
to an increasing Lost slots rate, or an increase in Activity may have increased the incidence of 
Lost slots. There were no other significant linear relationships identified for the other 
combinations of outcome measures.
Site type Variable 1 Variable 2 Sample N°. Year
Correlation 
Coefficient (rho)
P-value
MES Referral numbers Activity 22 2003 0.569 0.006
Lost slots Activity 15 2003 0.675 0.006
Referral numbers Activity 16 2004 0.574 0.02
Lost slots Activity 10 2004 0.681 0.03
Referral numbers Activity 21 2005/06 0.725 <0.001
Lost slots Activity 15 2005/06 0.649 0.009
Non-MES Referral numbers Lost slots 8 2004 -0.786 0.021
Referral numbers Activity 13 2004 0.61 0.027
Lost slots Activity 8 2004 -0.881 0.004
Referral numbers Activity 12 2005/06 0.799 0.002
Table 19: Table of all significant (p ^  0.05) relationships between total procedures data aggregated 
according to year for Referral numbers, Lost slots and Activity from MES and Non-MES group 
datasets using Spearman’s correlation coefficient {rbo).
For the Non-MES group, Referral numbers and Lost slots data for 2004 showed strong 
negative correlation, with increasing Referral numbers being significantly associated with low 
numbers of Lost slots (p = 0.021), indicating that for that point in time, these sites appeared to 
have successfully reduced their Lost slots whilst also coping with increasing Referral numbers 
(see Table 19). However, this result was obtained from relatively low sample numbers (n = 8)
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and may not be a true representation of the service in Non-MES sites for this time period. Data 
for 2003 and 2005/06 was not significant (p = 0.589 and 0.16 respectively), indicating that this 
change in services was not originally in place but was also not successfully maintained. There 
was a strong positive correlation between Referral numbers and Activity for 2004 (p = 0.027) 
and 2005/06 (p = 0.002), but not 2003 (p = 0.17), indicating that after a slow start the Non-MES 
group were also able to match Referral numbers with Activity. Lost slots and Activity showed a 
strong negative correlation for 2004 (p = 0.004), whereby increased Lost slots were significantly 
associated with decreased Activity. This was not the case for 2003 or 2005/06 (p = 0.148 and 
0.066 respectively). This may be explained by the fact that Activity is counted as the number of 
completed procedures and as the number of Lost slots increases, the number of procedures 
completed decreases proportionally. Again, low sample numbers (n = 8) may have affected the 
results in Non-MES sites for this time period. There were no other significant linear 
relationships identified for the other combinations of outcome measures.
12.2.5 Two-way Analysis of Variance
When using a two-way ANOVA to analyse the total procedures data, there were no statistically 
significant between-groups or within-groups effects for Referral numbers, Wait >3m, Snapshot, 
Lost slots or Activity. This meant that whilst the data for these outcome measures did change 
over time, it did not change to a point where the difference became statistically significant in 
either Site type. The results also showed that any changes in Referral numbers, Wait >3m, 
Snapshot, Lost slots or Activity in the MES sites were mirrored by similar changes in the Non- 
MES sites, resulting in no significant differences between Site types at any specific point in time 
for any outcome measure.
However, the Activity dataset did show a significant interaction effect (F (2, 26) = 3.594, p = 
0.042), indicating that there was a significant difference in the rate of the changes in the Activity 
data over time in the MES and Non-MES groups (see Table 20). Closer examination of the 
data indicated that the significant interaction effect was attributable to a decrease in MES group 
Activity over time corresponding with an increase in Non-MES group Activity over time. This 
can be visualised using a means plot whereby the lines for each Site type over time are not 
significantly parallel (see Figure 37).
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Figure 37: Mean Activity in MES and Non-MES groups using total procedures data.
When data were split by procedure type, there were no significant between-groups effects for any 
of the five outcome measures (see Table 20). The only significant within-group results were for 
UGEs over time for Referral numbers (F (1,11) = 5.15, p = 0.03) and for Activity (F (1,13) = 5.25, 
p = 0.012), indicating that those two outcome measures changed significantly over the three time 
periods analysed within the MES and Non-MES groups.
Post hoc analysis revealed that there was a significant difference between the UGE Referral 
numbers data for 2003 and 2004 (p = 0.05) and between the UGE Activity data for 2004 and 
2005/06 (p = 0.019). Further analysis split according to Site type using the Friedman test revealed 
that there were significant differences in the Non-MES group Referral numbers over time (n = 4, df 
= 2, x2 = 6, p = 0.05), but not for the MES group Referral numbers (n = 9, df = 2, x2 = 4.67, p = 
0.097). Friedman tests also revealed significant differences in the UGE Activity data for the MES 
group (n = 8, df = 2, x2 = 7, p = 0.03) but not for the Non-MES group (n = 7, df = 2, x2 = 2, p = 
0.368). On closer examination of the raw data, the mean Referral numbers data from the four sites 
constituting the Non-MES group significantly decreased from 310.7 in 2003 to 260.1 in 2005/06
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and the mean Activity data from the eight sites constituting the MES group significantly decreased 
from 274.2 in 2003 to 232.4 in 2005/06.
The only significant interaction effect found for split procedures data was associated with FS 
Snapshot data (F (1,6) = 4.43, p = 0.036), indicating that there was a significant difference in the 
rate of change in the FS Snapshot data over time in the MES and Non-MES groups, as highlighted 
by Figure 38.
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Figure 38: Mean FS Snapshot in MES and Non-MES groups using split procedures data
12.3 Discussion
The measurement and evaluation of NHS services is essential to ensure that a process is running 
optimally and to guarantee that there is no alternative way of doing things that would be even more 
efficient. The most effective way to evaluate NHS services is to look at different aspects of 
demand, capacity and activity and determine how well matched they are. This was one of the main 
principles of the MES Toolkit, using these measures to assess the performance of endoscopy 
services within MES sites during the MES project. The evaluation method used in this thesis was
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based on the MES Toolkit, measuring changes within each study site in Referral numbers, Wait 
>3m, Snapshot, Lost slots and Activity over time.
This study has shown that there was a high degree of variability in the services of the 20 
I endoscopy units participating in this study over time for all five outcome measures, especially from
i
the Non-MES sites. However, both the MES and Non-MES group means were more stable over 
time, although they were associated with large 95% CIs for some time points which was attributed 
to low sample numbers for those time points and the fact that these types of data are liable to be 
highly varied between sites. It was also feasible that the group means may have been affected by 
one or two rogue sites who did not perform in the same way as the majority of the sites in that 
group. Unfortunately, with such low sample numbers there was no way to control for it. Since the 
MES sites and non-MES sites were all geographically widespread, the data trends seen in this 
study were not likely to have been due to regional effects.
Variance analyses found that the MES sites tended to have more efficient services than the Non- 
MES sites as they were more efficient at balancing Demand with Activity. This may be attributed 
primarily to the fact that the MES Toolkit would have calculated this value and consequently, these 
I sites may have been more able to react to sudden increases in Demand. However, when we
| examine the Variance data from the Non-MES sites, it is clear that the values are smaller than
i
those seen in the MES sites, although many more sites have negative Variance values suggestive 
of a less efficient service and rising backlogs. However, when examining the Variance data for 
both Site types in a comparative manner, we must remember that the trend for Referral numbers 
differed in each Site type, with the MES group mean indicating slight decreases in Referral 
! numbers over time whilst the Non-MES group mean indicated slight increases over time.
Referral numbers decreased over time in the MES group, but were more variable in the Non-MES 
group. This may be explained by the MES sites taking a more proactive approach to managing the 
demand on their services, as advised by the MESPT. Examples of this management included 
validation of referrals, introducing new referral pathways and most importantly, the introduction of 
partial and full booking -  a MES project target. The implementation of partial and full booking for 
patients gave them the choice of appointment dates (and later evolved into the Choose and Book 
initiative -  see Chapter 2) and may have affected the demand for MES sites more than the Non- 
MES sites. Another major contributor to changing the demand on NHS endoscopy services in both 
MES and Non-MES sites has been the implementation of guidelines to allow healthcare
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professionals to correctly refer their patients (see Chapter 6). This should have reduced the 
number of inappropriate referrals to NHS endoscopy units, thereby reducing the demand on 
endoscopy services. Interestingly, the number of UGE referrals being made decreased in both Site 
types over time, possibly as a result of improved guidance regarding the referral of dyspepsia 
patients by NICE (National Institute for Clinical Excellence, 2004a).
The Wait >3m data remained relatively stable over time in MES sites, but was slightly higher and 
more variable in Non-MES sites. However, both Site types showed decreases in Wait >3m over 
time, as was expected given that it was a target stipulated in the NHS Plan (Department of Health, 
2000c). There were differences in the proportion of patients waiting for a colonoscopy between the 
MES group and the Non-MES group, although this decreased over time as the Non-MES sites 
reduced the number of patients waiting for this procedure more than three months.
The trend for Snapshot data differed significantly between the MES and Non-MES group, with the 
MES group Snapshot decreasing over time whilst the Non-MES group Snapshot increased over 
time to become more than double of the MES group. This difference may be due to initiatives 
advocated by the MESPT that the MES sites successfully, including waiting list validation and 
pooling. The Non-MES sites may not have had this advice and so, their waiting lists did not 
improve. The need to meet the three month target may have been another confounding factor for 
the Non-MES sites as they were forced to reclassify and then reorganise their patients onto a 
routine waiting list so that only “eligible” patients were given priority to be seen within three months. 
This theory is supported by looking at the number of patients waiting for a colonoscopy over time. 
The Wait >3m data in the Non-MES sites showed a marked decrease over time. When we look at 
the colonoscopy Snapshot data over time we see that it has increased. It is highly likely that many 
colonoscopy patients were moved onto another waiting list not affected by the three month target. 
Lost slots were lower in the Non-MES group than in the MES group and both showed differing 
trends: the MES group data showed a peak whereas the Non-MES group data showed a trough. 
The actual data also indicated that the mean MES Lost slots was consistently higher than the 
mean Non-MES Lost slots indicating that the Non-MES sites were better at reducing their Lost 
slots over time. This finding casts some doubt on the validity of the findings of the MES report 
which stated that during 2003, 71% of their 26 sites reduced their DNAs to less than 5%. These 
findings also show that any improvements in their DNA rates were subsequently not sustained over 
time. The reasons for this are unknown. However, it is difficult to compare the “% DNA rates” 
quoted by the MES report with the actual figures reported here -  we can only judge the data trend
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and comment that the increase makes it possible that the MES report is incorrect. It is also 
feasible that the 29% of MES sites who did not reduce their DNAs to less than 5% during the MES 
project were all represented in the 10 MES sites used in this study. If this was the case, then the 
MES final report is more likely to be correct.
It was interesting that the Non-MES group reduced their DNAs over time without any MES project 
support. Perhaps with less financial backing to implement changes, they sought to get the most 
out of their redesign initiatives and if DNAs and cancellations were a huge problem for these sites, 
they may have focussed on them in the hope that improving them would indirectly benefit their 
waiting lists as less people would be rebooked. However, this side effect was not evident in this 
analysis, probably because the number of appointments saved would have been a tiny proportion 
of the Snapshot dataset.
The Activity in the MES group decreased over time whilst the Non-MES group Activity increased, 
although the MES group Activity m s  far higher than that of the Non-MES group to begin with. The 
MESPT provided endless advice and support to allow MES sites to identify their potential capacity 
and increase their throughput accordingly. The introduction of NEs into NHS endoscopy units
| would have increased Activity in both Site types to a degree, depending upon when they were
| employed and the extent of their skills. It is feasible that the decrease seen in the MES sites may
j have been attributable to the introduction of nurse-led clinics as outpatient consultations which
!' would not have been recorded in this dataset, although there is no reason why this new way of
' working would not have been introduced in the Non-MES sites too. When looking at the spiit
procedures Activity data, it paints a clearer picture. The Activity in the MES sites for all three 
procedure types remains relatively constant, with only a minor drop in UGEs for 2005/06 whilst the 
Non-MES sites show an increase in colonoscopies that approaches that seen in the MES sites. It 
is possible that in an attempt to cope with their increasing waiting lists (as shown by the Snapshot 
data), the Non-MES sites successfully increased the number of colonoscopy procedures being 
performed. It is also possible that the increase in Activity is in part due to a decrease in Lost siots 
by the Non-MES sites, as described earlier. With less appointments lost, more procedures were 
being recorded as completed which may have contributed to the increase in the colonoscopy 
Activity figures.
There was a statistically significant, strong, positive correlation between Referral numbers and 
Activity over time in both the MES and the Non-MES group, indicating a successful and sustained
192
response to any increases in referrals in both Site types by increasing Activity. Lost slots and 
Activity in the MES group also showed a significant, strong, positive correlation over time, 
indicating that either these sites increased their Activity in response to an increasing Lost slots rate, 
or an increase in Activity may have increased the incidence of Lost slots proportionally. Lost slots 
and Activity in the Non-MES group showed a significant, strong, negative correlation at only one 
time point. This may be explained by the fact that Activity is counted as the number of completed 
procedures and as the number of Lost slots increases, the number of procedures completed 
decreases proportionally. Low sample numbers (n = 8) may have affected the results in Non-MES 
sites for this time period.
A two-way ANOVA using total procedures data showed that there were no significant differences in 
the data for any of the five outcome measures over time within both Site types. There was also no 
significant difference between the MES and Non-MES group data for any of the five outcome 
measures. The only significant interaction effect was for Activity, indicating that there was a 
significant difference in the rate of change in the Activity data over time in both Site types. This 
was illustrated graphically with decreases in MES group Activity mirrored by increases in Non-MES 
group Activity over time. This result highlights an interesting finding that was contrary to the
i original hypothesis that the MES sites would increase their Activity levels. The proposed
!
explanation discussed earlier regarding the possibility of outpatient procedures accounting for 
Activity that was not recorded in this study could partly explain this significant difference. Another 
contributory reason could be the fact that the Non-MES sites had obviously made a degree of
i
| improvement in their services that, when compared to the MES sites, resulted in the significant
j interaction effect found.
I[I
■ When data were split according to procedure types, more significant differences were found. For 
UGEs, there was a significant within-groups effect for Referral numbers and Activity, indicating that 
the data differed significantly over time within the MES and Non-MES groups for these two 
outcome measures. Post hoc analysis found that the Non-MES group had the significant 
difference in UGE Referral numbers data over time as the number of referrals decreased 
significantly from 2003 to 2004, whilst the MES group were the source of the significant result for 
UGE Activity as the number of procedures performed decreased from 2004 to 2005/06.
There was one significant interaction effect whereby the changes in FS Snapshot data were 
significantly different over time for both Site types. When the data were illustrated graphically,
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there was an obvious downwards trend in MES group data over time that was significantly different 
to the upwards trend in data seen from the Non-MES group data over time.
It is plausible that the number of comparisons made as part of a two-way ANOVA increases the 
chances of a statistically significant result occurring by chance. Setting the p-value at 0.05 meant 
that there was a 1 in 20 chance of a test being statistically significant when it was in fact not i.e. a 
type 1 error. When examining the proportion of significant tests in relation to the number of 
statistical tests performed in this type of multivariate analysis, there were approximately 51 
individual tests being done (repeated measures and between site measures for five outcome 
measures according to total procedures and split procedures datasets -  see Table 20), of which 
four were statistically significant (7.8%). Since this is close to the 5% figure we would expect to 
see given the number of tests being done, it is possible that there was only one truly significant 
two-way ANOVA result, with the remainder due to chance alone due to the p-value being set at ^  
0.05. Unfortunately, if this were true, it would not be possible to ascertain which of the four results 
was likely to be true by simply looking at the raw data. However, since there were no obviously 
incorrect significant results, the findings reported by this study will assume that all four significant 
results are in fact true.
Therefore, the findings of this study are that overall, there were very few statistically significant 
changes in the five outcome measures tested within both MES and Non-MES groups, and the MES 
and Non-MES groups were not significantly different at any point in time because any changes in
| the services of the MES sites were mirrored by equivalent changes in the services of the Non-MES
i
I sites.
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13. PAST INNOVATIONS WITHIN STUDY SITES
As part of this evaluation it was important to ascertain exactly which innovations each site had 
implemented to ascertain whether there were any key factors in terms of the number or type of 
innovations introduced that were associated with the MES sites that may have been attributable to 
the MES project, or for the Non-MES sites that could be attributed to their independent redesign 
strategies. To achieve this, a list of all the innovations implemented by each site during three 
specific time periods was collected to provide a description of innovations introduced by each site 
for descriptive purposes and to allocate a score to represent how innovative each site had been.
13.1 Methods
13.1.1 Questionnaire design and allocation
A list of innovations occurring in the study sites since 2000 was compiled based on the first round 
of qualitative interviews performed within the 19 participating ENIGMA endoscopy units with 
clinicians and change agents (see Chapter 8). An “Innovations Form” (see Appendix 16.9) was 
designed, asking respondents to tick ‘Yes" or “No” to whether they had implemented each 
innovation listed and to tick one box under the Timeframe column (“2000/02”, “2003” or “2004/05”) 
to indicate when it was first implemented. A section was added at the end for the addition of 
innovations not listed on the form and for any comments.
The form was piloted at Singleton Hospital in Swansea before being sent to the ENIGMA contact of 
all endoscopy units except Site 18 (which had withdrawn from any active participation in the 
ENIGMA study) during July 2005. Where a response had not been received after eight weeks, a 
reminder letter and form was sent.
The form was later revised with an additional 2006 column and resent to the original respondents 
in May 2006 to update the entries as far as April 2006 (T7). A third reminder and revised form was 
sent to sites who had not returned an Innovations Form at that time.
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13.1.2 Analysis plan
A description of the most commonly implemented innovations was drafted according to Site type. 
An independent samples t-test was used to determine whether there were any significant
i differences in the number of innovations implemented by MES and Non-MES sites.
f
Each innovation listed on the Innovation Form was scored according to whether it had been
I
I implemented or not. The scoring system was also devised to reflect any proactive redesign plans
I in each site by scoring innovations implemented earlier in the Timeframe more highly. Innovations
j implemented in 2000/02 scored “3”, innovations implemented during 2003 scored “2” and
| innovations implemented during 2004/06 scored “1”. Where the “Yes” column had been ticked but
no specific Timeframe was indicated, no score was given. Any additional innovations added by 
respondents were either integrated into the existing framework or were included as an additional 
innovation in the list. Each site was given a score for each Timeframe and a total score that was 
used to assign a rank (1 to 19) to all study sites, irrespective of Site type.
13.2 Results
i
I Of the 19 endoscopy units sent the Innovations Form, all returned it completed for 2005 and only
i
| two did not return the updated form with 2006 scores, both of which were MES sites (1 and 16).
i
| These forms were included in the analysis irrespective of the 2006 missing data, since any missing
i
j  data would probably not have scored highly and therefore would probably not have had a
| significant impact on the final scores. Of the additional comments entered by respondents, all
j could be reclassified as one of the innovations already listed.
[
13.2.2 Innovations introduced -  a descriptive summary
Of the innovations listed on the questionnaire, all were implemented by a minimum of two sites in 
each group out of a maximum of nine for the MES sites and 10 for the Non-MES sites. Table 21 
illustrates how many MES and Non-MES sites implemented each innovation, irrespective of when 
they were implemented.
When the data in Table 21 was examined according to the innovation category, there were more 
innovations implemented by Non-MES sites than MES sites for all categories except for “Alteration 
of roles” and “New nurse responsibilities”. Close examination of the raw data revealed that the 
Non-MES group implemented more innovations in total than the MES group (445 Vs. 394).
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Innovation category Innovation type Site type
MES (n = 9) Non-MES (n = 10)
New / additional staff
Nurse endoscopists 8 9
GP endoscopists 3 6
Consultants 6 10
Link / escort nurses 4 3
Health care assistants 5 7
Receptionist / other clerical staff 5 8
New management / leadership 6 5
Data collection staff 3 3
TOTAL 40 51
Alteration of roles
Changing roles of medical staff 3 2
Changing roles of clerical staff 6 7
Clerical duties taken from nurses 6 5
TOTAL 15 14
New nurse responsibilities
Nurse led clinic(s) 5 6
Nurse led consent 7 4
Nurses performing cannulations 8 7
PEG nurses 8 4
Training nurses to be nurse 
endoscopists 6 9
TOTAL 34 30
New working practices
New referral procedure(s) into the unit 6 9
Validation of referrals 7 8
New guideline(s) / protocols 7 9
Triage of emergency patients 6 6
Pre-assessment clinics 4 2
DNA strategies 6 8
Cancellation strategies 6 8
“6-week notice period for leave” policy 9 9
New procedure(s) performed 7 8
One-stop clinics / dedicated training lists 6 7
TOTAL 64 74
Increasing activity
Extra slots for emergency bleeds, etc 7 7
Scheduling extra list(s) (Mon to Fri) 6 9
Increasing the length of the working day 4 4
Weekend / out of hours working 6 4
TOTAL 23 24
Waiting list management
Validation of waiting lists 8 9
Pooling waiting lists 7 8
Waiting list initiative sessions 4 8
TOTAL 19 25
Booking
Open access booking 5 5
Full booking 6 8
Partial booking 9 9
TOTAL 20 22
(Cont’d...)
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(...Cont’d)
Innovation category Innovation type Site type
MES (n = 9) Non-MES (n = 10)
Structural changes
New hospital / unit 4 5
Structural alterations to current unit 5 4
Increasing capacity in recovery area 3 5
Centralising admin in one place 4 6
Moving some endoscopy externally 3 4
Refurbishment of reception / 
endoscopy suite
7 4
TOTAL 26 28
Analysis of working practices
New / improved in-house data 
collection
5 9
Demand and capacity studies 9 9
Audits 9 10
Process mapping 7 8
Patient surveys 8 10
TOTAL 38 46
Patient experience
New information leaflets for patients 8 9
Improving patient privacy & dignity 6 8
Home bowel preps 8 10
Improving experience of inpatients 6 6
Improving experience of diabetic 
patients 7 8
Improving experience of patients 
with other comorbidities 6 3
TOTAL 41 44
Staff experience
Staff training / development 7 8
“Protected time” for staff to meet / 
train 5 5
Surveying staff on changes wanted 5 7
New / improved staffroom 6 4
Endoscopy groups / staff meetings 6 10
Improving staff communication 6 9
TOTAL 35 43
Miscellaneous
New medical equipment 8 10
New IT equipment / software 7 8
Raising the profile of endoscopy 7 6
Advice or help from within the Trust 6 9
Advice or help from external 
agencies 4 6
Open days for hospital staff/ 
patients 7 5
TOTAL 39 44
Total score 394 445
Table 21: The number of MES and Non-MES sites implementing any of the 65 innovations listed between
2000 and 2006.
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However, there were only nine MES sites compared to 10 Non-MES sites, so when the average 
number of innovations implemented in the MES and Non-MES group was calculated, the result 
showed that the MES sites, on average, implemented more innovations than the Non-MES sites 
(MES group = 91.7 ± 37.1; Non-MES group = 81.3 ± 19) although the difference was not 
statistically significant (T = 0.78, p = 0.446).
i
j-
| All nine MES sites had implemented a six week notice period for leave policy, partial booking, 
demand and capacity studies and audits, whilst all 10 Non-MES sites had implemented the
| following: additional consultants, audits, patient surveys, home bowel preparations, endoscopy
i
t groups I staff meetings and new medical equipment.
When data were assessed to determine the largest difference in counts (three or more) between 
the MES and Non-MES groups, the results showed that there were four examples where the MES 
group implemented more of the following innovations than the Non-MES group: Nurse-led consent 
(7:4), PEG nurses (8:4), refurbished their reception I endoscopy suite (7:4) and improving the 
experience of patients with other co-morbidities (6:3). However, there were 11 instances where the 
Non-MES group implemented more innovations than the MES group: additional GP endoscopists 
(6:3) additional consultants (10:6), additional receptionist I clerical staff (8:5), training nurses to be 
NEs (9:6), new referral procedure(s) (9:6), scheduling extra lists (9:6), waiting list initiative sessions 
(8:4), in-house data collection (9:5), endoscopy groups / staff meetings (10:6), improving staff 
communication (9:6) and advice or help from within the Trust (9:6).
I.
!j
I 13.2.3 Examination of innovation scores
All sites were scored as previously described and all scores and ranks are described for each MES 
and Non-MES site in Table 22. The distribution of the Site types were evenly spaced throughout the 
ranks, with an MES site as the top scoring site and the highest position for a Non-MES site at third 
place. However, the lowest two ranks were also MES sites.
Of the 19 sites returning a completed form, 13 had their highest score corresponding to 2000/02. 
This was to be expected, since the scoring framework rewarded a more proactive approach to 
modernisation (pre-MES project innovations) more highly. Of these, seven were MES sites (1, 4, 
7, 11,13,16 and 19) with scores ranging from 27 to 129, whilst the other six were Non-MES sites 
(2, 5 ,9 ,15,17  and 20), with scores ranging from 30 to 84.
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Site ID Site type
Timeframe
Total score Rank
2000/02 2003 2004/06
19 MES 129 6 14 149 1
4 MES 111 20 7 138 2
15 Non-MES 84 18 10 112 3
20 Non-MES 90 8 11 109 4
7 MES 48 30 29 107 5
13 MES 66 22 12 100 6
12 Non-MES 18 42 33 93 7
11 MES 66 18 7 91 8
10 Non-MES 24 36 22 82 9
17 Non-MES 45 26 10 81 10 =
6 MES 3 50 28 81 10 =
5 Non-MES 42 16 21 79 12
9 Non-MES 45 18 12 75 13
16 MES 36 30 6 72 14
14 Non-MES 18 4 44 66 15
2 Non-MES 30 12 20 62 16
3 Non-MES 6 18 30 54 17
1 MES 27 12 12 51 18
8 MES 9 16 11 36 19
18 MES No form sent
Table 22: A breakdown of the Innovation Form scores for each Timeframe and the Total Innovation scores 
achieved by each MES and Non-MES site, listed according to rank.
The remaining six sites had their highest scores in either 2003 (6 ,8 ,10  and 12) or 2004/06 (3 and 
14). Of these, two were MES sites (6 and 8) and the remaining four were Non-MES sites (3,10,12 
and 14). The 2003 scores ranged from 16 to 50 for the MES sites and from 36 to 42 for the Non- 
MES sites whilst the 2004/06 scores ranged from 30 to 44 for the Non-MES sites (no MES sites 
scored more highly for 2004/06).
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13.3 Discussion
Whilst there were more innovations implemented by MES sites than by Non-MES sites, the 
difference was not statistically significant. This suggests that either the Non-MES sites were 
equally active in their redesign projects or the MES sites did not introduce any more innovations as 
would have been introduced “naturally”. Given that the Non-MES sites cited their intention to 
redesign irrespective of their exclusion from the MES project, the first explanation is most likely.
i
| When examining which of the innovations all nine MES sites had implemented, the only one that
; was also implemented in all 10 Non-MES sites was audits. Closer examination of the types of
i
| innovations implemented by all MES sites revealed that they were closely tied in with the targets
[
allocated and the advice given by the MESPT. Of those innovations implemented by the Non-MES 
sites, two were considered not to be innovations perse as they may have happened irrespective of 
any modernisation plans due to the evolution of the service -  additional consultants and new 
medical equipment. However, the other innovations were considered to be new ways of working.
When exploring the difference in MES and Non-MES sites in terms of the number implementing 
each innovation type, there were 11 innovations that were implemented in higher numbers by the 
Non-MES sites than the MES sites compared with only four innovations that were implemented in 
higher numbers by the MES sites than the Non-MES sites. This was surprising, since some of 
these innovations were considered to be expensive, although it is feasible that staff increases were 
funded by the Trust and would have happened anyway, irrespective of any modernisation drive (or 
lack thereof) occurring within the units. It is interesting that more Non-MES sites were keen to 
I introduce or enhance methods of communication, both internal and external, than the MES sites. 
They also appeared to be more amenable to data collection than the MES sites, a finding 
supported in Chapter 10 of this thesis.
It was originally thought that the financial implications of implementing innovations may have 
reduced the number of innovations introduced by the Non-MES sites compared to the MES sites 
as some would have had significant budget implications (additional staff and new equipment). 
Whilst partial funding for Non-MES sites may have been secured from other sources (e.g. 
charitable donations, business plans), the majority of sites would not have had a large amount of 
money with which to implement changes. They also would not have had the same level of access 
to advice from the MESPT during 2003 regarding how best to analyse and modernise their
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services. Many changes implemented by the MES sites were very simple and were cost-neutral 
and involved only changing the way a process was done, usually by reducing the number of 
resources or by transferring the responsibility of a process to a qualified but less expensive 
member of staff, freeing up the more specialist staff to provide their expertise more effectively.
| However, the same point can be made for the Non-MES sites, possibly because they had no 
additional MES funding and needed to find inexpensive solutions to improving their services.
i
It is clear from the forms submitted for this study that many of the Non-MES sites were equally as 
i proactive in their attempts to modernise their endoscopy services as those sites chosen to be MES 
project sites by the NHSMA. Discussions with NHSMA personnel via the ENIGMA study confirmed 
| that the sites were chosen based on their application form and were not chosen as either good 
sites who would inevitably do well in the project, or poor sites who would show significant 
differences in their services that would be attributed to the MES project, thereby artificially 
overestimating the impact of the MES project. The analysis of the Innovation Forms confirms that 
the MES and Non-MES sites did not appear to be extremely different in their pre-MES project 
redesign plans.
The ranking of the sites based on their scores revealed that MES sites held the two top and bottom 
spaces on the one to 19 scale. Overall, there were marginally more MES sites than Non-MES 
sites populating the top ten spaces. This result suggests that these MES sites were more 
proactive in their modernisation programmes, implementing changes at an earlier point in time than 
the Non-MES sites which would have been reflected in their scores in earlier Timeframes.
j There were two interesting points for discussion based on the Innovation Forms completed by the
I sites. The first was that only four of the MES sites (4, 7,13 and 19) had ticked the box indicating
that they had “help or advice from external agencies”. This meant that five MES sites did not 
acknowledge the role of the MES project in their modernisation programmes. The second was that 
five MES sites and nine Non-MES sites had ticked the box indicating that they had “new I improved 
in-house data collection”, a finding not reflected in the collection of routine data for this study. 
These two findings suggest that the results of this aspect of the study may not be entirely accurate, 
although one would expect any bias in a form of this type to be in the opposite direction, with sites 
ticking too many boxes instead of too few. However, the findings reported here do not constitute a 
major part of the study as this investigation was done as a secondary outcome measure only.
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14. OVERALL DISCUSSION
A focussed discussion of the results of this thesis has already been presented in the corresponding 
chapters (10 to 13). This discussion chapter will summarise all the results reported in this thesis 
and will link these results with the hypotheses listed in Chapter 9 to determine whether they were 
proven to be true or false. This will be followed by a broader discussion of the results of the study 
as a whole and how they link with each other. The strengths and weaknesses of all aspects of the 
study will be explored in detail and the study design and results will be put into context using 
comparable literature from the field of health services research. The implications of this study will 
be discussed and conclusions will be drawn from the results of this study on whether the MES 
project had a favourable impact on the modernisation of NHS endoscopy services. The thesis 
ends by drawing conclusions based on the results reported and making recommendations on how 
to improve NHS endoscopy services, how to improve the MES project for future use, how to 
improve this study design for application to the evaluation of NHS services in general and how 
future research might be conducted to further investigate some of the findings reported by this 
study.
14.1 Summary of results
This thesis independently evaluated the MES project by analysing and comparing the endoscopy 
services of 10 MES sites and 10 non-MES sites. All 20 sites were examined individually and 
grouped according to Site type using routinely collected, service-related data pertaining to eight 
calendar months ranging from Jan 2003 to Apr 2006. This thesis reported the following 11 
findings:
1. Service-related endoscopy data was not routinely collected by most of the NHS 
endoscopy units in this study.
The design of this study was based on the assumption that most endoscopy units collected basic 
service-related endoscopy data on a routine basis, especially the MES sites. This assumption was 
based on discussions with all study sites as part of the ENIGMA study. However, only eight 
endoscopy units submitted any routinely collected data for this study. Only one had collected all of
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the five outcome measures requested but data only corresponded to one month out of the eight 
requested. Consequently, Trust-held data was requested as a second source of data to fill in the 
gaps or else no analyses would have been possible. It was thought that as the Trust data was 
used by those endoscopy units who did not routinely collect their own service-related data, it would 
be feasible to use it as a supplementary source of data for this study.
2. HES data did not hold completely accurate Activity data for all study sites to use for 
validation purposes.
HES data was used to validate the data analysed in this study. Data for two sites were grossly 
underestimated in the HES dataset. The reason for this was the HES datasets did not include 
endoscopies as daycases for the time periods requested. Instead, they were classified as 
outpatient procedures and as such, they were not included in the HES dataset as it was not a 
compulsory field at that time. As a consequence, the data from these two sites was excluded from 
the validation process.
Comparing the six remaining sites revealed no significant differences between their HES data and 
Study data when data were combined, or when split by either Site type or Time. However, when 
split according to procedure type, there was a significant difference between HES data and Study 
data for FS, specifically for the data from Non-MES sites. However, the actual FS figures were 
relatively small, which may have affected this analysis. Based on these findings, it was possible to 
state that the data collected and analysed for this study were likely to be accurate and all results 
could be reported with a high degree of confidence.
3. Data trends were highly variable over time in individual sites and to a lesser extent 
in the MES and Non-MES groups.
EDA showed that the data from some sites showed large variations over time, irrespective of 
whether they were MES or Non-MES sites. The same was true when the MES group and Non- 
MES group datasets were examined in the same way, although the variation was to a lesser 
degree than for the individual sites. To adjust for this, all datasets were aggregated according to 
corresponding years to produce a mean value for that time period and this mean value would be 
used in subsequent analyses as a more reliable measure of service-related data.
4. Some outcome measures showed significant correlation within the MES and non- 
MES groups.
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For the MES group, there was strong positive correlation between Referral numbers and Activity 
that grew in strength over time, indicating a successful and sustained response to any increased 
demand by increasing Activity. Lost slots and Activity also showed strong positive correlation, 
although the strength of the relationship decreased slightly over time, indicating that either the sites 
increased their Activity in response to an increasing Lost slots rate, or an increase in Activity may 
have increased the incidence of Lost slots proportionally.
For the Non-MES group, Referral numbers and Lost slots data for 2004 showed strong negative 
correlation, indicating that for that point in time, these sites appeared to have successfully reduced 
their Lost slots whilst also coping with increasing Referral numbers. Data for 2003 and 2005/06 
were not significant, indicating that this change in services was not originally in place and was also 
not successfully maintained. There was a strong positive correlation between Referral numbers 
and Activity for 2004 and 2005/06, indicating that after a slow start the Non-MES group were also 
able to match Referral numbers with Activity. Lost slots and Activity showed a strong negative 
correlation for 2004, whereby increased Lost slots were significantly associated with decreased 
Activity. This may be explained by the fact that Activity is counted as the number of completed 
procedures and as the number of Lost slots increases, the number of procedures completed 
decreases proportionally.
5. There were no significant differences in total procedures data over time for any of 
the five outcome measures within either the MES group or the Non-MES group.
This study found that although changes did occur in the total procedures data for Referral 
numbers, Wait >3m, Snapshot, Lost slots or Activity, they did not result in a significant difference in 
the data over time within the MES group or the Non-MES group when data were aggregated 
according to year. This indicated that whilst endoscopy services may have changed, and in many 
cases improved, the degree of change over time was not statistically significant.
6. When data was split by procedure type, the only significant difference in outcome 
measures over time was in UGE Referral numbers and Activity.
When the data was split according to procedure type and reanalysed, the only significant within- 
group differences in data over time were for UGE Referral numbers and Activity, indicating that 
these data changed significantly over the three time periods analysed within the MES and Non- 
MES groups. Post hoc analysis revealed that the significant differences were between the UGE
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Referral numbers data for 2003 and 2004 for the Non-MES group only and between the UGE 
Activity data for 2004 and 2005/06 for the MES group only.
7. There were no significant differences between the MES group and the Non-MES 
group for any of the five outcome measures using either total procedures data or
I split procedures data.
| This study found that changes to service-related data had occurred in both MES and Non-MES
I groups, but there was no significant difference in their Referral numbers, Wait >3m, Snapshot, Lost
\ slots or Activity at any point in time when using either total procedures data or split procedures data
aggregated according to year. This indicated that the MES group’s involvement in the MES project 
had not resulted in any changes in the service that were significantly different to any changes 
occurring in the Non-MES group who had redesigned their services independently.
8. The only significant interaction effects were for Activity using total procedures data 
and for FS Snapshot data.
There was a significant interaction effect for the Activity dataset, indicating that there was a 
significant difference in the degree and direction of the Activity data over time in the MES group 
when compared with that of the Non-MES group. Closer examination of the data showed that the 
decrease in Activity in the MES group over time was mirrored by an increase in the Non-MES 
| group.
j There was also a significant interaction effect associated with FS Snapshot data, indicating that
| there was a significant difference in the changes in the Snapshot data over time between the MES
I
and Non-MES groups. Closer examination of the data showed that the FS Snapshot decreased in 
the MES group over time whilst it increased in the Non-MES group over time. No other statistically 
significant effects were observed.
9. There was no significant difference in the number of innovations implemented by 
MES sites and the Non-MES sites.
When each site was asked to complete a questionnaire asking which innovations had been 
implemented, the results indicated that there was no statistically significant different in the number 
of innovations implemented by MES sites and Non-MES sites.
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10. Different types of innovations had been implemented by the MES group compared 
with the Non-MES group.
All nine MES sites had implemented the following: a six week notice period for leave policy, partial 
booking, demand and capacity studies and audits, whilst all 10 Non-MES sites had implemented 
the following: additional consultants, audits, patient surveys, home bowel preparations, endoscopy 
groups I staff meetings and new medical equipment.
14.2 Linking the results to the research hypotheses
Based on these results, the author was able to address the research hypotheses listed in Chapter 
9 as follows:
Hypothesis 1 - The MES sites would have a better system of routine data collection 
implemented than the Non-MES sites.
The availability of routinely collected, service-related endoscopy unit data was poorer from MES 
sites than from Non-MES sites, with only three MES sites submitting at least one item of routinely 
collected data compared with five Non-MES sites. This meant that it was not possible to accept 
the research hypothesis that the MES sites were better at routinely collecting data. However, it 
was also not appropriate to accept the null hypothesis that there was no difference in the data 
collection practices of these sites because there clearly was. Instead, an alternative research 
hypothesis stating that Non-MES sites were better at routinely collecting service-related data was 
formed and accepted.
Hypothesis 2 - The MES project significantly improved various aspects of the endoscopy 
services of the MES sites.
The data submitted from the MES sites indicated that there was no statistically significant 
improvement in any aspects of their services over time and so, rather than accepting the research 
hypothesis, the null hypothesis that stated that there was no significant change in endoscopy 
services over time was accepted instead.
Hypothesis 3 - The Non-MES sites would not have significantly improved their services, 
although some changes would be inevitable due to the natural evolution of their services 
and their notification to the NHSMA of their intention to redesign independently.
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The data submitted from the Non-MES sites indicated that whilst some aspects of their services 
improved over time, the improvement was not statistically significant and so, the research 
hypothesis was accepted.
Hypothesis 4 - There would be a significant difference in the endoscopy services of the MES 
group and Non-MES group.
Based on the data received from the MES and Non-MES groups, there were no significant 
i differences between MES and Non-MES groups for any of the five outcome measures at any point 
in time. Consequently, the null hypothesis that stated that there was no significant difference in the 
services of MES and Non-MES sites was accepted.
Hypothesis 5 - The MES sites would have introduced more innovations during the study 
period than the Non-MES sites.
This study found that there was no significant difference in the number of innovations introduced by 
the MES and Non-MES group and so, the research hypothesis was rejected and the null 
hypothesis that stated no difference between the Site types was accepted.
14.3 Strengths of the study
This study had a number of strengths that can be attributed to the author’s study design that will be 
discussed in this section. The strengths arising as a consequence of being affiliated with the 
ENIGMA study are also discussed.
i
}
14.3.1 The originality of the study
One of the main strengths of this study was its originality. To date, no other study has attempted to 
collect and analyse routinely collected, service-related NHS endoscopy data to independently 
evaluate the impact of any modernisation project initiated by a high-level organisation such as the 
NHSMA under the direction of the local government. Literature searches performed to date were 
unable to retrieve any comparable studies. Whilst the ENIGMA study also evaluated the MES 
project, the aims and objectives differed as the primary focus of their evaluation was patient- 
centred using patient questionnaires and interviews, closely followed by the viewpoints of the 
health professionals involved with endoscopy services from primary and secondary care.
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This study is also original in its innovative methods for the compilation of routinely collected, 
service-related endoscopy data from multiple hospitals and NHS Trusts. It is also unique in that it 
provides a caveat of the many pitfalls in the availability and analysability of this type of data not 
previously addressed in the literature until now (Thome et al., 2008).
| This study was also unique in its analysis of service-related endoscopy data. There were only a
; small number of published studies that analysed service-related endoscopy data. No studies had
; requested retrospective, routinely collected, service-related endoscopy data from more than one
NHS endoscopy unit. Two studies were identified that used retrospectively collected endoscopy 
I service-related data from individual NHS hospitals using data that was compiled deliberately for
S those studies and not routinely collected (Mulcahy et al., 2001, National Confidential Enquiry into
j Patient Outcome and Death, 2004). Other studies using endoscopy service-related data collected
it prospectively using a specific format (Elwyn et al., 2007, Davies et al., 2007).
14.3.2 The design of the study
This study was designed with strict exclusion criteria applied to the routinely collected, service- 
related datasets from all sites and sources to minimise potential methodological and outcome
i
| biases and confounding to increase the internal validity of the study, which would have impacted
on the results of the evaluation. The design of the study aimed to maximise its generalisability -  
the degree to which the results of the study hold true for situations other than those pertaining to 
the study (external validity). The outcome measures were datasets that are commonly available to 
| NHS endoscopy units on request from the Trust or as a result of their own data collection regimes.
This study used a similar method of demand and capacity analysis to identify trends in outcome 
measures for each study site as the MES Toolkit. This was done firstly to substantiate or disprove 
the original findings by the MES project final reports for the MES sites and secondly, to determine 
whether this type of data collection was suitable for all NHS endoscopy units based on the service- 
related endoscopy data provided by Non-MES sites for this study.
The outcome measures requested covered most aspects of NHS endoscopy services and their 
potential problems, including high numbers of Referral numbers, N° patients waiting and Lost slots 
together with low Activity. The need for a Capacity measure was also identified early on in the 
design phase but the measure was not routinely collected by endoscopy units. It was specified
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that all data were further split according to procedure type to ensure any changes in service 
delivery that were specific to a particular endoscopy type (e.g. increased demand for colonoscopy) 
were identified and not hidden within the total procedures data.
Whilst it is entirely possible that someone in each unit held data that were not submitted to this 
I study due to our external presence, time pressures, workload, etc. Every effort was made to obtain
: data from these units and the author was confident that all potential avenues of routinely collected,
I service-related data were explored.
| The validation technique used to compare the study data with an equivalent HES dataset allowed
some degree of confidence in the use of the data in these analyses. It meant that the study could 
not be overly criticised for the decision to use two data sources when faced with the obstacle of no 
data for many sites.
Data were aggregated according to specific time periods (corresponding years) to increase sample 
numbers, to make the mean values more accurate and to make statistical testing more credible. 
EDA, correlation, independent samples t-tests and two-way ANOVAs were used appropriately to 
explore the relationships within and between the MES and Non-MES sites. All datasets were 
tabulated and graphically illustrated to better illustrate the trends over time within and between Site 
types.
The list of innovations was taken from the face to face interviews with 38 NHS endoscopy staff 
| previously conducted by the author of this thesis and a qualitative researcher as part of the
ENIGMA study. It was considered to be as comprehensive as possible to as to act as a memory 
aid for the person completing it. The Timeframes used were few in number to encourage its 
completion whilst the length of the Timeframes were extensive (one to two years) to allow sufficient 
accuracy in applying the correct Timeframe to the date the innovation was first implemented, given 
the retrospective nature of this data request and its reliance on temporal recall.
14.3.3 The affiliation with the ENIGMA study
The ENIGMA study randomly selected their MES and Non-MES sites from larger groups of 26 
MES project sites and 27 Non-MES project sites. The selection by interval choice following ranking 
by bed number ensured that there was no selection bias for the choice of study sites. There was
210
no selection bias by the MES project in its selection of MES project sites as they claimed that each 
site had been selected by a panel based on the application form submitted. The selection of the 
Non-MES sites from which the sample was taken was based on those sites who had explicitly
| indicated their intention to modernise their services irrespective of their failure to participate in the
| MES project to ensure a true evaluation of the impact of the MES project on modernisation.
I
I
i Some of the service-related data collected and analysed by this study came originally form the
ENIGMA study. Whilst this study could have proceeded without the input of the ENIGMA data
; collection forms, its use did enhance this study.
I The qualitative interviews conducted by the ENIGMA study led to the design of the Innovation form.
| It is possible that without the interviews to use as a guide for the list of innovations to act as a
memory aid, the data for this part of the study may have been less accurate.
14.4 Weaknesses of the study
This study also had a number of weaknesses, some of which were attributable to the research
I design and some to external factors, but most of which were due to its operation within the
|
! boundaries of the ENIGMA study.
|
I
| 14.4.1 The design of the study
i
| The primary objective of this study was to compare changes in Referral numbers, Wait >3m,
; Snapshot, Lost slots and Activity over time, based on the assumption that all endoscopy units
would collect some or all of these data variables in a user-friendly format that could be used in this 
study. This was later proved to be untrue, with many sites unable to provide even the most basic 
level of service-related data (Thome et al., 2008), possibly because they did not feel the need to 
collect it or because it was readily available from the Trust on request, or because they were 
unable to collect it due to the nature of their clinical information systems, since NHS databases 
were not built to help clinical research (Pilote and Tager, 2002), only to record and store patient 
details and notes.
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Strict exclusion criteria may have ensured the highest degree of accuracy in the final dataset but 
also contributed to low sample numbers following the exclusion of incompatible or incomparable 
data from certain sites, which may have affected the group means for individual time points.
i
There were problems with missing data for specific time points in many sites, irrespective of data 
! source. Data were often missing for the early time points in Non-MES sites because many sites
had not initiated a data collection programme, whilst end point data were missing in many sites,
| irrespective of Site type due to a drop off in response rates. This was not surprising, since the
I endoscopy units and Trusts were providing data with no financial remuneration. This may have
resulted in less than accurate means for the MES and Non-MES groups for early and late time 
points when compared to the middle time points where higher sample numbers provided a more 
realistic mean value for the group. The accuracy of the datasets were improved to a degree by 
aggregating them.
Another problem with data accuracy was the different terminology used between sites. An 
example of this was the classification of UGEs in endoscopy units, with some discriminating 
between OGDs and gastroscopies whilst others did not. This led to the amalgamation of all UGEs
I
I into one category.
Where some endoscopies were done as an outpatient procedure, it may have resulted in a 
difference in endoscopy service data from the Trust and the corresponding endoscopy unit. The 
Trust may have included outpatient endoscopies in their dataset because they were unable to 
determine the location of the procedure whereas the endoscopy unit would only count procedures 
within their own department. A few TIS contacts indicated that their data may have potentially 
included endoscopy procedures not done within the endoscopy unit and that the coding framework 
did not identify these procedures, artificially inflating the values provided.
Discussions with endoscopy staff prior to the data request meant that one outcome measure not 
available -  Capacity. This would have incorporated a number of sub-variables: the number of 
endoscopy rooms, the number of slots per session, staff availability and equipment availability. It 
was made clear by the endoscopy staff that this variable was extremely difficult to collect 
prospectively and that a retrospective data request for Capacity was not likely to be of sufficient 
quality as to be useful in the evaluation.
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The problem with the data collected by the Innovation Form was that it was collected 
retrospectively and was potentially exposed to recall bias by the individual completing it, both in 
terms of the innovation ticked and the Timeframe allocated. There was also the danger that the 
form was completed by more than one person where specialist knowledge was required, or if that 
person was not in post as far back as 2000. Every effort was made to convey the importance of 
the accurate completion of the Innovation Forms with innovations that had been introduced,
i
j  irrespective of whether or not they worked, and when they were first implemented. Also, the
updating of the forms for 2006 may have resulted in the inclusion of some planned but not yet 
| implemented innovations. Fortunately, the low scoring of that category would mean that the impact
of this effect should have been minimal. The potentially bias nature of this data meant that it did 
not feature too prominently in the analysis of services and was used primarily in a descriptive 
manner to identify those sites that were proactively modernising prior to the MES project, and to 
describe the most commonly introduced innovations in the MES and Non-MES groups.
14.4.2 The affiliation with the ENIGMA study
TO (January 03) was used in this study as the baseline time from which all redesign programmes 
were implemented in the MES sites because it signified the true start of the MES project following
s\
| the three month pilot whereby the sites had already analysed their services and had submitted
I redesign plans for approval by the NHSMA. However, the true baseline time point for an accurate
[ evaluation should have begun in January 2002 to explore the data for any temporal trends prior to
j the MES project beginning so that “natural” cyclic changes in service delivery data would not be
t
i incorrectly attributed to the project. There was no way of controlling for any temporal trend bias
i
I within the remit of the ENIGMA study and there was not enough time or goodwill from study sites to
!
collect enough pre-2003 data points to allow the exploration of any underlying seasonal or cyclical 
trends in data to allow a true estimate prior to the implementation of any modernisation agenda.
A true baseline data time point for the Non-MES sites was impossible because there was no 
defined period of modernisation -  each would have begun their redesign programmes at different 
time points. It was also difficult to define periods of modernisation in many Non-MES sites, since 
all were operating independently of any common project target. They tended to introduce small 
changes sporadically as opposed to planning a modernisation programme for implementation 
during a given time period, making estimates of dates problematic.
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These two problems with “baseline” effects would inevitably impact on the comparison of the MES 
and Non-MES groups overall, given that they may not experience the same secular trends or 
sudden changes due to the implementation of innovations. Also, the rate of progress of the Non- 
| MES sites would have varied according to the type of redesign planned, resources available and
| staff involved.
I This study was restricted to just eight time points for data collection so the initiation of a redesign
; programme may have fallen immediately after one of the time periods of data collection for this
; study. This would leave a number of months before the next period of data collection for any
| changes in the delivery of their services to be identified. The time intervals between datasets
| should have been greatly reduced. Ideally, monthly datasets should have been requested from
j each site to allow a more detailed analysis of the data over time using time series analysis.
Unfortunately, the data request for this study was not a feature of the ENIGMA study when they 
agreed to participate and so, this could not feasibly be done without the risk of sites withdrawing.
The intervals separating the eight time periods actually used were not equally spaced and ideally 
would have been six months apart. The ENIGMA study specified their preference for the collection 
of any service-related endoscopy data to correlate with the same time periods as their patient QoL 
I scores, a request which this author was obliged to adhere to -  hence the choice of T3 to T7 time
r
| periods.
i
i
[
| The 2003 time periods for the data collected (TO, T1 and T2) were selected to signify the start,
i middle and end of the MES project. There was a possibility that T2 data were affected by the
seasonal variation common with Christmas period. However, a recent study by Auslander et al 
concluded that endoscopic procedures and diagnoses were not affected by seasonal variation 
(Auslander etal., 2006).
This study was obliged to use the same 20 study sites as were used in the ENIGMA study. 
Consequently, there may have been a degree of “size effect” from the endoscopy units 
participating in the study, since some Trusts had only one endoscopy unit and these would handle 
larger volumes of patients than those Trusts with two or more endoscopy units at various locations. 
This would have affected the group means for each outcome measure. However, since the 
ENIGMA study recruited a random selection of sites based on bed number from both the 26 MES
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and 27 Non-MES sites, we would expect a similar proportion of these sites to be in each group so 
their size should not have affected the overall study results.
Since the ENIGMA study was partially funded by the NHSMA and had the MES project lead on its 
PSG there was, in theory, a possibility of funding bias that may have influenced not only the 
ENIGMA study but also this study. However, during the course of the ENIGMA study, the MES
| project lead did not contribute to the design or analysis plan of this study, or the ENIGMA study.
[ As such, this study was untouched by the possibility of funding bias.
Finally, the study was unable to determine the extent to which the modernisation of endoscopy 
services in each site would have taken place as a result of the natural evolution of the service with 
no NHSMA interaction because there were no suitable control sites enrolled into the ENIGMA 
study and it was beyond the remit of this study to include any due to funding and time restrictions.
14.4.3 The impact of external factors
Other weaknesses of this study were due to external factors outside the control of both the author 
and the ENIGMA study and are discussed below in more detail.
Some study sites moved into new premises or units during the course of the study. This meant 
that modernisation programmes in these sites were deliberately temporarily suspended or in some 
cases not initiated until the relocation had taken place. It also meant that many sites had their 
| operational capacity and activity dramatically altered and this may have affected the data from
i
| these sites. This study was unable to compensate for any potential impact this may have had.
Other important confounding factors were the introduction of external modernisation plans such as 
the NBAP and the TWR initiative, both of which were instigated to facilitate improvement within 
endoscopy services but not within the remit of the MES project. Initiatives such as these made it 
difficult to disentangle forced changes arising from external pressures from the "planned” 
modernisation of the MES project in the MES sites.
The introduction of the GRS (see Chapter 6) in Spring 2005 heralded a new drive to improve 
services following the completion of a web-based tool that asked endoscopy staff to voluntarily rate 
various aspects of their service on a twice yearly basis under two broad headings: Clinical quality
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and Quality of patient experience. It is highly likely that, given the exceptional uptake of the GRS 
: by NHS endoscopy units (according to the GRS website at www.grs.nhs.uk. 203 of 207 units in
England completed the scale for Oct 2007), it has facilitated many changes in these endoscopy 
units that cannot be disentangled from the long-term impact of the MES project.
I
j 14.5 Discussion of results of the study as a whole
Based on the data collected and analysed for this study, the endoscopy services of the MES sites 
: did not improve significantly over time. There could be any number of reasons for this, including a
: lack of ongoing, high quality data collection, a lack of ongoing external funding and support from
the NHSMA, internal and external pressures to meet targets impacting on services and the 
introduction of unsustainable innovations. It is feasible that whilst the MES sites implemented 
numerous successful innovations during 2003 the evolution of the service following new politically- 
driven and locally-driven targets may have diluted the effect of past reforms under the MES project 
whilst also reducing the time and resources available to implement any further redesign plans. It is 
also possible that, given the strict nature and intensity of the MES project, many sites were 
experiencing “reform exhaustion” and felt unwilling to proceed with either the planning or the 
\ implementation of any further modernisation programmes once the MES project ended.
i
Another factor may have been the loss of the “change agent” in the MES sites after 2003. The 
MESPT stipulated that a change agent had to be designated to lead and facilitate the project and 
these people played a significant role in the management of modernisation during the MES project.
| However, during the course of the ENIGMA study it became apparent that many of these people
I had been reappointed to other departments within the Trust to act as modernisation managers
based on their success with the MES project. For those who were originally endoscopy unit staff, 
the close of the project meant the end of their project management role and they quickly resumed 
their original duties, although they would do so with the experience of the project to bring to bear 
when necessary. This key fact brings to attention the fact that sustained leadership is equally as 
important as good leadership in any modernisation programme.
It was not so surprising that the Non-MES sites did not significantly improve their services, since 
they had no external support or funding during 2003 but were expected to address many of the 
same external and internal pressures that were imposed on the MES sites. Their intention to
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modernise following their rejection from the MES project should have led to them implementing at 
least some minor improvements resulting in a small but statistically insignificant change to their 
services. However, the MES project may have acted as a catalyst in these sites, prompting them 
to think about modernising their services based on the original bid submitted to the NHSMA.
Ij
i
| The lack of unmarked funding may have led to smaller changes to the service but should have 
I caused Non-MES sites to think about implementing cost-neutral innovations. However, it would
I
j  have taken a great deal of initiative from the people managing the modernisation programme in the 
I Non-MES sites to locate and interpret the NHSMA literature to be applied to their own services. It
[ was also clear from the ENIGMA study that there were more consultants than unit managers
i-
assuming a role equivalent of the change agent in the Non-MES sites and whilst they probably had 
a more explicit understanding of the way the service ran, they may not have had the time or project 
management skills to use the NHSMA literature to great effect.
It is plausible that the messages relayed to the MES sites from the MESPT may have been further 
disseminated between health professionals from MES and Non-MES sites at national 
gastroenterology-related events and conferences. Also, the literature published by the NHSMA 
was widely and freely available to all NHS endoscopy units, irrespective of whether they
! participated in the MES project or not. As a consequence, it was reasonable to anticipate that the
Non-MES sites would have redesigned their service, but at a later date than the MES sites and 
possibly at a more fundamental level. However, the high 2000/02 innovation scores from many
i
| Non-MES sites indicated that the Non-MES sites secured their own resources for redesign plans
I
prior to the MES project. This may go some way to explaining why this study was unable to report 
any significant differences in the service-related data from the MES and Non-MES groups.
It is of great importance to note that whilst this study has reported no statistically significant 
differences both within each Site type over time and between both Site types, that does not mean 
that the services did not make clinically significant improvements. It may be that, for example, a 
5% increase in Activity over time is not statistically significant but to the endoscopy staff it could be 
clinically significant as it may mean an increase in throughput in their services and may also 
indirectly result in a reduction in waiting lists. However, since all MES and Non-MES sites would 
have had different service characteristics, it would have been inappropriate for this study to 
propose an ideal figure of what was considered to be a clinically significant improvement in each 
outcome measure against which to compare all study sites.
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The lack of availability of data was a major problem for this study as it was designed on the basis 
of this data being available following discussions with ENIGMA contacts. Consequently, alternative 
data sources had to be sought to replace missing datasets if the study was to continue. The 
corresponding NHS Trusts held a wealth of information that were suitable, in principle, for this
i
j  study, although they could have led to potential inaccuracies in the final dataset due to the 
additional and potentially incomparable sources of data. However, the alternative was to only 
analyse the endoscopy unit data which would not have produced any reliable results given the low 
[ sample numbers involved.
i
Whilst the use of Trust-held data was agreed for this study, these additional datasets were treated 
with caution. There have been a number of publications highlighting deficiencies in NHS Trust- 
based clinical information systems over the years (Whates et al., 1982, Gibson and Bridgman, 
1998, Sherrard, 1999, Ballaro et al., 2000, Ola et al., 2001, Khwaja et al., 2002), although none 
refer to inaccuracies in gastroenterology-based datasets. Discussions were held with both the 
endoscopy unit contact and TIS contact to ensure the datasets received were suitable and 
accurate in terms of items requested and the format in which they were submitted.
i
I
| It was likely that the waiting list data that were “routinely collected” by the endoscopy units and
!
I submitted as such to this study were actually data sent to them by their TIS department. This
j  brings the issue of data ownership to the forefront. Whilst the NHSMA advocates the routine
! collection of service-related data for all NHS endoscopy units, it is usually the Trust that provides
j this dataset to most endoscopy units on a regular basis to ensure that they are meeting targets. It
is possible that proactive endoscopy unit staff will create their own queries to interrogate their 
clinical information systems regarding waiting lists but this was not considered to be routine 
practice for most sites.
When the data were plotted as part of an EDA exercise, the high degree of variability of the data 
for many of the outcome measures within and between sites over time gave cause for concern. 
This may have been attributable to the different data sources used in this study. To assure the 
accuracy of the datasets received, they were compared with a nationally-held dataset from HES. 
The validation process found that the datasets used in the analyses were comparable with the 
equivalent HES datasets in most cases and therefore, could be analysed with confidence.
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This study has shown that when using routinely collected endoscopy service-related data it is 
important to validate it against a comparable dataset. In the case of Activity data, the HES dataset 
was the most suitable. However, there are a number of publications that warn about the accuracy 
of HES data (Williams and Mann, 2002, Croft and Williams, 2005). The discrepancies commonly 
originate from coding errors by NHS Trusts (Ballaro et al., 2000, Khwaja et al., 2002). The 
validation process highlighted deficiencies in the HES dataset in terms of the reporting of
i
[ endoscopies as either day cases or outpatient procedures during those time periods. HES needed
I
| to issue stricter guidelines regarding the completion of their data requests by Trusts to ensure they
all used the same terminology, as defined by national guidelines and to ensure that they were not
| manipulated in any way by the Trust in a bid to secure more funding via the PbR scheme, or to
meet national waiting list targets. HES now provide the opportunity to complete their datasets with 
this level of detail, but in the past it was not compulsory and since not all sites had been 
forthcoming with the appropriate data in the past, retrospective analyses over a long period of time 
could be problematic.
Given the potential for inaccurate data from both HES and the Trust, it is advisable that future 
health services research should attempt to use routinely collected data directly from the relevant 
NHS departments as they are more likely to hold the most accurate dataset. However, this brings 
problems in itself if the specialty being studied does not routinely collect any service-related data. 
There is also the problem of making routine datasets comparable when more than one site is being 
studied as their terminology can differ. If these obstacles can be overcome by first ensuring that 
relevant data is available retrospectively and secondly, that each dataset can be retrieved using a
| rigorous set of definitions to ensure accurate comparability, then the quantitative analyses should
i
be based on data of the highest possible quality.
One major point of concern was the lack of uptake of the MES Toolkit after the MES project had 
ended. The routinely collected datasets did not feature this data collection software tool for any of 
the MES sites during 2004 or 2005/06 and none of the nine MES sites in the ENIGMA study had 
opted to continue using it after the MES project ended, although most commented that they would 
take on board the message of high quality data collection and create their own versions of the MES 
Toolkit which they would operate internally. However, based on the availability of data illustrated 
by this study it would seem that their intentions were not followed through to fruition.
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One MES site’s Innovation Form claimed to have collected routine data but this was not reflected 
by this study. However, closer examination of the raw data revealed an even more complex 
picture, with many sites who provided routinely collected data for this study not indicating so on 
their Innovation Forms, whilst other sites claimed that they did routine data collection when this 
study indicated otherwise.
|
!
! By matching the data collected for different sections of this study, the data collection practices of
i most sites could be compared using the Innovation Forms (see Chapter 13) and the actual
I availability of data (see Chapter 10). Five MES sites (4 ,7 ,11 ,13  and 19) and nine Non-MES sites
! (2, 3, 5, 10,12, 14,15,17 and 20) had ticked the box on the Innovation Form indicating that they
had “new I improved in-house data collection” and of those five MES sites claiming to collect in- 
house data, at least one source of data had been secured from all five prior to exclusion criteria 
being applied. However, of the nine Non-MES sites who claimed to collect data, data had only 
been secured from five sites (2, 5,10,12 and 17), although one additional site had commented on 
the existence of data but not submitted it to this study due to time constraints (15). This brings into 
question the validity of the Innovation Forms as a good source of evidence in this study. It is 
interesting that the difference in the data collection habits of the MES and Non-MES sites reported 
in Chapter 10 are also reflected here, with nine Non-MES sites reporting the initiation of in-house 
data collection compared with only five MES sites.
The validity of the information on the Innovation Forms was also identified as inaccurate when 
examining the number of MES sites acknowledging the NHSMA’s role in the “help or advice from 
j external agencies” row. Only four of the MES sites (4,7,13 and 19) had ticked that box. It brings
into question whether the forms were given the due care and attention desired by the study when 
thinking about each innovation listed. It is also possible that the forms were completed by 
someone who was not in post in 2003 and was unaware of the MES project.
One issue arising from this study was the fact that the evaluation in the Non-MES sites was not 
likely to be typical of the natural evolution of endoscopy services over time, given that they were 
motivated to modernise. Both this study and the ENIGMA study were only able to ascertain the 
impact of the MES project on those sites who applied to participate, some of which were successful 
and others were not. A comparison of the MES sites with the Non-MES sites does not address 
how sites would have modernised their services completely independently of the MES project. 
This third group of sites could have provided a real insight into the benefits of the MES project by
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acting as a Control group to illustrate the natural evolution of the service without NHSMA 
interference.
The design of this study using retrospective, routinely collected data meant that it was not possible 
to define modernisation as introducing innovative ways of working, since there was no way for the 
data being analysed to disentangle and identify such effects. Instead, the study defined 
modernisation as the introduction of a change to the service with a view to improving it. This 
meant that the study captured the impact of both innovative changes and those changes that were 
basically doing more of the same and as such, not truly innovative changes. In the same respect, 
it was also impossible to decipher those changes implemented as a result of the MES project (in 
the MES sites only) and those implemented as a consequence of other government-instigated 
redesign initiatives such as booking and waiting list initiatives, the introduction of DTCs and the 
TWR to name a few. Therefore, any conclusions drawn from this study had to be mindful of the 
potential confounding effects discussed here.
Whilst all five measures used were considered to be good measures of service efficiency and were 
also used by the MES Toolkit, it is entirely feasible that they were not the optimum outcome 
measures for performing an evaluation of the MES project. There was no capacity measure 
against which to measure the ability of a unit to increase their activity and reduce their waiting lists 
by exploring staff, room and equipment availability. This additional outcome measure would have 
allowed a more complex examination of the services of each site and allowed a level of 
predictability that would have allowed sites to forward plan their service usage to optimum effect 
and would have allowed this study to explore the more complex relationships between supply and 
demand for NHS endoscopy services over time. Unfortunately, capacity variables are not routinely 
collected by either endoscopy unit staff or the Trust in any analysable format. This issue needs to 
be addressed for a more complete service overview.
14.6 Results in context
Following the discussion of the results reported in this study, it was necessary to place them into 
context by comparing them with similar research. Since this study was completely original in both 
its research question and design, there was no truly comparable peer-reviewed literature against 
which to compare this study. Therefore, this discussion will focus on comparing the results with (1)
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non-peer reviewed evaluations of the MES project and (2) the independent evaluation of other 
NHSMA-led modernisation programmes.
14.6.1 The evaluation of the MES project
This study is completely original in its evaluation of NHS endoscopy services using service-related 
endoscopy data and comparing sites who had participated in the MES project with those who had 
indicated their intention to modernise independently. Since the final report of the ENIGMA study 
had not been completed at the time of this thesis being submitted, the only literature available that 
can be closely compared with this study would be the NHSMA’s final report of the MES project 
(NHS Modernisation Agency, 2004e). More specific details of the findings of the ENIGMA study 
are due to be published by the NIHR SDO in summer 2008.
The MESPT final report described improvements in the services of the MES sites participating in 
the project with regards their planned and active waiting lists, their DNA rates, the introduction of 
booking systems, patient-led changes, new ways of working and self assessment. Each of these 
were illustrated with a selection of case studies reported by the sites themselves. However, 
independent statistical analyses by this study using routinely collected, service-related data 
showed no significant improvement in any aspects of service delivery over time in 10 of the MES 
sites in the MES project. On the other hand, when compared to the Non-MES group, the MES 
group data were significantly lower than that of the Non-MES group for Snapshot data following the 
MES project close, and for Activity data at the earlier stages of the evaluation. There may be a 
number of reasons for the different findings reported by the MESPT and this study, each of which 
I are discussed below:
•  The MES project had different datasets for their analyses. Whilst this study opted to
analyse retrospective, routinely collected data from both NHS endoscopy units and the
corresponding Trusts, the MESPT used the prospectively completed, high quality MES
Toolkit data and reports completed by endoscopy staff.
•  The MESPT analyses were based on data collected on a monthly basis from January to
December 2003, whereas this study analysed data collected at approximately six monthly 
intervals from January 2003 to April 2006, a substantially longer period of time with longer 
intervals between datasets, and aggregated them according to year for analysis.
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•  This MES report had 26 sites on which to base their findings and highlight examples of 
good practice whereas this study looked at a random selection of 10 of those 26 MES sites 
grouped into one MES group.
i
| •  The improvement in services was based on clinically significant targets allocated by the
| MESPT whereas this study evaluated endoscopy services according to whether the data
changed over time to a point where it became statistically significant.
i
Based on these facts, it was felt that whilst the content of MESPT report on the second wave of the 
MES project was correct based on the analysis of their data, it only corresponded to a relatively 
small window in NHS endoscopy services modernisation during 2003. There was no follow-up 
report by the MESPT to fully explore the impact of the project in the 26 MES sites following its 
close. As a result, the MES report could be considered misleading as it failed to ascertain the 
sustainability of the innovations that the project had helped to introduce and it did not make any 
comparisons with sites who did not participate in the MES project. It was also biased in its 
reporting of the impact of the MES project, only illustrating examples of success and good practice.
14.6.2 The independent evaluation of NHSMA-directed modernisation projects 
| Other NHSMA modernisation projects have been implemented in the last decade, many of which
i
have been independently evaluated. This section will discuss how well the findings of this study 
compare with the results of those other evaluations.
The independent evaluation of the NBAP by the Health Services Management Centre at 
Birmingham University reported that these systems can be implemented in the NHS and that there 
5 had been real progress in day case bookings, with reductions in the number of patients with no 
appointment date as well as the number who fail to attend appointments. Inpatient and primary 
care booking systems were under development. The 24 pilot sites in the study showed increased 
access and convenience for patients when compared to Trusts not participating in the pilot (Kipping 
et al., 2000).
The independent evaluation of the CSC was commissioned by the DH and was based on patient 
flow (time from referral to treatment) and access to services (Robert et al., 2003). The only Gl 
cancer service included in the evaluation was for CRCs. Whilst the study was mixed methods, 
using qualitative interviews to arrive at many of its conclusions, it also had a substantial
223
quantitative element using patient-level data on booking and waiting times to be completed 
retrospectively by the hospital on data collection forms. However, there were clear indications in 
the report that even this level of data was not readily available for a large proportion of projects 
examined and subsequent analyses were restricted to those sites able to provide the appropriate 
datasets. They reported that 29% of CRC patients had been affected by the CSC programme and 
that in three individual colorectal projects there was a decrease in the median waiting times from 
j 64.5 days to 57 days, a non-significant reduction of 11.6%. They also reported the implementation
of full booking in seven of 11 sites. The study concluded that the CSC was a success in the view 
of the participants themselves but it also acknowledged that it was the beginning of a much longer 
term process.
The NHSMA commissioned an independent evaluation of the CSC-IP using an appreciative inquiry 
method (Reed and Turner, 2005). The study used this organisational development technique to 
explore the skills and strategies employed by CSC staff to facilitate development. The study 
reported many interesting findings: traditional line management strategies did not work due to the 
CSC’s structure; resistance to the messages of the CSC were resisted at the outset, but decreased 
over time; CSC staff had to function as both “coaches” and “ambassadors”; people had to be 
j “encouraged” to learn from any information presented and finally, perseverance and consistency
| were essential attributes for CSC staff. Unfortunately, no evaluation of the effectiveness of the
( CSC was reported by this study.
i
i
I
| 14.7 Implications of the findings of this study
14.7.1 Implications for the NHSMA
Unfortunately, the NHSMA disbanded in March 2005, making this evaluation of the MES project 
less applicable to today’s NHS endoscopy services. However, there are still numerous important 
messages that have been derived from this evaluation in terms of NHS modernisation strategies 
and the importance of sustaining improvements in endoscopy units. It found that the MES project 
did not significantly improve service delivery in MES sites above and beyond what could have been 
achieved independently of the MES project with only the intention to redesign. This finding should, 
in theory, have had a major impact on the NHSMA had they still been in operation today. This study 
presents evidence to challenge to the value of the NHSMA’s approach to modernising NHS 
services and should have forced a major reappraisal of their modernisation strategies. More
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specifically, it should have led to a major change in the way they introduced compulsory, stringent 
data collection regimes.
Expanding of the issue of poor data collection, this study found that none of the MES sites 
continued to use the MES Toolkit following the close of the MES project. The data collection 
aspect was a significant portion of the redesign message advocated by the MESPT that allowed 
sites to evaluate their services pre- and post-redesign, but that message did not have the intended 
impact on MES sites. There is a clear message here for all externally-led modernisation agendas 
-  no matter how good the concept, there is no guarantee that it will remain in use once it becomes 
voluntary. This means that future modernisation programmes will need to consider not only how 
they encourage NHS services to redesign and improve their services, but how they will sustain the 
importance of the key messages and the prolonged use of any ideas or tools after the projects 
close. It is vital that they recognise many external and internal pressures placed on NHS staff and 
that they are taken into account when designing and implementing data collection practices if they 
are to be sustained long-term. In the case of the MES Toolkit, its complexity and rigorousness 
actually added to the workload of the endoscopy staff and so, was never likely to be sustained long 
term for that reason. New modernisation concepts need to be time- or resource-savers, adapted
| for more practical use and easily embeddable into everyday use in the service so that it takes more
effort to withdraw it from use than to keep it in use. Without the promise of sustainability, every 
modernisation agenda is set to fail before it has begun.
14.7.1 Implications for NHS endoscopy units
[ This study provides an invaluable resource for NHS endoscopy staff wishing to modernise their
i
I services as it gives clear messages on the necessity for routine data collection practices to be
instigated and maintained if services are to be measured, monitored and evaluated over time. It 
also provides a comprehensive list of innovations implemented by NHS endoscopy units to use for 
ideas on how to change a process, many of which were cost-neutral and only involved a change of 
working practices.
The lack of routinely collected, service-related data from this selection of 20 NHS endoscopy units 
highlighted the inadequacies in the NHS as a whole to proactively evaluate and manage services 
from within those departments. This is because the NHS as a whole is not rigorously managed by 
data. There are numerous audits and improvement projects that occur within the NHS but they are
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sporadic and isolated. The NHS needs to adopt an ethos of data collection and analysis 
throughout the organisation, across primary, secondary and tertiary care boundaries for the whole 
of the UK if it hopes to make and sustain any improvements in its delivery of care to patients. Staff 
! should be trained in the importance of data collection and analysis in its application to improve
I service delivery and patient satisfaction to motivate them to accept a data collection regime as part
j of their daily tasks. This issue cannot be overstated as it is one of the keys to initiating change in
[ the NHS. This would take time, investment, training and better IT provision but the end result
should be a vastly improved service which would probably cost less to run in the longer term.
Perhaps the government should consider taking a business-like approach to improving NHS 
services and place greater importance on the findings of data analyses when introducing new 
policies and targets. They also need to realise that setting NHS targets does not facilitate data 
collection - it only encourages the manipulation of data to best meet the needs of the department.
It is feasible that the compulsory collection and analysis of rudimentary service-related data such 
as demand, activity and capacity would lead to an improvement in NHS endoscopy services, and 
maybe NHS services as a whole, as they are forced to collate the data and use it to measure their 
services themselves instead of waiting for a third party to highlight bottlenecks and problematic 
areas. This would allow NHS services to be proactive in process monitoring and would provide a 
good evidence base for building business plans for funding improvements. It is clear from this 
study that even the most basic datasets are of high enough quality to perform rudimentary data 
analysis -  staff only need to be taught how to perform and interpret it effectively to examine their 
services.
; 14.7.3 Implications for external researchers 
Finally, this study provides two warnings for external researchers intending to use routinely 
collected, service-related endoscopy data to analyse NHS endoscopy services. The first relates to 
the availability of this type of data, since not all endoscopy units collect service-related data 
routinely and even when they do, it is not necessarily easy to compare them as different definitions 
may be used nationwide. Prospective data collection may be more advisable to improve 
availability and accuracy but prevents any historical analyses. Alternatively, the clinical information 
system could be interrogated by endoscopy staff, probably at a cost.
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The second warning relates to the reliability of older HES Activity datasets, which were shown in 
this study to be flawed in two sites due to the terminology applied to their endoscopies by the Trust, 
with both classifying them as outpatient procedures which were not recorded in their returns to 
HES for the time periods used in this study.
The findings of this study highlighted the importance of independent evaluations to provide clear, 
unbiased conclusions using a high quality study designs and sound research experience. It placed 
the impact of the MES project in a more realistic light by describing the services of the MES sites in 
vivo using unbiased data that were analysed using the appropriate statistical tests. This thesis fully 
illustrated different aspects of service delivery relating to all 20 study sites where available for any 
interested parties to examine the data trends over time to make their own decisions about whether 
these sites were truly successful in clinical terms, as well as in statistical terms.
This study also brought into the research setting a group of sites that had not participated in the 
MES project to evaluate their attempts at service redesign over the same time period and in doing 
so, provided a more realistic picture of what was achieved by the MES project and what was 
achieved independently. In doing this, it was able to give a clear message that even though some 
endoscopy units were not part of the MES project they still made clear improvements to their 
services over time, a message that may serve to sufficiently motivate endoscopy staff to improve 
their services.
14.8 Conclusions
With NHS endoscopy services facing their biggest challenge yet with increasing demand from new 
referral guidelines and cancer screening programmes, it is vital that the true impact of 
modernisation be reported so that any important findings can be used as a building block with 
which to further improve services. With this in mind it was crucial that the MES project was 
independently evaluated to determine whether it provided any significant advantage to those 
participating sites over and above what could have been achieved with only the intention to 
modernise. This study has reported a number of findings that can be drawn together to formulate 
the final conclusions regarding the impact of the MES project on NHS endoscopy services.
1. Endoscopy data is not routinely collected and analysed by endoscopy unit staff.
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IThere was a noticeable lack of service-related endoscopy data being routinely collected by the 
NHS endoscopy units in this study since 2003. This could be because firstly, it is not compulsory
|
for endoscopy units to collect service-related data and secondly, many units did not see the 
benefits of collecting the data for analysing their services. Participation in the MES project did not 
; encourage the MES sites in this study to maintain a high standard of data collection. In fact, the
; Non-MES sites appeared to be more willing to routinely collect data. Fortunately, data were widely
| available for this study from TIS contacts but there were instances where their accuracy was
| questionable and was later excluded.
I 2. The MES project did not have a significant impact on the endoscopy services of 
MES sites.
The results of this study indicate that whilst the MES project may have improved the endoscopy 
services of the MES sites in this study, it did not do so in sufficient quantities as to produce a 
statistically significant difference in Referral numbers, the Number of patients waiting more than 
three months, the Total number of patients waiting, the Number of lost appointment slots or Activity 
over time. Equally, the endoscopy services of the Non-MES sites in this study also improved, 
although it was not sufficient to produce a statistically significant difference in data over time. 
However, they improved their services to a point where some areas of improvement seemed to be 
on a par with those seen in the MES sites, resulting in no significant difference between MES and 
Non-MES groups for any outcome measure. There was also no significant difference in the 
number of innovations introduced by MES and Non-MES sites between 2000 and 2006. This 
implied that the MES project did not significantly improve the endoscopy services of MES sites 
| over and above what could have been achieved independently, so long as the intention to
I
modernise was present.
3. HES Activity data were not accurate for all sites.
I When using HES to validate the use of two data sources in the study datasets used in the analyses 
reported in this thesis, it was proven to be incorrect in two sites due to imprecision from the Trusts 
in their reporting of endoscopies as outpatient procedures as opposed to day cases. This resulted 
in the HES datasets grossly underestimating the Activity in those two sites.
14.9 Recommendations
Based on the conclusions of this thesis, the following recommendations are being made:
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1. The compulsory collection and analysis of rudimentary service-related data in all 
NHS endoscopy units.
Based on the data availability reported by this study (Thorne et al., 2008), the first recommendation
| would be for all NHS endoscopy units to record basic demand, capacity and activity data
I
! themselves and to avoid relying on the Trust to provide them with information. The routine data
; provided by endoscopy units for this study was not complicated or deemed difficult to collect by
| those submitting it and it was considered to be of utmost importance by those sites for the unit to
| run efficiently and effectively, and to implement a strategic modernisation plan with targets
I identified by the data.
[
This study showed that basic demand and activity data can be used to effectively plot and analyse 
services over time to allow NHS endoscopy staff to monitor their services, identify problems and 
evaluate the impact of modernisation. Where possible, capacity data should be collected and 
analysed. All data should be split according to procedure type to identify any anomalies obscured 
by aggregating the data into a “total procedures” dataset. It would also be invaluable if the data 
variables collected could be further split into their constituent data types. For example, the number 
of lost appointment slots should be split according to the reasons for these lost slots, including 
patient DNAs, patient cancellations and hospital cancellations to get a clearer picture of where the 
problems lie and how effectively they are being managed.
i-i!
Further to this, the compulsory training of selected NHS endoscopy staff in the accurate collection 
and analysis of service-related data is also essential to help them better understand the beneficial 
applications of high quality data and to ensure that they use it properly to analyse the service and 
| evaluate changes to the service over time.
These recommendations can also be extended to all NHS services, not just endoscopy. The 
fundamental principles of the importance of data collection and analysis to monitor processes are 
well used in all successful businesses, but not by the NHS. Perhaps it is time for NHS 
management to shift their attention towards implementing a culture of process evaluation within 
each NHS department and to make more use of the data sent to HES internally.
2. The standardisation of data collection processes in Trusts using a proforma.
The TIS data used in this study differed in their structure and content. Whilst most were kept in 
Excel files, some kept patient-level data whilst others logged daily or weekly counts. The
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definitions and abbreviations used between Trusts differed, making it difficult to make a quick 
visual comparison of datasets. Data received were often riddled with abbreviations that were often 
unique to that site and were not explained until they were discussed with the TIS contact. All data 
had to be “translated” into a common phraseology to make them comparable. In some cases the 
I data had to be excluded due to comparability issues, 
i
j
i A few Trust contacts indicated that their data may have potentially included endoscopy procedures
| not done within the endoscopy unit and that their coding framework did not identify these
| procedures, artificially inflating the values provided. The reclassification and standardisation of
endoscopy coding practices for all Trusts as part of the standardisation of data collection 
processes would be ideal so that all types of endoscopy in all locations, not just the endoscopy unit 
could be identified. It is also important that any changes to coding are traceable so that any 
retrospective analysis of data over time would be feasible.
A nationwide proforma for all NHS Trusts would rectify the geographic inconsistencies within data, 
accompanied by strict instructions for its correct use with no possibility of misinterpretation of the 
quality or quantity of data variables needed. It would require regular updating and ideally, would be
[ accessible to external parties to facilitate research studies, both NHS-based and externally-based,
!
j thereby supporting the quality of evidence available on which to base any clinical decisions.
I?
j 3. Changes to NHS modernisation programmes.
Since the MES Toolkit was considered by most MES sites to be extremely complicated to 
complete, both in terms of data collection and input, a more basic data collection tool should be 
[ developed for distribution to all NHS endoscopy units to facilitate service modernisation. The tool
would require less rigorous data collection and all data would be in counts instead of timings, a far 
easier measurement to collect. This would also facilitate the collection of data in one format from 
all sites if used as a proforma, as recommended earlier.
It is also advisable to abandon any financial remuneration as it appears from this study that it does 
not provide any direct improvement in service delivery. The Non-MES sites were able to improve 
their services in line with the MES sites and they did so without the £30,000 provided by the 
NHSMA. By removing funding, a modernisation programme will indirectly promote the need to 
make changes to the service sustainable long-term.
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14.10 An ideal study design
Given a dedicated budget, adequate resources and complete autonomy from any other study, any 
further evaluation of the modernisation of NHS endoscopy services (or indeed any NHS 
modernisation strategy) should include the following changes to the design used in this study:
•  The selection of a wider range of study sites with a proven record of high quality service- 
related data collection by the corresponding endoscopy unit.
•  The inclusion of a further two groups who had not applied to participate in the MES project 
to act as true control groups. One of these would have indicated their intention to 
modernise whilst the other would not have any intention of initiating redesign plans. In this 
way, we would be able to ascertain the impact of the natural evolution of the services over 
time due to external factors (e.g. government targets, cancer screening programmes) and 
internal impetus to improve services driven from within the unit by endoscopy staff. This 
would mean four study groups: 1) sites who successfully bid to participate in the MES 
project -  the MES sites, 2) sites who were not successful in their MES project bid but who 
intended to modernise anyway -  the Non-MES sites, 3) sites who did not bid to participate 
in the MES project but intended to modernise - the first Control group and 4) sites who did 
not bid to participate in the MES project and did not intend to modernise -  the second 
Control group.
•  The inclusion of a Capacity variable in the outcome measures would have greatly 
expanded the ability of this study to analyse data to ascertain whether units were operating 
at full capacity. It was a useful variable in the MES Toolkit and any future evaluations of 
NHS services should aim to capture and analyse it wherever possible.
•  Monthly data collection intervals should be enforced to allow time series analysis within 
each site. This would give a better idea of short-term changes in data to allow the study to 
more easily identify the impact of any modernisation plans.
•  Extending the time period of the study to a pre-baseline period would be ideal for the study 
to identify any underlying secular or temporal trends in the data prior to the study phase.
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These can be controlled for during the analysis phase so that findings are not inadvertently 
attributed to what is actually a natural, cyclic or seasonal occurrence.
•  Financial compensation for study sites would facilitate more comprehensive, prospective 
data collection whereby forms similar to the TIS forms used in this study are completed by 
endoscopy staff.
s’|
•  Assuming that better data will be available as a result of some of the recommendations 
above, more rigorous statistical analyses would be feasible, for example, Time Series 
Analysis.
| •  Completion of the Innovation Form by verbal communication, either face to face or by
[ phone rather than sending it by post may elicit a more accurately completed form as
people could be asked to provide clarification regarding dates.
Ei
[
I 14.11 Recommendations for future research
t
I Whilst it is clear that this study had a number of shortcomings, to repeat it with the improved study
I design outlined above would only waste resources answering a question that is actually no longer
relevant, since the NHSMA and its modernisation programmes have largely dissipated over the last 
| few years, making any further work in this field already out of date. It is more important that we
address the three key issues highlighted by this study, namely the issue of NHS data collection,
I NHS modernisation and the use of HES data in research.
The importance of high quality data collection and analysis has been a recurrent theme in this
thesis. It would be interesting to determine the current state of play in terms of the type and quality 
of data routinely collected within NHS endoscopy units nationwide, not just in the 20 units sampled 
here. From this, evidence could be presented in the hope of changing data collection policies for 
not only endoscopy services but for NHS services overall.
Since the GRS has succeeded the MES project in attempting to improve the standard of NHS 
endoscopy services, it would be interesting to independently evaluate the impact of the GRS on 
NHS endoscopy units, especially since it has had a wider uptake and so, more units would be
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available for sampling. The services of these units could be monitored and analysed over time 
using facets of the ideal study design discussed above to determine whether the GRS has 
significantly improved endoscopy services.
Another avenue for future research would be to further investigate the reliability of the HES 
dataset. This study has highlighted the potential for inaccurate data to be recorded on the HES 
Activity dataset by Trusts and it is important that the true extent of these inaccuracies are explored 
and documented to make researchers aware of the reliability of these datasets prior to applying 
them to their work. This could be done by collecting and comparing equivalent activity datasets 
from both the endoscopy unit and corresponding Trusts in England. An additional feature of this 
would be to perform the same comparison using Welsh endoscopy units and Trusts and comparing 
their data with the Patient Episodes Database Wales and with Scottish endoscopy units using the 
Scottish Morbidity Records database.
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16. APPENDICES
16.1 A table describing the peer reviewed literature featured in Chapter 6.
16.2 A table describing the non-peer reviewed literature featured in Chapter 6.
16.3 The TIS form proforma.
16.4 HES Activity data in Sites 2, 3, 6, 9,12,16,18 and 19, split according to procedure type and time 
period.
16.5 Total procedures data submitted by highest ranking source for each site.
16.6 Data submitted from highest ranking source for FS procedures only.
16.7 Data submitted from highest ranking source for Colonoscopy procedures only.
16.8 Data submitted from highest ranking source for UGE procedures only.
16.9 Innovation form proforma.
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16.4 HES Activity data in Sites 2, 3, 6, 9, 12, 16, 18 and 19, split 
according to procedure type and time period.
Site ID Site type Procedure type Time
TO T1 T2 T3 T4 T5 T6 T7
6 MES UGE 247 188 168 188 167 176 210 127
6 MES Colonoscopy 41 63 58 35 62 76 67 56
6 MES FS 73 54 59 33 50 114 55 42
6 MES Total procedures 361 305 285 256 279 366 332 225
16 MES UGE 29 25 37 26 25 22 34 19
16 MES Colonoscopy 10 16 16 14 14 21 25 13
16 MES FS 4 3 9 10 5 4 6 7
16 MES Total procedures 43 44 62 50 44 47 65 39
18 MES UGE 50 43 51 53 42 48 38 55
18 MES Colonoscopy 15 23 22 29 28 33 20 17
18 MES FS 5 5 2 3 4 3 5 4
18 MES Total procedures 70 71 75 85 74 84 63 76
19 MES UGE 205 219 187 175 253 228 234 207
19 MES Colonoscopy 41 48 49 40 87 80 74 73
19 MES FS 132 120 77 87 108 94 107 87
19 MES Total procedures 378 387 313 302 448 402 415 367
2 Non-MES UGE 399 472 408 425 408 425 412 379
2 Non-MES Colonoscopy 135 130 146 115 140 142 170 179
2 Non-MES FS 51 53 41 55 78 59 75 74
2 Non-MES Total procedures 585 655 595 595 626 626 657 632
3 Non-MES UGE 318 289 327 313 334 292 285 275
3 Non-MES Colonoscopy 73 107 75 82 111 106 120 86
3 Non-MES FS 26 33 47 32 54 39 50 40
3 Non-MES Total procedures 417 429 449 “ 427 499 437 455 401
9 Non-MES UGE 422 425 405 122 122 128 137 303
9 Non-MES Colonoscopy 158 151 145 33 51 26 48 125
9 Non-MES FS 9 13 21 13 12 10 22 43
9 Non-MES Total procedures 589 589 571 168 185 164 207 471
12 Non-MES UGE 199 186 143 194 164 150 178 147
12 Non-MES Colonoscopy 109 105 107 113 119 115 128 122
12 Non-MES FS 65 64 61 63 98 73 71 61
12 Non-MES Total procedures 373 355 311 370 381 338 377 330
262
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16.9 Innovation form proforma
Instruction sheet for the completion of the 
ENIGMA Innovations Form
NIGMA
Please fo llow  the instructions be low  to com plete the Innovations Form.
1. Indicate which of the  innovations listed have taken place at the [NAME] 
endoscopy unit by ticking e ither the “Y es” or “N o” column.
2. Indicate the approxim ate  year when the innovation took place by ticking the 
“2000 -  2002” colum n, the “2003” colum n or the “2004 -  2005” colum n.
3. If any innovations that have taken place in your departm ent are not listed, 
p lease list these in the blank table on page 4.
4. W here relevant, p lease com plete the “C om m ents” section on page 4 quoting 
the re ference num ber of the  innovation and any additional inform ation. 
C ontinue on a separate sheet if necessary.
Notes:
Som e changes m ay be applicab le to more than one category of innovations listed. 
P lease tick as m any as apply and m ake a note in the C om m ents section.
W here changes have occurred tha t were not part of the  endoscopy un it’s 
m odernisation plans, we would still like to know  about them  if they im pacted on the 
endoscopy services. P lease include them  when com pleting the form  and m ake notes 
in the com m ents section.
If you have any queries on the com pletion of the Innovations Form, please contact 
Kym Thorne on 01792 602062.
(Cont’d ...)
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(...C on t’d)
L is t o f in n o v a tio n s
Implemented? Timeframe
Yes No “2000 -  2002” “2003” “2004 - 2005”
NEW/ADDITIONAL STAFF: .
1. Nurse endoscopists
2. GP endoscopists
3. Consultants
4. Link / escort nurses
5. Health care assistants
6. Receptionist / other clerical staff
7. New management / leadership
8. Data collection staff
ALTERATIONS OF STAFF ROLES:
9. Changing roles of medical staff
10. Changing roles of clerical staff
11. Clerical duties taken from nurses
NEW NURSE RESPONSIBILITIES:
12. Nurse led clinic(s)
13. Nurse led consent
14. Nurses performing cannulations
15. PEG nurses
16. Training nurses to be nurse 
endoscopists
NEW WORKING PRACTICES:
17. New referral procedure(s) into the unit
18. Validation of referrals
19. New guideline(s) / protocols
20. Triage of emergency patients
21. Pre-assessment clinics
22. DNA strategies
23. Cancellation strategies
24. “6-week notice period for leave” policy
25. New procedure(s) performed
26. Introducing dedicated training list(s)
(Cont’d...)
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(...Cont’d)
L is t o f in n o v a tio n s
Implemented? Timeframe
Yes No “2000 -  2002” “2003” “2004 - 2005”
INCREASING ACTIVITY:
27. Extra slots for emergency bleeds, etc
28. Scheduling extra list(s) (Mon ->  Fri)
29. Increasing the length of the working day
30. W eekend/out of hours working
WAITING LIST MANAGEMENT:■ ' ■ .
31. Validation of waiting lists
32. Pooling waiting lists
33. Waiting list initiative sessions
CHANGES IN BOOKING PATIENTS APPOINTMENTS:
34. Open access booking
35. Full booking
36. Partial booking
STRUCTURAL CHANGES TO THE UNIT:
37. New hospital / unit
38. Structural alterations to current unit
39. Increasing capacity in recovery area
40. Centralising admin in one place
41. Moving some endoscopy externally
42. Refurbishment of reception / endoscopy 
suite
ANALYSIS OF WORKING PRACTICES:
43. New / improved in-house data collection
44. Demand and capacity studies
45. Audits
46. Process mapping
47. Patient surveys
IMPROVING THE PATIENTS’ EXPERIENCE:
i
48. New information leaflets for patients
49. Improving patient privacy & dignity
50. Home bowel preps
51. Improving experience of inpatients
(Cont’d...)
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(...Cont’d)
L is t o f in n o v a tio n s
Implemented? Timeframe
Yes No “2000 -  2002” “2003” “2004 - 2005”
52. Improving experience of diabetic 
patients
53. improving experience of patients with 
other comorbidities
IMPROVING STAFF EXPERIENCE:
54. Staff training / development
55. “Protected time” for staff to meet / train
56. Surveying staff on changes wanted
57. New / improved staffroom
58. Endoscopy groups / staff meetings
59. Improving staff communication
MISCELLANEOUS CHANGES:
60. New medical equipment
61. New IT equipment / software
62. Raising the profile of endoscopy
63. Advice or help from within the Trust
64. Advice or help from external agencies
65. Open days for hospital staff / patients
OTHER INNOVATIONS NOT INCLUDED IN TF ELIST: - . .  . .
'
66 .
67.
68.
69.
70.
Comments
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